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ABSTRACT OF DISSERTATION

CORRELATING THE PHYSICOCHEMICAL PROPERTIES OF
MAGNESIUM STEARATE WITH TABLET DISSOLUTION AND LUBRICATION
Magnesium stearate (MgSt) is the most commonly used pharmaceutical excipient
and is present in over half the tablet formulations on the market. In spite of its popularity
as an effective lubricant, it has been repeatedly recognized that there is significant
variability between MgSt samples, which can cause inconsistent lubrication between
batches of MgSt. The hypothesis of this research is that the batch-to-batch variability in
tablet lubrication and dissolution observed in tablet formulations containing different
MgSt samples can be correlated with differences in MgSt physicochemical properties
(fatty acid salt composition, crystal hydrate form, particle size and surface area).
Developing correlations between MgSt properties has been challenging in part because
there has not been a reliable method for determining crystal form. Recently, 13C solidstate nuclear magnetic resonance (SSNMR) has been used to clearly identify the MgSt
crystal forms.
13
C SSNMR is used extensively throughout this work to identify the crystal forms
of samples of MgSt. Thermogravimetric analysis and dynamic scanning calorimetry
were used as complimentary techniques to understand thermal behavior of the samples.
MgSt is typically used in tablets at low levels (0.2-5%), leading to challenges with
detection of MgSt in formulations. To enhance detection in SSNMR, samples of MgSt
have been synthesized in the lab using 13C-labeled stearic acid. Specific surface area
(SSA) results were determined using N2 and Kr adsorption with BET calculations, and
samples were dried using nitrogen flow for various times. A discriminating dissolution
method was developed to differentiate between MgSt samples with varying properties.
Lubrication efficiency was performed using a Presster compaction simulator and tensile
strength determination using diametrical compression.
Synthesis studies showed that the fatty acid composition and synthesis method
affects the crystal form of MgSt produced, with higher stearic content preferring the
dihydrate form. Temperature and humidity affect the form of MgSt and facilitate
interconversion between forms. Drying MgSt was found to affect surface area results,
with the dihydrate converting to the disordered form. Dissolution of indomethacin tablets
containing various types of MgSt showed a strong dependence on particle size and
surface area, with smaller particle size and higher SSA samples having slower dissolution
rates. Fatty acid composition and hydrate form were investigated as secondary variables

influencing dissolution, with fatty acid showing no correlation with dissolution.
Lubrication efficiency and tabletability studies showed an effect of crystal form, with
monohydrate and dihydrate forms showing good lubrication efficiency compared to the
disordered form, but also poorer tabletability.
In conclusion, the potential for variability in the crystal form of MgSt was found
to be an important property of MgSt. There is variability in the form produced from
synthesis, as well as interconversion between forms. Temperature, humidity and drying
conditions are particularly important in controlling the crystal form of MgSt, as this can
impact formulation stability and storage conditions. The primary variable affecting
dissolution is particle size and surface area, but crystal form is a potential secondary
variable. The physicochemical properties of MgSt, particularly crystal form and surface
area, showed trends with lubrication and dissolution. This highlights the importance of
choosing a MgSt material with the desired crystal form and surface area properties to
match the lubrication and dissolution requirements for the formulation.
KEYWORDS: Magnesium stearate, solid-state NMR, crystal form, surface area,
dissolution, lubrication
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CHAPTER 1.  
INTRODUCTION TO MAGNESIUM STEARATE
VARIABILITY
1.1   Previous Investigations into the Variability of Magnesium Stearate (MgSt)

Magnesium stearate (MgSt) is the most commonly pharmaceutical excipient in
solid oral dosage forms and is used as a lubricant in over half of the tablet formulations
on the market.(1) Tablet prescriptions include a paper insert listing the active
pharmaceutical ingredient (i.e. the drug), along with dosing information and a list of the
inactive ingredients (known as excipients) used in the tablet formulation. Tablets are
often the preferred dosage form, as they are convenient to administer, have fewer
physical and chemical stability problems and can be manufactured in large quantities.
Still, the manufacturing process involves many steps to produce a tablet with the desired
characteristics. To make a tablet, the excipients are mixed together with the drug, making
a blend. Typically, MgSt is added as the last excipient at a level of only 0.5 – 2% to the
powder blend prior to compaction with a tablet press. After the formulation powder is
compacted, the tablet must be removed (or ejected) from the tablet die. Lubricants, such
as MgSt, aid in the tablet ejection during the manufacturing process by reducing the
friction between the compacted tablet and the tablet press die. Without proper lubrication,
part of the tablet can adhere to the tablet die and punch faces of the tablet press, in what
has been called “picking and sticking.” If the formulation is over-lubricated, such as by
mixing too long or adding too much MgSt, the tablet will not dissolve in the proper
amount of time. MgSt is a very effective powder lubricant and has been used in
pharmaceutical formulations for decades.(2)
In spite of its popularity as an effective lubricant, it has been repeatedly
recognized that there is significant variability between MgSt samples which can cause
inconsistent lubrication between lots and batches of MgSt. Figure 1-1 is an illustration of
the balance between lubrication efficiency and dissolution which is necessary for good
tablet manufacturing. Typically, this balance is achieved by pharmaceutical formulators
by adjusting the mixing time in a trial-and-error process. Ideally, the mixing time would

1

be near the middle line, with high lubrication and minimal effect on dissolution. This
process of adjusting the mixing time is acceptable as long as every MgSt sample behaves
the same. However, many formulators have experienced lot-to-lot variability in the
functional performance of different MgSt samples. For example, a new lot of MgSt
mixed for the same amount of time may be under-lubricated, such that the line will shift
to left, while another lot of MgSt may be over-lubricated, such that the line will shift to
the right side of the figure. Either situation of under-lubrication or over-lubrication can
yield unacceptable tablets, causing loss of time and money due to discarding the
unacceptable tablet lots. In order to highlight the variability of MgSt impacting tablet
lubrication, the current knowledge about magnesium stearate is reviewed in this chapter.
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*

Mixing Time

Figure 1-1. Impact of Lubrication – Dissolution as a function of mixing time. An ideal
MgSt has high impact on lubrication and low impact on dissolution, as indicated by the
asterisks in the green areas and the vertical line.
Magnesium stearate has been used in pharmaceutical formulations for decades.
One of the early indications of MgSt variability came in 1970, when Hanssen et al. noted
that different grades of MgSt affected compression properties (3) Soon after, Butcher et
al. focused on how differences in packing and sieving affect lubrication (1972).(4) Then
in 1984, Hoelzer published on “batch to batch variations of commercial magnesium
stearate” focusing on surface area variations,(5) and Dansereau discussed how the
variability in physicochemical properties of MgSt affects tablet lubrication, specifically
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noting that excipients such as microcrystalline cellulose had decreased tablet tensile
strength with increasing MgSt surface area.(6, 7) A little later in 1996, Barra and Somma
investigated the physicochemical variability of MgSt with thirteen commercial samples
and showed a range of results with minimal correlation.(8) Researchers from
Mallinckrodt, a prominent supplier of magnesium stearate, have extensively studied and
presented on the properties of MgSt and their effects on tablet lubrication, with a focus to
describing the specific materials they manufacture with minimal lot-to-lot variability.
Their conclusion is that the dihydrate form is a better lubricant than the more popular
monohydrate form. (9) More recently, Kushner et al. have used quality by design (QbD)
experiments to study excipient variation(10) and Haware et al. have used multivariate
analysis (MVA) methods to identify significant variables affecting the lubricating
properties of commercial MgSt.(11, 12) Most recently, Wang, Potts and Hoag also used
principal component analysis (PCA) to investigate the variability of MgSt using
analytical techniques such as near-IR spectroscopy, Raman spectroscopy and scanning
electron microscopy (SEM).(13, 14) It is clear that the variability of MgSt still warrants
significant study.
The hypothesis of this research is that the observed variability in lubrication
efficiency and dissolution rate between batches of MgSt can be correlated with the
physicochemical properties of MgSt samples, specifically fatty acid composition, crystal
form, particle size and surface area. Several researchers (including reviews by Moody et
al.,(2) Wang et al.,(15) Li et al.(16) and Kahner et al.(17) have identified chemical
composition, particle size/surface area and crystal form as possible important variables
impacting MgSt function,(7, 8) so these properties will serve as the starting point for the
current investigation. The remainder of this chapter will focus on a review of the most
prominent physicochemical properties of magnesium stearate (chemical composition,
crystal form, particle size and surface area), followed by a discussion of how processing
effects MgSt (focusing on mixing and disproportionation) and finally the effects of MgSt
properties on function, in terms of lubrication and dissolution.
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1.2   MgSt Physicochemical Properties
1.2.1   Fatty Acid Composition and Synthesis of MgSt

A wide range of chemical composition is allowed for magnesium stearate
samples. The US Pharmacopeia is “a scientific, nonprofit organization that sets public
standards for the identity, strength, quality and purity of medicines” and excipients.(18)
The first US pharmacopeia was issued in 1820, with specific standards called
monographs for a variety of drugs. Additionally, compounding standards are found in the
USP and National Formulary (USP-NF) which includes monographs for many excipients,
including magnesium stearate. The USP-NF monograph for MgSt allows for “variable
proportions of magnesium stearate and magnesium palmitate”(19). To meet USP
standards, the MgSt sample must be derived from at least 40% stearic acid, and at least
90% of the sample must come from a combination of stearic and palmitic acids. The
remaining 10% of the sample may be derived from other fatty acids, such as myristic,
pentadecanoic, margaric, arachidic and behenic acids. This leads to a Mg metal content
between 4-5%, depending on the chain lengths of the fatty acids and their ratios. The
content of stearic and palmitic acids in a MgSt sample can be determined using a boron
trifluoride-methanol extraction method to convert the stearate and palmitate to their
methyl esters and separate and identify them using GC-MS. (19-22) Although
commercial MgSt samples have a range of chemical compositions, and USP has set broad
guidelines for chemical composition requirements, several researchers have suggested
that within these guidelines the fatty acid composition does not seem to affect lubrication.
Interestingly, Rajala et al. found that two lots with similar chemical composition behaved
very differently, possibly due to their hydration state differences.(23)
The synthesis preparation of MgSt has been described in the literature using two
basic reaction methods. Equation 1-1 is the most basic reaction for MgSt synthesis, and
was noted in Kahner’s 2017 review as one of two methods to make MgSt.(17) The
second reaction, shown in Equation 1-2, is a two-step reaction published by Miller and
York in 1985, Ertel et al. 1987 and Rajala et al. in 1995. (23-25)
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2 H-St + Mg(OH)2 à Mg-St2 + 2 H-OH
2 H-St + 2 NaOH à 2 Na-St + MgCl2 à Mg-St2 + 2 NaCl

Equation 1-1
Equation 1-2

Parts of the reaction shown in Equation 1-2 has subsequently been patented by
Mallinckrodt for manufacturing use with high ratios of stearate to prepare the dihydrate
form of MgSt with a plate morphology. (26, 27) It is noted that other alternative salts may
be substituted for NaOH and MgCl2 in Equation 1-2. In particular, Wu at Mallinckrodt
has also presented the same synthesis reaction substituting MgSO4*7H2O for the
MgCl2.(28) As Mallinckrodt recognized, the most important effect of chemical
composition appears to be its effect on the hydrate form produced during synthesis.(29)
Marwaha and Rubenstein suggested that the alignment of fatty acid chains in a crystal is
governed by the chain length in the crystal packing structure, which would affect the
shearing potential of MgSt.(30)
Fatty acid composition has not yet been systematically investigated in relationship
to dissolution and lubrication. To facilitate that study, the relationships between fatty acid
composition and crystal form needs to be addressed. Also, the differences between the
two synthesis methods for MgSt have not been defined in terms of their effects on the
properties of MgSt produced. Chapter 4 addresses some of these questions around
relationships between fatty acid composition and crystal form, in the context of MgSt
synthesis. Of particular interest is the forms produced by the two known reaction
methods, using varying fatty acid ratios.
1.2.2   Hydration State, Crystal Forms and Pseudopolymorphism

Magnesium stearate is currently known to exist in multiple pseudopolymorphic
forms, but it has taken a few decades to reach this point. Back in 1977, Mueller et al.
noticed that the amount of water in a MgSt sample was related to its lubrication
properties, and that thermal drying can change its polymorphic properties. They
suggested that drying changes the crystal structure from an orthorhombic or monoclinic
crystal structure to hexagonal structure.(31) A few years later, Miller and York began
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their investigation into physical characterization of MgSt powders by preparing and
characterizing pure magnesium stearate and magnesium palmitate samples, without
mixing fatty acids. They identified that both pure samples were associated with two
molecules of water, and suggested that synthesis conditions such as pH played a role in
hydration state.(25) Ertel and Carstensen also studied the physical properties of pure
MgSt throughout the 1980s.(24, 32, 33) They determined that preparation conditions
affect the hydration state and modifying the relative humidity (RH) can convert to a
different hydration state. For example, heating at 105 °C led to water loss as well as
crystal lattice collapse. In addition, they noted the importance of the long spacing of the
crystal lattice structure, which is dependent on the hydration state.(18) Wada specifically
looked at MgSt pseudopolymorphism and hydration using differential scanning
calorimetry (DSC),(34) but it was not until 1997 that Sharpe et al. appears to be the first
to identify the pseudopolymorphs as anhydrate, dihydrate and trihydrate (but without
mention of a monohydrate form).(35) They proposed structures for the dihydrate and
trihydrate phases based on the long crystal spacing from x-ray powder diffraction
(XRPD) and deduce that the pseudopolymorphism is a result of “changes in the angle of
inclination of the hydrocarbon chains relative to the plane of the Mg atom head groups,
brought about by the water content in the lattice.”(35) Bracconi et al. performed a
thorough XRPD investigation of two commercial lots without single crystals in an
attempt to fully elucidate the crystal structure.(36) Their subsequent differential scanning
calorimetry (DSC) evaluation of the same two lots did not “fully clarify the relation
between thermal and structural properties.”(37) Although the single crystal structures of
MgSt forms are still elusive, Delaney et al. showed that SSNMR can uniquely and
reliably identify the different crystalline forms of MgSt. Five forms were identified as
anhydrous, ordered monohydrate, dihydrate and trihydrate forms and an additional
disordered monohydrate.(38) In terms of form conversions, Swaminathan and Kildsig
published a schematic in 2001 showing conversions between the different hydrate
forms,(39) which was updated to include the monohydrate form in a presentation by Wu
et al. along with extensive evaluation of MgSt dihydrate properties from a commercial
manufacturer’s point of view.(28)
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The ability to identify MgSt crystalline forms using 13C SSNMR (Delaney et al.)
is critical, as it not only allows for identification of the existing hydrate variability, but
also provides a foundation for studying hydrate form interconversions, as well as the
observation of MgSt forms in tablet formulations before and after processing.(38)
Chapter 3 presents characterization data for MgSt, emphasizing the power of SSNMR to
distinguish between crystal forms of MgSt and laying a foundation for the remainder of
this research. Additionally, Chapters 5 and 6 take another step in furthering the
understanding MgSt form conversions.
1.2.3   Particle Size and Surface Area

In addition to chemical composition variability and pseudopolymorphism
variability, the particle size and surface area of MgSt have been investigated for their
impact on MgSt performance variability.
In 1984, Frattini and Simioni reported a correlation between MgSt surface area
and tablet ejection force. (40) Hoelzer also published on “batch to batch variations of
commercial magnesium stearate” focusing on surface area variations.(5) Phadke et al.
suggested that particle size analysis would be a potential way to evaluate batch-to-batch
variation in MgSt, and also studied the degassing effects on MgSt, associated with
surface area analysis, hypothesizing that lower surface area after degassing could be due
to hydrate form conversion.(41, 42) In 1996, Barra and Somma tested 13 commercial
samples which showed a range of results with minimal correlation, although chemical
composition, particle size/ surface area and crystal form were all believed to be
significant contributing variables affecting MgSt function.(8) A study of MgSt surface
area by Andres et al. in 2001 recognized the need for an improved understanding of MgSt
isotherm mechanisms and degassing effects,(43) followed by Koivisto et al. who noted in
2004 that although all hydrate forms converted to anhydrous at 105 °C, the hydrate
surface area isotherms did not properly fit with BET theory, the standard method of
surface area analysis. (44) Extensive investigation of the degassing of MgSt has recently
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been undertaken by Lapham and Lapham, revealing dehydration and unreliable surface
area results with degassing as low as 40 °C.(45, 46)
In the Lapham 2019 paper, the surface area and isotherms of four commercial
samples were analyzed before and after degassing at temperatures ranging from 30 – 110
°C. The hydration state of the starting materials was determined from thermogravimetric
analysis (TGA) weight loss and vacuum drying, with assumptions of anhydrous and
hydrated forms based on weight loss temperatures. Looking closely at isotherms and low
pressure hysteresis, the differences in adsorption/desorption isotherms for the samples
were found to be related to the hydrated water in the starting form for each batch and a
swelling effect causing adsorbate to be entrapped in the sample during the adsorption
process.(45-47) The Lapham work stops short of relating the dehydration changes to
MgSt crystal forms. This next step in understanding the dehydration of MgSt required a
technique which can readily identify the crystal forms of MgSt. 13C SSNMR enables this
type of study and the form changes of MgSt with dehydration were clearly identified in
Chapter 6.

1.3   Effects of Processing on MgSt
1.3.1   Mixing

In addition to the physicochemical properties of MgSt, processing conditions
affect MgSt functional properties. The most important aspect of processing for MgSt is
formulation mixing time. It is well-known that short mixing times for MgSt result in poor
distribution of MgSt, but Ragnarsson et al. showed that this did not hurt lubrication
efficiency in 1979.(49) However, longer mixing times with MgSt did affect tablet
strength.(49) In 1993, Ong et al. compared surfactants mixed with MgSt in formulation
blends and showed drug-excipient interactions taking place with extended mixing.(50)
Chaudhuri discussed cohesion and mixture homogeneity with a description of the mixing
model, finding that for free-flowing mixtures, higher mixing speed enhances mixing.(51)
Virtanen showed that tablet crushing strength decreased with mixing time, and scale-up
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conditions led to a greater decrease in tablet strength.(52) Then in 2010, Perrault et al.
used gamma ray detection to investigate the blending mechanisms of mixing performance
of MgSt and sodium laurel sulfate with a V-blender. The results indicated that shear
mixing (blender rotational speed and fill volume) was more important than dispersive or
convective mechanisms of blending.(53) Kushner followed with a mixing model for
Turbula blenders using 1% MgSt.(54) Jojart analyzed the optimal mixing time and
Turbula speed using energy dispersive x-ray fluorescence analysis.(55) Nakamura et al.
determined ideal mixing time and MgSt amount based on the relationships between
Carr’s flowability index and practical angle of internal friction with tablet properties. It
was found that powder flowability correlated with mixing time and tablet properties (but
not with MgSt concentration).(56) A 2018 study by Horibe et al. used three different
scales of V-type blenders to study mixing and lubrication with MgSt. Mixing time
efficiency was determined to be related to the travel distance of the particles in the
different blenders.(57)
In all of these studies, ranging from effects of colloidal silica and surfactants,
mixing models, gamma ray detection of MgSt in tablets and flowability index, it was
assumed that all MgSt lots will behave the same way. However, the previous three
sections have shown significant variability in MgSt sample properties that can affect
performance. A discussion of the effects of hydrate form on mixing would be a good
addition to this discussion of the effects of processing on MgSt.
1.3.2   Chemical Reactions and Disproportionation

Another aspect of processing involves the effect of water to mediate chemical
reactions between MgSt and the salt of an API, such as with disproportionation reactions.
A disproportionation reaction is where a salt converts back to the free form, particularly
for systems where the slurry pH of formulation needs to be greater than pHmax of the salt
of a weak base.(58, 59) In 2009, Guerrieri and Taylor introduced disproportionation of
salts in the solid state as an important topic in pharmaceutical science, identifying
solubility and pHmax as important parameters for understanding disproportionation.(60)
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Stephenson et al focused their efforts on understanding the importance of pHmax, pH
microenvironment and Gibb’s free energy, trying to determine what pH is too low to
develop a salt. They concluded that active pharmaceutical ingredients (APIs) with low
intrinsic solubility and low pKa are likely to disproportionate and John et al. noted that
carboxylate groups with pKa above the pHmax of the salt are likely to disproportionate.
(61) Hygroscopicity, alkalinity and stearate particle size were also found to impact the
extent of disproportionation, as well as deliquescence of reaction products such as
MgCl2.(62-64)
With the basic theory of disproportionation established, the research turned to
elucidating which materials promoted and hindered disproportionation. John et al.
investigated several excipients for disproportionation likelihood. Formulations containing
MgSt had a high water uptake above 31% RH and MgSt was the most likely to cause
disproportionation because the disproportionation reaction yields the deliquescent MgCl2
as a reaction product.(65) Merritt et al. performed quality by design (QbD) modeling for
thirteen drugs in four formulations with XRPD and SSNMR analysis(66) while Wray et
al. and Ewing et al. used NIR imaging and Raman mapping to study disproportionation
during dissolution.(67, 68) Nie et al. studied the impact of polymers on
disproportionation and investigated ways to stop or reduce disproportionation of
Pioglitazone HCl (pHmax 2.8). In addition to using acidic pH modifiers such as maleic
acid, crystalline solid dispersion with HPMC-AS was found to slow disproportionation of
PIO HCl.(69) Further study by this group investigated the disproportionation of metallic
stearates including MgSt, calcium stearate (CaSt) and sodium stearate (NaSt).(64) MgSt,
CaSt and NaSt are stearate soaps with different counter ions, with NaSt being the most
commonly used soap. It was suggested that sodium stearate (NaSt) may be an adequate
lubricant to replace MgSt when disproportionation is a concern. Thakral studied the role
of solubility and developed a flow chart to describe when to expect disproportionation
based on the system conditions,(70) followed by a review of disproportionation from a
material science perspective.(71) Koranne et al. investigated PIO-HCl mixtures with
various excipients using synchrotron x-ray diffractometry to study disproportionation in
tablets. It was found that MgSt showed greatest disproportionation followed by
croscarmellose sodium. The reaction was mediated by water, initiated at the surface of
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the tablets, and there was correlation between microenvironment pH acidity and
disproportionation extent.(72) Patel et al. studied disproportionation using surface
topography analysis and suggest that salt crystal structure plays a role in a drug’s
propensity to disproportionate.(73) Hirsh et al. are recently using 35Cl SSNMR to
quantify the disproportionation of Pioglitazone HCl in reaction with MgSt.(74)
The tendency to disproportionate is important to consider when formulating with
MgSt and basic salts in the lower pKa range. However, there have been no studies so far
investigating the effect of MgSt hydrate forms or other physicochemical properties on the
extent of disproportionation. Additionally, SSNMR might easily be used to follow
disproportionation reactions. It is also interesting to note that much of the
disproportionation investigation comes out of industry, with Merck, Eli Lilly, BMS,
Amgen and Pfizer all represented.

1.4   Effects of MgSt on Functional Properties
1.4.1   Effects of MgSt on Lubrication

Lubrication is the primary function of MgSt in pharmaceutical formulations. That
is, a lubricant reduces friction by forming a film between two surfaces and is easily
sheared.(2) MgSt has been used as a lubricant for many years and was recognized to
reduce ejection force in 1979.(49) A review of lubrication was done by Moody et al. in
1981,(2) defining MgSt as a low shear strength laminar solid that adheres to the
lubricated surface with the polar head, with the long hydrophobic fatty acid chains toward
the opposing surfaces. MgSt is considered to be an effective lubricant due to its high
melting point and good shear properties, as well as being able to reduce static charges in
the formulation powder.(75) Shear strength has been measured using punch
penetration,(76) but shear strength evaluations have not found correlations with
lubricity.(77) One mechanism of action says that the lubricating film for MgSt is thought
to be only one or two molecules thick.(2) It has also been shown by SEM that in granule
lubrication, MgSt can fill the particle cavities and spaces between the lubricated
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surfaces.(78) Johannson et al had previously showed that granular MgSt had better tablet
properties than powdered MgSt when used at 2-5%. At low concentrations, powdered
MgSt works better to prevent adhesion to punch faces.(79)
In 1988, Vromans et al. reported that MgSt did not always lubricate the same
way. This was attributed to differences in particle size and surface area, flowability and
mixing process.(80) Mixing time has often been implicated in MgSt lubrication
performance.(81, 82) Many other studies have investigated the effects of different MgSt
lots on lubrication properties. Marwaha et al. studied various % of St:Pa related to
compression and ejection properties,(30) Ertel and Carstensen correlated MgSt fatty acid
composition, moisture content and surface area with lubricant properties for three
monohydrate commercial samples and three pure MgSt anhydrous, dihydrate and
trihydrate samples.(33) Hussain looked at dissolution using different grades of MgSt.(83)
Leinonen et al. noted that it was hard to make correlations because for most samples, too
many properties varied at the same time, but they did find a correlation with particle
size/surface area and lubricity.(84) Particle size and crystalline structure were found to
impact the lubrication properties of MgSt in the thirteen commercial batches studied by
Barra and Somma.(8) Six commercial samples and their physical properties were tested
for lubrication efficiency using a texture analyzer in a study by Rao et al. again finding
that particle size/surface area and crystal form impact lubrication.(85) Okoye, Hamad,
Wu and Lugge also showed lubrication effects varied with hydrate form.(9, 86-88) A
recent review by Kahner discusses the impact of hydration states on MgSt lubrication and
demonstrates that more work is needed to understand the properties of the different forms
and their effects on tablet performance.(17)
None of these studies was designed to isolate and control the range of
physicochemical properties of a variety of MgSt samples. In order to further the
understanding of MgSt properties on lubrication, the crystal form needs to be
deconvoluted from the other properties. Chapter 9 begins to address this by looking at the
effect of crystal form on lubrication properties.
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1.4.2   Effects of MgSt on Dissolution

Dissolution is an important functional property for pharmaceutical formulations.
It is known since before 1963 that MgSt causes slowed dissolution of API
formulations(89) and that formulation mixing time and compression force, as well as the
amount of MgSt in the formulations affect the dissolution rate.(90, 91) The mechanism of
MgSt lubrication was investigated and the effect of MgSt on mixing time and
compression force has been attributed to lamination and adhesion of MgSt to the other
particles in the formulation, along with the flaking of MgSt causing an increase in surface
area.(90, 92) Hussain et al. suggested that the extent of surface coverage of the
hydrophobic film on the particles is the most important factor in affecting
dissolution.(83) Patra et al. studied the effect of MgSt concentration and granule size on
the dissolution rate of ciprofloxacin HCl and found that a hydrophobic lubricant like
MgSt decreases the drug-solvent interface, causing slower dissolution due to decreased
wettability and increased dissolution rate with smaller granules.(93) Possible interactions
with MgSt have been explored for their effects on dissolution, including the addition of
colloidal silica by Johansson et al.,(94) the interactions of surfactants with MgSt during
mixing,(50) and the interaction of MgSt with HPMC-AS in ASDs and hydrogen bonding
with itraconazole ASDs.(95, 96) The effects of acidic media was also investigated by
Ariyasu et al. and indicates conversion of MgSt to stearic acid during dissolution.(97, 98)
Additionally, other lubricants were explored as alternatives to MgSt, including calcium
stearate,(98) glycerin fatty acid esters,(99, 100) Stear-o-Wet,(101) talc.(102) Hussain,
York and Timmins compared the dissolution of paracetamol tablets with different grades
of MgSt. No relationship between physical properties such as surface area and dissolution
was found at the conditions used in their study.(83) In 2013, Okoye et al. observed
differences in dissolution between naproxen and acetaminophen when comparing MgSt
dihydrate, monohydrate and anhydrate forms.(87)
In general, it is known that MgSt particle size and surface area can affect
dissolution of tablet formulations. However, the relationship of surface area with
dissolution is not well-defined, possibly due to other factors also contributing to the
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behavior of formulations containing MgSt. A definitive study of the influence of MgSt
crystal forms on dissolution has not yet been published.

1.5   Conclusions and Next Steps

In conclusion, there has been significant research on many aspects of MgSt.
However, there remains a lot to do. One of the primary knowledge gaps seen throughout
the literature is a difficulty identifying crystal form. Without a technique to clearly
identify the crystal forms, it is difficult to deconvolute the effects of form from the other
physical properties, or to understand the relationships of the physical properties of MgSt
with each other. It has also been challenging to monitor the forms of MgSt in a
formulation, since MgSt is added to the formulation in a low amount. 13C SSNMR
addresses both of these issues by allowing straight-forward identification of MgSt crystal
forms, paving the way for the study of MgSt forms in pharmaceutical formulations.
The theme of the present research is understanding the variability between
different MgSt materials, as it relates to tablet function, with a focus on crystal forms.
Investigations of the impact of MgSt physicochemical properties (chemical composition,
hydrate crystal forms, particle size and surface area) on the functional properties of
tablets in terms of dissolution and lubrication will be the subject of the following
chapters.
Chapter 2 is a discussion of solid-state NMR (SSNMR) theory and methods
employed during this research. Chapter 3 is an adaptation of a paper focusing on the
characterization of MgSt. In this paper by Delaney et al., SSNMR is shown to clearly
identify five different forms of MgSt, paving the way for easier study of MgSt hydration
states and crystalline forms. Chapter 4 discusses the synthesis of MgSt, showing the
trends in crystal form produced with differences in fatty acid composition and synthesis
method conditions. Chapter 5 discusses form conversions between the different MgSt
crystal forms and the conditions required to affect the form conversions, specifically the
effects of temperature, relative humidity and rehydration. Chapter 6 takes a further step to
understand the MgSt form conversions that may result from drying and dehydration, for
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surface area analysis. Chapter 7 describes the method development process for a
discriminating dissolution method for MgSt in tablet formulations, followed by Chapter 8
with an investigation into the effects of physicochemical properties (chemical
composition, crystal forms, particle size and surface area) on dissolution of indomethacin
tablet formulations. Chapter 9 is an investigation of the effects of MgSt hydrate form on
the lubrication properties of ejection force, tensile strength, compactibility and
compressibility. Chapter 10 has conclusions and next steps, followed by Appendices
including tables of MgSt samples and their properties.
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CHAPTER 2.  
BACKGROUND ON SOLID-STATE NMR
SPECTROSCOPY

SSNMR is one of the primary analysis techniques used in this work. For
magnesium stearate (MgSt), 13C SSNMR gives the clearest and most straight-forward
distinction between crystal forms, compared to the other analytical techniques used to
probe crystallinity. Using SSNMR to evaluate the crystal forms of MgSt, it was possible
to separate and study the complicated and often convoluted properties of MgSt. Without
SSNMR it has previously been impossible to accurately characterize the form of MgSt in
tablets. Using 13C labeled stearate and palmitate, MgSt and Mg palmitate were
synthesized to enhance the 13C level in the samples, enhancing the sensitivity by
increasing the population of 13C in the samples. Using this technique, tablets containing
MgSt at a level of 1% in the formulation can be easily detected by SSNMR. This enabled
the analysis of MgSt crystal form changes in tablets before and after processing. Another
SSNMR experiment used in this research was 1H T1 relaxation values, which were found
to show important correlations with fatty acid composition, water content and other
properties of MgSt, as well as useful information relating to structural order. Overall,
SSNMR proved to be a critical part of this research work with MgSt. However, since it is
a technique that is much less widely understood compared to the other analytical
techniques, such as diffraction scanning calorimetry (DSC), gas chromatography (GC),
etc., it is important to describe the essential components of solid-state NMR as it relates
to MgSt characterization.
This chapter will give an introduction to the basic theory of NMR, as well as basic
SSNMR concepts as it applies to pharmaceutical industry, with special attention to
techniques which are used in this dissertation research. For a more comprehensive study
of SSNMR theory, the reader is directed to other sources.(103-106)

2.1   Basic NMR Theory
2.1.1   Nuclear Magnetic Resonance

Nuclear magnetic resonance is a technique that measures how nuclei in a
magnetic field respond to an electronic pulse resonating at the same frequency.
Specifically, nuclear magnetic dipole moments interact with the external magnetic field,
providing chemical information on the sample. Nuclei contain protons and neutrons
surrounded by electrons. In a strong magnetic field, B0, the nuclei are moving charges,
which creates a nuclear magnetic dipole moment, µ. All nuclei have a spin quantum
number, I, which are quantized and can be 0, 1 or multiples of ½ (I = ½, 1, 3/2, 2, 5/2,
etc.). There are 2I +1 possible spin states for a nucleus. Nuclei with spin quantum
numbers greater than 0 possess nuclear spin angular momentum, P, and are considered
NMR active. In this dissertation, only 1H and 13C will be discussed, which are both spin
½ nuclei.
The spin angular momentum, P, is proportional to the spin quantum number, I,
and the nuclear magnetic dipole moment, µ, according to Equation 2-1.
µ = g P = g I !

Equation 2-1

where h is Planck’s constant and g is the gyromagnetic ratio, specific to each type
of nucleus. This means that nuclei having angular momentum with nuclear spin are like
tiny bar magnets, precessing about the applied magnetic field at a frequency
corresponding to the angular momentum of the nuclear spin. The rate of precession is
called the Larmor frequency and is proportional to the external magnetic field, B0, and
the gyromagnetic ratio, g. The gyromagnetic ratio is an indication of the magnitude of the
interaction between nuclei, according to Equation 2-1:

P = B0 g

Equation 2-2
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For a 1H nucleus in a 7.05 T magnetic field, the Larmor frequency will be 300 MHz,
while a 13C nucleus in the same magnetic field will precess at 75 MHz.
In an external magnetic field, the spin states of spin ½ nuclei split into m = + ½
and m = – ½, and their magnetic moments are aligned with and against the magnetic
field. The spins that are aligned with the magnetic field have lower energy and the spins
aligned against B0 have higher energy.
m =#+#½#

m =#& ½#

B0

Figure 2-1. Model of precessing nuclear spins in a magnetic field, B0, for a spin ½ nuclei
with m = + ½ and m = - ½.
There is a slight population difference between lower energy and higher energy states,
which is governed by the Boltzmann distribution (see Figure 2-2):
DN0 = NeDE/kT

Equation 2-3

where N is the number of nuclei present, DE is the energy between the two spin states, k
is the Boltzmann constant and T is temperature. The slight excess of spins in the lower
energy state allows for nuclear magnetic resonance to occur when a nucleus can change
its spin state by absorbing energy equal to:
DE = hn = g ! B0

Equation 2-4

where n is the resonance frequency, or Larmor frequency. Applying a pulse at the
resonance frequency, n, excites the spins to absorb energy. The energy is also related to g
and B0. A stronger external magnetic field, B0, increases the population difference of
nuclei in the two spins states and increases the sensitivity of the NMR signal. The
population difference between NMR states is very small, on the order of 10-6 compared

18

with other spectroscopic techniques such as IR with population difference on the order of
108. As a result, NMR is a relatively insensitive technique requiring high magnetic fields
as a primary way to enhance sensitivity.

B0 = 0

B0 >"0
m"="( ½"

I"="½"
!E"="" h"B0
m ="+"½"

Increasing external magnetic field,"B0
Figure 2-2. Diagram illustrating the splitting of nuclear spin states in a magnetic field.
There will be a slight population difference between the states, according to the
Boltzmann distribution of spins.
In an NMR experiment, a sample is placed inside a coil in a static external
magnetic field. A radiofrequency pulse at the Larmor frequency is applied to the coil,
perturbing the precessing spins and creating an alternating current in the coil surrounding
the sample. The 90 ° radiofrequency pulse is applied at the resonance frequency and
interacts with the nuclear spins, pushing the nuclear spin from rotating around the z-axis
to rotate around the x-axis. This excites the nuclei to absorb energy, DE, and a signal is
recorded as the sample returns to equilibrium. The resonating signal rings out with all the
frequencies in the sample. The decaying resonance signal is collected as a free induction
decay (FID) in the time domain, which is then amplified and processed through Fourier
transform into an NMR spectrum in the frequency domain.(107, 108)
NMR is an inherently quantitative technique with the signal, S and magnetization,
M0, directly proportional to the number of nuclei in the sample, N:
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S ~ M0 = N(g !)2 B0 /4kT

Equation 2-5

where N is the number of nuclei in the sample, k is the Boltzmann constant and T is
temperature.
The relative amounts of two ingredients in a sample can be determined by
comparing the ratios of the peak signals. Equation 2-5 illustrates that sensitivity is
enhanced with higher external magnetic field and lower temperatures. The
proportionality to N means that using isotopically-labeled material can have a significant
effect on sensitivity. Throughout this dissertation, 13C labeled magnesium stearate is used
to enhance the sensitivity of the carbonyl peak of MgSt when it is used low levels in
tablets. Additionally, signal-to-noise is proportional to the square of the number of scans,
so increasing the signal by a factor of two requires four times the number of scans.
2.1.2   Chemical Shift

The most common use of NMR is to determine the chemical structure of a
molecule based on the resonance frequency of the nuclei. The resonance frequency is
usually plotted as the difference from a reference standard in parts per million (ppm). The
chemical shift was first observed by Arnold et al. in the 1950s when distinct 1H
resonances were observed for ethanol, following the discovery of nuclear magnetic
shielding(109). Nuclear magnetic shielding refers to the effect of electrons moving
around the nucleus. When the negatively charged electrons circulate around the nucleus,
a magnetic field is induced which changes the local magnetic field of the nucleus. The
same type of nuclei experiencing a slightly different electronic environment can have
different resonance frequencies, since magnetic field around the nucleus is affected by
both the external magnetic field, B0, and the local magnetic field from the orbiting
electrons around each individual nucleus. The local magnetic field lowers the total
magnetic field experienced by the nucleus, lowering their Larmor frequencies, and this
effect is called shielding. Small differences in local magnetic field between different
nuclei in a molecule result in slightly different magnetic shielding, referred to as chemical
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shift. Differences in electronegativity of different functional groups in a molecule affect
the magnetic shielding and determine the chemical shift. In this way, the chemical shifts
of peaks in the NMR spectrum are dependent on the electronic environments of the nuclei
in the sample. The electronic environment can be affected by the electronegativity of the
attached atoms/functional groups, the molecular conformation of the molecule (or crystal
packing in solids), and the ionization state of the molecule and interactions between
molecules (such as hydrogen bonding). As noted before, chemical shifts are the peak
positions of the nuclei in the sample, reported in parts per million (ppm) with respect to a
reference peak. The frequency of the nuclei in Hz with respect to the external magnetic
field in MHz gives the value in ppm. 13C chemical shifts typically range from 0 – 200
ppm, while 1H chemical shifts typically range from 0 – 10 ppm.
Lower ppm chemical shift values in the NMR spectrum indicate stronger
shielding, so methyl and aliphatic carbons have lower chemical shifts. In a 13C NMR
spectrum, aliphatic carbons generally have a chemical shift of 10 – 40 ppm, alcohols are
50 – 70 ppm and aromatics are typically found in the range 110-150 ppm. Carboxyl and
carbonyl carbons experience greater deshielding due to the electronegativity of the
attached oxygen atoms and are usually in the 160 – 200 ppm chemical shift range.

2.2   Solid-State NMR Spectroscopy

Solid-state nuclear magnetic resonance (SSNMR) spectroscopy is an important
analytical tool in pharmaceutical science. It is non-destructive, selective and quantitative
and can be used to aid understanding of the structure and molecular dynamics of a solid
material, particularly as it relates to identifying polymorphic forms. Solid-state NMR is
unique in being able to provide information on structure (chemical identification), order
(crystalline form) and dynamics (through relaxation properties). However, there are a few
important differences between solution and solid-state NMR.(110)
The chemical shift is orientation dependent, causing an important difference
between solution NMR and solid-state NMR. In solution, molecules are able to move
freely, resulting in sharp peaks with high resolution. In contrast, solids are rigid with
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fixed orientation with respect to the magnetic field, leading to chemical shift anisotropy
(CSA). CSA means that there is a distribution of chemical shifts, resulting in broad peaks
and poor resolution in the solid state.
Several techniques are commonly used in solid-state NMR to alleviate the effects
of CSA and line broadening, which will be discussed here: magic angle spinning (MAS),
high powered dipolar decoupling (DD), cross polarization (CP) and total spinning
sideband suppression (TOSS).
2.2.1   Magic Angle Spinning (MAS) and Total Sideband Suppression (TOSS)

One of the causes of CSA in the solid state is the rigid structure of solid materials
that do not move freely in space compared to molecules in solution. The observed
chemical shift is described by Equation 2-6:
sobs = siso + saniso (3 cos2 q -1)

Equation 2-6

where sobs is the observed chemical shift, siso is the isotropic component of the chemical
shift and saniso is the anisotropic component of the chemical shift. Magic angle spinning
is a technique where the sample is placed in the magnetic field at an angle of 54.7°. The
magnetic pole of the proton nucleus sits at an angle of 54.7°.(110, 111) The nucleus
cannot line up straight with the B0 field and instead precesses around the B0 axis. When
the sample is spun at this angle, it spends equal amounts of time oriented at the x, y and z
axes and most of the anisotropy averages to zero. Mathematically, the anisotropic
contribution to sobs in Equation 3 goes to zero when q = 54.7°. Samples are typically
spun at rates between 2 kHz and 100 kHz, depending on the rotor size and capability of
the sample probes holding the sample. When the spinning rate is changed, the width of
the spinning sidebands changes, but the position of the isotropic chemical shift, siso, does
not move with variable spin speeds. The spinning rate used for the experiments discussed
in this dissertation is 4kHz.
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When samples are spun at a spinning rate faster than the width of the anisotropic
chemical shift, the anisotropic contribution is zero and a single peak is observed for the
chemical shift. If the sample spinning is slower than this, a residual anisotropic peak
intensity can manifest, called spinning sidebands. Spinning sidebands are observed on
both sides of a peak at a distance equal to the spinning speed. These spinning sidebands
can be mathematically removed using a pulse sequence called TOtal Suppression of
Spinning Sidebands (TOSS). Using MAS and TOSS together produces a spectrum with
only the isotropic chemical shifts present.(112)
2.2.2   High-power Decoupling

High-power decoupling is another technique to minimize the effects of peak
broadening in the solid-state NMR spectrum. Dipolar decoupling is when two or more
nuclei interact through space, with the magnetic moment of one nucleus interacting with
the magnetic moment of another neighboring nucleus. Again, the fast molecular motion
of molecules in solution averages out to zero, but the effect of dipolar decoupling is
pronounced in solids with rigid molecular structure. Dipolar decoupling can be
homonuclear (i.e. between 1H – 1H or 13C – 13C) or heteronuclear (i.e. 1H – 13C). The
interactions are very strong, causing large line broadening in the solid state, so SSNMR
primarily focuses on 13C analysis. The chance of 13C – 13C coupling is small due to the
low relative abundance of 13C, but the dipolar decoupling effect of 1H – 13C is significant.
The dipolar coupling effect is strongest for CH > CH2 > CH3 and less for quaternary
carbons. In solution, the effects are averaged to zero, but anisotropy is seen in solids due
to the fixed orientation dependence.
High power 1H decoupling sequences such as Spinal 64 or two-pulse phase
modulated (TPPM) sequences can be used to minimize this effect, giving narrower peaks
and better resolution. In the decoupling phase of such an experiment, the magnetic
moments are prevented from interacting by pulsing such that the nuclei are flipped back
and forth between the up and down states very fast in order to average the dipolar
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interaction to zero. The experiments in this work are performed using a Spinal 64 high
power decoupling sequence.
2.2.3   Cross Polarization

Low sensitivity of the 13C nuclei is addressed in NMR by the cross-polarization
technique. Cross-polarization (CP) is used to improve the sensitivity of SSNMR for lowabundance nuclei such as 13C, which has only 1.1% natural abundance. During CP, the
magnetization of a high abundance nucleus (i.e. 1H, 99.9% natural abundance) is
transferred to a low abundance nucleus (i.e. 13C, 1.1% natural abundance). The increase
in magnetization transfer from 1H to 13C is proportional to the gyromagnetic ratios and
results in a gain in sensitivity of four for 1H to 13C.(113) A 90 ° pulse is applied at the
proton resonance frequency, causing the magnetization to align in the xy plane. Then the
phase of the pulse is rotated by 90 ° to lock the spins in the xy plane. At the same time, a
pulse is applied to the resonance frequency of the 13C spin, for a specified “contact time”.
When the pulse times and power levels are chosen according to the Hartmann-Hahn
matching equation (see below), cross polarization is achieved. That is, the spins precess
at the same frequency, allowing them to interact for the specified contact time. During
CP, magnetization is transferred from the high abundance nuclei (1H) to the low
abundance nuclei (13C), thereby increasing the sensitivity of the low abundance nuclei
being detected. The Hartmann-Hahn matching condition is given as:
gH BH = gC BC

Equation 2-7

where gH is the gyromagnetic ratio of the 1H nucleus, gC is the gyromagnetic ratio of the
13

C nucleus, and BH and BC are the magnetic strength applied to the 1H and 13C nuclei,

respectively.
Using CP, the magnetization transfer rates are not the same for every nucleus in
the sample. This means that CP is not quantitative without special considerations, which
will be discussed in section D. This property also means that CP can be used for spectral
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editing purposes, such as when a sample contains a solvent that is not chemically bound
to the molecule of interest. CP can filter out the more mobile parts of the sample by
varying the contact time. Using shorter contact times (i.e. 50 µs instead of 2 ms), CP will
not transfer the magnetization of the more mobile carbons in the sample, such as unbound
solvent and some CH3 peaks that relax fast. Using these techniques, the cross polarization
can be exploited to understand the sample in greater detail.

2.3   Relaxation

SSNMR is a versatile technique which not only gives chemical structure
information, but also information about the dynamics of a sample.(114) This information
on sample dynamics (i.e. sample mobility) can be probed through relaxation experiments,
three of which are discussed here. Relaxation is a term used to describe the process in
NMR where the nuclear spins in a sample return to equilibrium after an NMR pulse. This
usually happens through spin-lattice relaxation (T1), spin-lattice relaxation in the rotating
frame (T1,rho) and spin-spin relaxation (T2).
Spin-lattice relaxation (T1), also called longitudinal relaxation, occurs when the
spins relax after a 90 ° pulse. In other words, the nuclear spins that were excited to a
higher spin state during the pulse lose their energy and the population difference of the
nuclear spin states returns to what it was before the pulse. The magnetization of the T1
relaxation is described by Equation 2-8:
DN = DN0 (1-e-t/T1)

Equation 2-8

where DN is the population difference, DN0 is the population difference at thermal
equilibrium, and t is the recycle delay time. Note that DN is proportional to the
magnetization of the spins. The relaxation decay is an exponential process where the T1
value can be measured using a saturation recovery experiment or inversion recovery
experiment. In a saturation recovery experiment, the spins are allowed to return to
equilibrium after a pulse. The time, t, is varied and the time to return to 63% of
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equilibrium is taken as the T1 value. In order to acquire quantitative data, the spins must
fully relax between scans. This requires five times the T1 time. For non-quantitative
analysis, the highest signal with the best signal-to-noise comes from using a recycle delay
of approximately 1.2 times the T1 value.
1

H T1 relaxation happens through a process of spin diffusion. In spin diffusion,

the magnetization of a nuclear spin is transferred to a neighboring spin through dipolar
coupling. When one spin changes from + ½ to – ½ , it prompts the next one to change,
and next and the next, until it reaches the end of the domain or edge of the particle. As a
result of this spin diffusion, all the spins in a homogeneous sample have the same 1H T1
time. Spin diffusion also allows for the measurement of domain sizes, and is related to
particle size, in solid samples. 1H T1 values are used for the experiments shown here and
were acquired using CP. For magnesium stearate samples, the 1H T1 value is related to
the crystal hydration state, as well as disorder and crystal defects originating from
processing conditions.
Additionally, the 1H T1 values are typically much shorter than 13C T1 values,
allowing for more scans in a shorter period of time, due to shorter relaxation time
between scans. This greatly decreases the amount of time required for a 13C SSNMR
experiment. The T1 relaxation experiment will be discussed in the next section.
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Figure 2-3. T1 Relaxation Experiment. The magnetization intensity is plotted as a
function of recycle delay time. The data is fitted to an exponential curve to determine the
T1 value.
Spin-spin relaxation (T2), also called transverse relaxation, describes the
relaxation after the 90° pulse, when the magnetization fans out in the x-y plane. The
magnetization is losing coherence in the x-y plane and T2 is the time it takes to return
back to equilibrium. It occurs prior to T1 relaxation and if the T1 is set shorter than the T2,
then the T1 is affected by the T2 loss in coherence. The FID is dependent on the T2 and a
longer T2 relaxation rings out longer in the FID, which is the order of milliseconds in
solids. T2 is proportional to the line width (line width ~ 1/T2), being much longer in
solution than in solids.
T1,rho is the relaxation in the rotating frame (i.e. when the magnetization is spinlocked in the yz plane). It can give information on dynamics in a system and is often used
along with T1 to evaluate miscibility of mixed samples such as amorphous solid
dispersions. T2 and T1,rho values are both shorter than the T1 relaxation, but effects of
T1,rho on magnetization transfer can be seen when the CP contact time is varied. Offerdahl
et al. describes quantitation of neotame using 13C SSNMR CP experiments where the CP
contact time is varied. The magnetization of variable contact time experiments decays
according to the T1,rho relaxation. Extrapolating back to contact time of zero corrects for
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the variability in CP magnetization transfer between different nuclei. This allows for
quantitation of different forms in a solid sample, specifically using the CP variable
contact time method for quantitation of the various forms of MgSt in tablet formulations.

2.4   Pharmaceutical Applications of SSNMR

There are several reviews discussing solid-state NMR applications to
pharmaceutical science.(114-119) Using SSNMR, there is a sensitivity trade-off between
sample size, sidebands from the MAS spinning rate and magnet size. Larger samples
provide more molecules to increase the signal based on the number of nuclei in the
sample between spin states. Spinning sidebands can be eliminated by spinning fast, but
spinning at ultrafast spin rates can be physically challenging. Consider that 4 kHz is
250,000rpm, which is slow for SSNMR but 100X faster than a car engine. Smaller rotors
can spin faster, but smaller samples have a lower number of nuclei, and therefore produce
less signal. Large magnets can increase sensitivity, but cost is often prohibitive. Overall,
in the current state of the field, 400 - 600 MHz magnets seem to be the sweet spot to
balance between MAS rates and sample size.
In a pharmaceutical setting, the most useful nuclei to study with solid-state NMR
are 13C, 1H, 19F, 15N, 31P and 23Na. Table 2-1 shows some basic SSNMR data for these
nuclei, including natural abundance and relative sensitivity, which are very important for
choosing a nucleus that will give sufficient signal for useful analysis. The practical notes
indicate nuclei-specific considerations. Proton (1H) is highly abundant and highly
sensitive, allowing for single pulse experiments, but the resolution of peaks in the solid
state is often very poor, requiring fast spinning to eliminate dipolar coupling. Carbon
(13C) is the most common nuclei used, but it has low abundance and low sensitivity, and
several accommodations are needed to get useful data, including magic angle spinning
(MAS), cross polarization (CP), dipolar decoupling (DD) and total sideband suppression
(TOSS). Nitrogen (15N) has lower abundance and sensitivity than carbon, but can supply
information about ionization and pKa information if accommodations such as CP, MAS,
DD are used. Fluorine (19F), with high abundance and high sensitivity, has been gaining
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popularity in pharmaceutical settings in recent years, since fluorine is becoming more
commonly incorporated into drug molecules. It can be ran using single pulse or DD
experiments and is often ideal for quantification studies. Phosphorus (31P) has high
abundance and low sensitivity, requiring only CP to obtain good signal. Sodium (23Na)
has high abundance and is useful for studying Na salts, but has a quadrupolar spin which
results in line broadening. Many other nuclei can be studied using SSNMR, but these
nuclei are the most relevant to drug development and have NMR properties that facilitate
their common use in pharmaceutical industry.(120)

Table 2-1. NMR Information for Selected NMR-active Nuclei
Nuclei % Natural
Relative
Gyromagnetic
Frequency
Abundance Sensitivity Ratio (MHz/Tesla) at 7.05 T
1
H
99.99
1
42.58
300
13

C

1.13

0.016

10.71

75.4

15

N

0.37

0.001

-4.32

30.4

19

F

100

0.83

40.05

282.3

31

P

100

0.0663

17.24

121.4

23

Na

100

0.0927

11.26

79.4

*Note that all nuclei require magic angle spinning (MAS)
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Practical
notes*
Fast spinning
Single pulse
Most common
CP/MAS/DD/
TOSS
Ionization, pKa
CP/MAS/DD
Quantitation
Single pulse or
HPdec
High abund,
Low sens CP
Quadrupolar
spin 3/2
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CHARACTERIZATION OF THE CRYSTAL FORMS OF
MAGNESIUM STEARATE USING DIFFERENTIAL SCANNING
CALORIMETRY, THERMOGRAVIMETRIC ANALYSIS, X-RAY
POWDER DIFFRACTION AND SOLID-STATE NMR SPECTROSCOPY
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3.2   Abstract

Magnesium stearate (MgSt) is the most popular pharmaceutical excipient used in
tablet formulations. MgSt is the fatty acid salt of stearic acid and often is a mixture of
fatty acid salts, such as palmitic acid. Additionally, there are several reported crystal
forms. It is used as a powder lubricant in tablet formulations, typically added at a level of
0.5 – 2% and is typically mixed into the formulation as the last step, with a controlled
mixing time. Inadequate lubrication results from too low an amount of MgSt or too short
a mixing time, too much MgSt or excessive mixing time often results in slower
dissolution rates. Switching between MgSt samples with variability in the properties of
MgSt can cause variable performance of samples with the same mixing time, so it is
important to understand the variable properties of MgSt. Several advanced analytical
techniques were used to characterize the properties of commercial MgSt and synthesized
MgSt samples. Solid-state NMR (SSNMR) was able to uniquely identify several crystal
forms of MgSt. Several additional techniques also showed correlations with MgSt crystal
form, including thermogravimetric analysis (TGA), differential scanning calorimetry
(DSC) and scanning electron microscopy (SEM).

3.3   Introduction

Magnesium stearate (MgSt) is the most popular pharmaceutical excipient used in
tablet formulations. It is included as an excipient in over half of the tablet formulations on
the market, and is an effective solid lubricant, reducing the friction between the
formulation powder and manufacturing equipment during the tableting process. (23, 121,
122) Chemically, MgSt is the fatty acid salt of stearic acid and often is a mixture of fatty
acid salts, such as palmitic acid. The chemical structure of magnesium stearate is given in
Figure 3-1. It is a di-salt of Mg, with Mg2+ ionically bonded with the carboxyl ends of
two stearic acid (C18) fatty acid chains.
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Figure 3-1. Chemical structures of magnesium stearate, the magnesium di-salt of stearic
acid, with chemical formula of Mg(C18H35O2)2.
MgSt has been used as a solid lubricant in pharmaceutical tablet formulations
since its introduction in 1970 by Hansen et al.,11 typically added at a level of 0.5 – 2%
and is mixed into the formulation as the last step, with a controlled mixing time.
Inadequate lubrication and tableting issues such as picking and sticking results from too
low an amount of MgSt or too short a mixing time, (123-126) while too much MgSt or
excessive mixing time often results in slower dissolution rates and potential
bioavailability problems.(126-128) The proposed mechanism for MgSt is that it provides
a hydrophobic coating on the surface of the drug and other excipients in the formulation,
acting to reduce friction and lubricate on the one hand, and simultaneously inhibit
dissolution on the other.(129)
Although MgSt is very popular and investigated extensively,(33, 130) the
complex nature of the crystal forms and hydration state of MgSt is still not well
understood.(7) There are at least five different crystal forms of MgSt: an anhydrous form,
a disordered form and three hydrate forms: monohydrate, dihydrate and trihydrate form.
Delaney et al. have suggested that the disordered form is a monohydrate, ordered on the
fatty acid end of the molecules, rather than the carbonyl end. Some MgSt samples,
including many commercial samples, exist as mixtures of two or more forms.
Distinguishing between crystal forms to identifying and/or quantifying these crystal form
mixtures can be challenging using many traditional analytical techniques. For instance,
results from XRPD are often complicated by the variability in chemical composition
between MgSt samples. Other techniques provide results which are not specific. As an
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example, TGA analysis provides information about dehydration temperatures and total
water content, but not about where the water is located in the crystal lattice.
In addition to the variety of crystal forms that may exist in a MgSt sample, the
chemical composition can also vary. As noted earlier, the salt of the fatty acid (e.g.
stearate) is present in MgSt, but the fatty acid may also be described using the acid form
(e.g. stearic acid) and the two notations are used interchangeably in this work.
Traditionally, MgSt is found as a natural product in both plants and animals, but
pharmaceutical use is restricted to plant-based MgSt. (43) According to United States
Pharmacopeia (USP) monograph for MgSt, at least 40% of MgSt must be derived from
stearic acid (C18) and > 90% must come from a combination of stearic and palmitic
acids. This allows for the remaining 10% to come from other fatty acids with varying
chain lengths, including myristic, margaric, arachidic, etc.(19) Any crystal form can exist
in any fatty acid combination and the chemical composition was found to vary with
commercial suppliers. MgSt forms crystals in lipid bilayers with MgSt with the long fatty
acid chains aligned together and the hydrophilic carboxylic acid groups aligned with the
magnesium ions on the other end. (34, 131) The different hydrates are thought to
incorporate water molecules into the crystal lattice between and around the magnesium
ions.(36)
Many investigations have attempted to understand the effects of MgSt on tablet
properties, (132-135) York and coworkers were among the first to thoroughly investigate
MgSt properties. Their early work focused on characterization of the synthesized
dihydrate form of MgSt, as well as the pure stearate and pure palmitate materials. (136,
137) Later studies focused on tableting properties, finding that commercial MgSt samples
affected the dissolution more than the pure stearate samples.(83, 138-140)
Back in 1977, Mueller et al. noticed that the amount of water in a MgSt sample
was related to its lubrication properties and that thermal drying can change its
polymorphic properties. Their work investigating the pseudopolymorphism and crystal
structure of MgSt(141) led to an interest in the hydration state and polymorphism of
MgSt by many groups.(23, 24, 30, 33, 36, 131, 136) The most detailed study by Brittain
and coworkers used DSC, PXRD and microscopy to analyze three forms of MgSt: the
anhydrate, dihydrate, and trihydrate forms of pure magnesium stearate and magnesium
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palmitate.(35) Their analytical and thermal investigation suggested that the dihydrate
water of hydration is bound more tightly than the trihydrate water of hydration.
In a 2005 paper, Bansal and coworkers thoroughly characterized six different
MgSt lots by DSC, TGA, XRPD, particle size, morphology, specific surface area, optical
microscopy and Fourier-transform infrared spectroscopy.(85) The lubrication
performance of their six samples suggested that the interplay of particle-level
characteristics (particle size, larger specific surface area, and plate-like crystal habit)
were more important than molecular level characteristics in terms of lubrication potential.
This interplay of characteristics highlights possible causes of lubrication issues when
using MgSt.
This chapter focuses on the variability that exists in MgSt samples using advanced
analytical techniques to characterize MgSt materials from both commercial and labsynthesized sources. In addition, this work incorporates 13C solid-state NMR (SSNMR)
spectroscopy(142) of MgSt, a non-destructive and quantitative technique that can provide
detailed information about not only structure and form quantification, but also
miscibility, and mobility through 1H T1 relaxation values. The results show that 13C
SSNMR can uniquely identify the distinct crystalline forms of MgSt, and these forms
correlate well with other analytical techniques such as DSC, TGA, and PXRD.

3.4   Materials and Methods
3.4.1   Materials

Eight magnesium stearate samples were obtained from six different commercial
sources: Alfa Aesar (lots H03W054 and C01Y019), MP Biomedicals (lot 75281), ChemImpex International (lot 6301123019902), Acros Organics (lots A0288107 and
A0235781), Sigma Aldrich (lot STBC0861V), and Fisher Scientific (lot 740042). The
samples will be identified by their source and lot, as needed.
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3.4.2   Synthesis of MgSt

The dihydrate form of MgSt was synthesized by dispersing a combination of
stearic, palmitic, and other fatty acids (~0.1 mole) in 600 mL of Milli-Q water previously
heated to 90 °C. Ammonium hydroxide solution (14.8 N) was added drop wise until the
solution reached a pH of 9, generating a fatty acid soap with the stearic/palmitic acids.
MgSt was precipitated out of solution by the addition of a stoichiometric excess of MgCl2
* 6H2O. Finally, the magnesium stearate was isolated by vacuum filtration and was
washed with acetone and water for 24 hour periods.(24, 30) Although ammonium
hydroxide was used for this work, sodium hydroxide could also have been used to change
the pH.(24, 131) Utilizing sodium hydroxide for the reaction results in a sodium soap
being formed which is then replaced by the magnesium ions with the addition of the
MgCl2.
A second method for synthesizing magnesium stearate, specifically magnesium
stearate monohydrate, has been developed. In this synthesis, ~0.1 mole of a combination
of stearic, palmitic, and other fatty acids was placed into a beaker with a stir bar and was
heated in an oil bath to ~90 °C. Once the fatty acids are melted, ~650mg of Mg(OH)2
(Sigma Aldrich) was added to the melt followed shortly by 10mL of Milli-Q water to
precipitate the magnesium stearate. The final product was washed with water for 24 hours
and allowed to air dry (placing sample in a vacuum oven at 25 °C can also be done to
hasten the drying process).
The anhydrous form of MgSt was made by placing the dihydrate form in an oven
overnight at 105 °C, while the trihydrate form of MgSt was made by placing the
anhydrous form in a container with a relative humidity of 75% or greater (although other
studies have determined that 50% RH will also produce the trihydrate).(131) The
disordered monohydrate form can be made by placing a monohydrate sample in the oven
at 105 °C for two or more hours.
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3.4.3   Solid-state NMR Spectroscopy

SSNMR spectra were acquired at ambient conditions using a Tecmag Redstone
spectrometer (Tecmag, Inc., Houston, TX) operating at 100.57 MHz for 13C (9.4 T static
magnetic field). Samples were packed into 7 mm zirconia rotors and sealed with Teflon
or Kel-F end caps (Revolution NMR, LLC, Fort Collins, CO). Experiments were
performed using a 7 mm double resonance MAS probe (Varian, Palo Alto, CA). All 13C
spectra were acquired under MAS(143) at 4 kHz, using ramped-CP(144), TOSS(145),
and SPINAL64 decoupling(146) with 1H decoupling field about 66 kHz. A 1.5 ms
contact time was used in all experiments. 3-methylglutaric acid (MGA) was used for
optimizing spectrometer and as an external standard, with the methyl peak referenced to
18.84 ppm(147). Spectra were acquired with a 3 – 5 second pulse delay (~1.5 - 2 times
the measured T1 value).
1

H T1 relaxation values were measured using a saturation-recovery experiment

through 13C observation. In the Fourier-transformed spectra, the peak of interest was
integrated and plotted against recovery delay times and the values were fitted to the
following equation:
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Equation 3-1

where M is the integrated signal intensity and 𝜏𝜏 is the recovery delay time. M0 is an

amplitude parameter obtained from the fit and T1 is the obtained spin-lattice relaxation
time.

3.4.4   Thermal Analysis

DSC thermograms were acquired using a Q2000 differential scanning calorimeter
equipped with an RCS90 refrigerated cooling system (TA Instruments, Newcastle, DE).
Nitrogen was used as the purge gas at a flow rate of 50 mL/min. Temperature and
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enthalpy were calibrated using indium. Samples (~2-5mg) were placed in TZero
aluminum pans and sealed with TZero aluminum hermetic lids with one pinhole (TA
Instruments, New Castle, DE). Samples were heated at 10 °C/min from room
temperature to 200 °C. Data were processed using Universal Analysis software (TA
Instruments, Newcastle, DE).
A Q50 thermogravimetric analysis system (TA Instruments, Newcastle, DE) was
used for investigation of the water content, i.e. hydration state, of the magnesium stearate
samples. Nitrogen was used as the purge gas at a flow rate of 40 mL/min for the balance
and 60 mL/min for the samples. Temperature was calibrated using a nickel standard and a
magnetic bar for the Curie Point Temperature. Weight was calibrated using standard
weights (200mg and 1g). Approximately 10mg of sample was placed on a platinum pan
and heated at 10 °C/min from room temperature to 200 °C. The total weight loss from
room temperature to ~125 °C was analyzed for water content.
3.4.5   X-ray Powder Diffraction

Differences in the hydrate form of magnesium stearate samples were also
investigated using a powder X-ray diffractometer (MiniFlex 600, Rigaku Corporation,
Japan) with Cu K𝛼𝛼 radiation operating at 40 kV and 15mA. Samples were scanned from
a 2𝜃𝜃 of 2-45° at the rate of 2°/min and a step size of 0.02°.
3.4.6   Scanning Electron Microscopy

Scanning electron microscopy (SEM, Hitachi S-4300) was used for visual aid and
particle size approximations in the investigation of the commercial samples. The SEM
used a cold-cathode field emission filament type and has SE/BSE/EBSD detectors
attached. The image resolution was secondary electron (1.5 nm). Various images were
taken between 500x and 10000x zoom, although only the 1000x images are shown
herein.
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3.5   Results and Discussion
3.5.1   Synthesized MgSt Samples
Thermal data (DSC thermograms and TGA gravimetric weight loss) for the five
forms of MgSt are shown in Figure 3-2. The TGA weight loss for the monohydrate form
indicates ~ 3.0% water, with ~ 6% for the dihydrate and ~ 9% for the trihydrate. The
observed weight loss amounts are consistent with the expected stoichiometric weight loss
of ~ 3% weight loss per water molecule associated with the MgSt, with slight variations
depending on fatty acid composition. The weight loss temperature range for the
monohydrate, dihydrate and trihydrate are 100 - 125 °C, 80 - 110 °C and 60 - 80 °C,
respectively. The dehydration difference between the hydrates suggests a difference in
thermal stability between the mono-, di- and tri- hydrate forms. The disordered form
shows a similar amount of total water loss as the monohydrate (~3%), but the weight loss
event is much broader than for the hydrates. The monohydrate water loss is measured
from around ~100 °C to 125 °C and the disordered weight loss is measured from 25 °C to
125 °C, since it begins losing water at a much lower temperature compared to the
monohydrate. This can be an indication of surface bound water for the disordered form,
rather than hydrated water bound in the crystal lattice.
The DSC thermograms show thermal transitions for the mono-, di-, and trihydrate
forms, where the trihydrate has a dehydration onset around 60 °C, the dihydrate around
80 °C and the monohydrate has the highest transition with dehydration onset around 90
°C. Both the trihydrate and the dihydrate have a secondary transition with a peak around
120 °C, potentially indicating that there is a second thermal event occurring for these
samples. It is possible that this is a conversion to monohydrate and the onset is obscured
by the first transition. The disordered form and the anhydrate form have low temperature
thermal events, occurring around 55-70 °C. The early transition for the disordered form
appears to be a glass transition, with a subsequent melting onset matching the anhydrate
melting onset around 130 °C. This is supported by the observation that the disordered
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form converts to the anhydrous form upon extended heating above 100 °C. The low
temperature transitions in both the disordered and anhydrous samples are consistent with
the idea that a disordered structure around the fatty acid head group does not retain the
water as effectively as the ordered crystalline forms.

Anhydrate
Disordered
Monohydrate
Dihydrate

Trihydrate

Figure 3-2. Differential Scanning Calorimetry (DSC) thermograms and
Thermogravimetric Analysis (TGA) gravimetric weight loss plots for the five different
forms of MgSt. DSC thermograms from top to bottom: Disordered, Anhydrate,
Monohydrate, Dihydrate, and Trihydrate. TGA plots from top to bottom (at 175° C):
Anhydrate, Disordered, Monohydrate, Dihydrate and Trihydrate. Figure used with
permission.
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Figure 3-3 shows the X-ray powder diffraction (XRPD) patterns of the five forms
of MgSt. In general, the peaks for the monohydrate, dihydrate and trihydrate forms are
slightly sharper than the peaks for the disordered and anhydrous forms. The disordered
and anhydrous forms do not show a broad amorphous halo, but each has several poorly
crystalline peaks, consistent with a partially ordered crystal structure. It appears that the
XRPD analysis of the crystal structure of these materials may be complicated due to the
differences in ordered and disordered structures in the carbonyl and the aliphatic regions
of the fatty acid chains, respectively. Diffraction peaks in the 10 – 30 degrees 2q region
show clear differences in the diffraction patterns for the mono-, di- and tri- hydrate forms,
allowing for identification of the different pure hydrate forms. However, other studies
have shown that the peak positions can change depending upon fatty acid
composition.(85, 131) Additionally, many MgSt samples are mixtures of forms. These
variations in fatty acid composition and/or crystal forms make it very challenging to rely
on XRPD to identify the form of MgSt.
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Disordered

Anhydrate

Monohydrate

Dihydrate

Trihydrate

Figure 3-3. Powder X-ray diffraction patterns (PXRD) of the five different forms of
magnesium stearate. Patterns from top to bottom: Disordered, Anhydrate, Monohydrate,
Dihydrate and Trihydrate. Figure used with permission.
The 13C CP/MAS NMR spectra of five crystalline forms of MgSt are shown in
Figure 3-4. These materials were prepared according to the synthesis methods described
earlier. The spectra can be divided into two sections. The left side shows the chemical
shift region 170 – 190 ppm, which corresponds to the carbonyl carbon of the fatty acid
chain. Four of the samples show sharp peaks, indicating an ordered, crystalline region
around the carbonyl carbon. The fifth spectrum shows a broad peak, indicating disorder
and a lack of long-range order in the carbonyl region. It has been designated
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“disordered,” rather than amorphous, due the apparent order in the aliphatic region.
Multiple peaks for the carbonyl carbon indicate multiple molecules in the
crystallographic unit cell. The dihydrate appears to have two molecules in the unit cell,
while the anhydrate and monohydrate appear to have six molecules in the unit cell.

Disordered

Anhydrate
Monohydrate
Dihydrate
Trihydrate

Figure 3-4. 13C CP/MAS SSNMR spectra of five forms of magnesium stearate. The
spectra show the carbonyl region (170–200 ppm) and the aliphatic region (10-50 ppm), as
there are no other peaks in the spectrum. The forms are denoted in the figure by their
hydration state, except for the disordered form, which is identified based on the disorder
in the carbonyl region.
The aliphatic region of the spectrum (10 – 50 ppm) shows distinct peaks
corresponding to the C2, C3, C4-(n-2), Cn-1 and Cn carbons. The n designation refers to the
carbon on the end of the fatty acid chain, e.g. n=18 for stearic acid, and n=16 for palmitic
acid. The chemical shifts of the aliphatic carbon peaks can be observed for C2 (~38 – 41
ppm), C3 (~28 ppm), C4-(n-2) (33 – 36 ppm), and Cn-1 (~25 ppm). The methyl carbon of the
fatty acid chain, Cn, has a chemical shift around ~14 ppm in the aliphatic region of the
spectrum. The fatty acid ratio affects the sharpness of the Cn peak, with pure samples
having sharper peaks and mixed fatty acid samples having broader peaks in the aliphatic
region. Pure fatty acid samples are expected to have sharper peaks than mixed fatty acid
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samples, due to the overlap of peaks from different fatty acids (i.e. the C2 peaks of stearic
and palmitic). The synthesized samples in Figure 3-4 are relatively pure mixtures, and the
sharper peaks in the aliphatic region reflect this.

Figure 3-5 shows the TGA weight loss and 1H T1 relaxation times for several
monohydrate, dihydrate and disordered samples prepared in the lab. The low water
content of the disordered samples reflects the fact that they were prepared by drying, as
well as the extent of drying. The disordered samples also have the lowest 1H T1 relaxation
times reflecting the lack of order in the sample particles. The monohydrate and dihydrate
samples have TGA around 3% and 5.5% water loss, respectively. The corresponding 1H
T1 relaxation times for the monohydrate cluster around 3s, while the dihydrate 1H T1
relaxation times range from 5 – 17 s. It is interesting that the points for each form cluster
together, suggesting distinctly different structural properties for each form. Figure 3-6
shows that the scatter in the dihydrate 1H T1 relaxation values appears to be impacted by
the fatty acid composition (% stearate), with lower 1H T1 relaxation values correlating
with lower stearate content. This suggests a higher amount of order in the dihydrate
samples with higher stearate content and lower order in the mixed fatty acid samples. The
lack of spread in 1H T1 relaxation values for the monohydrate suggests that the order in
monohydrate crystal structure is less affected by fatty acid composition, likely due to
higher mobility in the carbonyl region due to relaxation sinks. It appears that the higher
amount of water in the MgSt crystal structure gives the molecules less mobility and leads
to longer relaxation times. Additionally, the 1H T1 relaxation values in Figure 3-5 are
notably higher than those observed for the commercial samples, indicating that the
particles in the samples have less order, possibly from smaller particles or other
processing that may have affected the order in the commercial samples.
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Figure 3-5. TGA weight loss and 1H T1 values for lab-synthesized MgSt samples,
comparing pure monohydrate, pure dihydrate and disordered forms.
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Figure 3-6. 1H T1 relaxation values for MgSt dihydrate samples prepared with varying
compositions of stearic acid.
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The 13C SSNMR of a representative dihydrate sample from each stearate:
palmitate composition is shown in Figure 3-7 with the 1H T1 relaxation values listed in
Table 3-1. The carbonyl region (160 – 190 ppm) indicated the double peaks characteristic
of the dihydrate form of MgSt, with no obvious differences in crystal form between fatty
acid compositions. However, the aliphatic region (0 – 50 ppm) showed a trend with fatty
acid composition, particularly with the methyl peak ~ 14 ppm. The 100:0 St:Pa spectrum
showed a single, sharp methyl peak. Notably, the C16 peak of the pure palmitate (0:100
St:Pa) sample also has a single, sharp peak. For the mixed fatty acid concentrations, a
broader, double peak was observed, indicating a mixture of stearate and palmitate, with
the C18 and C16 methyl carbons having slightly different chemical shifts. The
implication of this is that fatty acid composition differences can be detected in the
aliphatic region of the 13C SSNMR spectrum, and the extent of fatty acid mixture is
reflected in the lower relaxation times.
Table 3-1. 1H T1 relaxation values for lab-synthesized dihydrate samples
St:Pa 1H T1 (s) Std dev
0:100
11.3
n/a
40:60
8.5
n/a
66:34
5.8
1.3
80:20
6.8
0.3
90:10
10.5
1.1
100:0
15.0
2.1
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Figure 3-7. 13C SSNMR for lab-synthesized dihydrate samples with various St:Pa
compositions
This section has shown the different forms of MgSt may be identified by 13C
SSNMR, DSC, TGA, and XRPD. Additionally, it is shown that 13C SSNMR is the only
technique which can easily identify the unique forms of MgSt for samples when mixtures
of fatty acids and form are present in the sample. 13C SSNMR also makes it possible to
quantify mixtures of forms in MgSt, based upon the carbonyl region of the spectrum.
Additionally, 1H T1 relaxation times appear to generally correlate with TGA weight loss
for the different forms, with a possible influence of fatty acid composition on 1H T1
relaxation times.
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3.5.2   Commercial MgSt Samples

Eight samples of MgSt from several different suppliers were characterized for
physical form, to determine the typical variety of forms present in commercial MgSt
materials. The 13C SSNMR spectra of these eight commercial MgSt is shown in Figure
3-8. The two Alfa Aesar samples have a disordered form, as indicated by the broad peak
in the carbonyl region between 170 – 200 ppm. The spectra of the Fisher and Acros
A0235781 samples show a distinctive pattern of 6 peaks shown 178 – 184 ppm region,
which corresponds to the monohydrate form. The spectra from MP Biomedicals, ChemImpex, Aldrich and Acros A0288107 samples show mixtures of monohydrate and
dihydrate. The clear distinction between the monohydrate peaks and the two dihydrate
peaks between 185 – 187 ppm allows for quantification of the forms in these samples,
although quantitation analysis was not performed for these samples.
In addition to the differences in the carbonyl region, there are also differences in
the aliphatic region of the spectra. The disordered Alfa samples appear to have a sharper
peak at the methyl group ~ 14 ppm, indicating increased order in the aliphatic end of the
molecules. If the fatty acid chains are ordered in the aliphatic region, it could explain the
disorder observed in the carbonyl region. However, all of the other aliphatic peaks are
also broad, suggesting that the structure of the disordered material is not straight-forward.
In the C2 region, differences between the monohydrate and dihydrate are observed, with
several peaks for the monohydrate in the 38 – 41 ppm region, but only the samples
showing dihydrate in the carbonyl region have a C2 peak at 36 ppm.
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Figure 3-8. 13C CPMAS NMR spectra of the eight samples of commercial magnesium
stearate. The spectra show the carbonyl region (170–200 ppm) and the aliphatic region
(10-50 ppm), as there are no other peaks in the spectrum. The samples are denoted in the
figure by their source and, if two samples were obtained from the same source, lot
number. Used with permission from Delaney et al.
The 1H T1 relaxation times for the carbonyl peaks in the commercial samples
were also measured and shown in Figure 3-9. A higher 1H T1 relaxation time typically
indicates higher order in the crystal. The low 1H T1 values for the disordered samples are
consistent with this idea, having 1H T1 values of 0.8 ± 0.2 s and 0.9 ± 0.2 s. Comparing
the relaxation times for the mixed samples, we see that the dihydrate peaks have different
relaxation times than the monohydrate peaks, indicating that the forms are not intimately
mixed in the sample. Because the 1H T1 relaxation times are different for the two sets of
peaks, these two forms are not intimately mixed at the 50 nm level in these samples.(148)
It is likely that the samples are mixtures of monohydrate and dihydrate particles rather
than crystals with large domains of both forms.
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Figure 3-9. 13C CPMAS NMR spectra of the carbonyl region (170–200 ppm) of the eight
samples of commercial magnesium stearate. The 1H T1 relaxation times for the
monohydrate and dihydrate peaks are shown in the figure. Figure used with permission
from Delaney et al.
Figure 3-10 shows the DSC thermograms for the eight commercial samples. The
forms observed in the thermograms for these samples are consistent with the DSC results
in Figure 3-2. The Alfa Aesar samples assigned as disordered form from SSNMR show
broad thermal events in the DSC and broad weight loss of ~ 3% in the TGA plots. The
Acros and Fisher samples, which are both designated as monohydrates, have thermal
events with onset around 105 °C, as well as weight loss events around the same
temperature. The four samples with mixtures of monohydrate and dihydrate have
overlapping peaks in the DSC thermograms consistent with the dehydration events
described for the pure MgSt forms in Figure 3-2. These four monohydrate-dihydrate
mixtures also show at least two weight loss dehydration events in each TGA plot,
corresponding with the relative amounts of dihydrate and monohydrate present in each
sample. From the DSC, the qualitative amount of dihydrate in the mixed form samples is
MP Biomedicals > Chem-Impex > Acros ~ Aldrich, which is consistent with the SSNMR
data. Although in general, it is possible to correlate the thermal data with the known
forms of the MgSt samples, it is very challenging to identify the forms in the mixtures
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from the complicated thermograms alone. Using the SSNMR and thermal data together,
the differences between the forms of MgSt can be clearly identified and quantified.

Figure 3-10. Differential Scanning Calorimetry (DSC) thermograms and
Thermogravimetric Analysis (TGA) gravimetric weight loss plots for the eight samples
of commercial magnesium stearate. DSC thermograms from top to bottom are listed by
source and lot number, but are ordered as: Disordered, mixtures of dihydrate and
monohydrate going to monohydrate. TGA plots from top to bottom are plotted in the
same color as the DSC thermograms. Figure used with permission.
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XRPD diffraction patterns for the eight commercial samples are shown in Figure
3-11. There are a few differences that can be observed between the samples, particularly
between the disordered and monohydrate forms. The two Alfa Aesar samples show broad
peaks indicating disorder, while rest of the samples have multiple sharp peaks. The
Aldrich and Acros monohydrate samples show slight differences from the
monohydrate/dihydrate mixtures, with the appearance of a peaks around 23° 2𝜃𝜃 and 30°
2𝜃𝜃 indicates the dihydrate form. The relative ratios of the peaks for the Acros A0235781
and Fisher monohydrate samples initially appear different, but this is likely due to
preferred orientation in the sample preparation. Overall, the mixture of monohydrate and
dihydrate forms is difficult to deconvolute using XRPD.
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Figure 3-11. Powder X-ray diffraction patterns (PXRD) of the eight samples of
commercial magnesium stearate. Patterns are labeled based upon their source and lot
number. Figure used with permission.
This section has presented data characterizing the physical forms of eight
commercial MgSt samples. DSC and TGA thermal data indicate differences between
MgSt samples having different forms, but it is difficult to interpret mixtures of forms.
XRPD also shows differences between samples having different forms, but mixtures of
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forms and samples of mixed fatty acid compositions were difficult to interpret. In
contrast, 13C SSNMR was able to clearly distinguish between monohydrate, dihydrate
and disordered forms in the commercial MgSt samples.

3.6   Conclusions

This chapter presented solid-state characterization for eight commercial MgSt
samples and five lab-synthesized samples having five different pure forms of MgSt. Five
different crystalline forms of MgSt were identified using 13C SSNMR. The TGA water
loss dehydration peaks were used to assign the proposed hydration states for
monohydrate, dihydrate and trihydrate samples. DSC and XRPD data were consistent
with SSNMR form trends and it was possible to identify the forms, especially for the pure
forms. However, it is much more challenging to distinguish and/or quantify for mixtures
of MgSt forms with traditional techniques, compared with 13C SSNMR. The additional
correlation of 1H T1 relaxation values with TGA weight loss and potentially fatty acid
composition may provide insight into structural aspects of the various forms.
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4.2   Abstract

Magnesium stearate (MgSt) is a popular pharmaceutical lubricant, but batch-tobatch variations in physical properties can cause variability in performance. In order to
understand the variability of MgSt properties, it is important to understand how MgSt is
prepared and the effects of various factors on the crystal form produced from the
synthesis reaction. Two synthesis reactions were investigated: the “melt method”, a onestep spontaneous reaction of magnesium hydroxide with melted stearic and palmitic acids
and the “bath method”, a two-step reaction involving addition of magnesium chloride to
ammonium stearate soap. Samples of MgSt were prepared to investigate various reaction
conditions: 1) including the effect of fatty acid content on the crystal form produced for
both methods, 2) the amount of reaction water for the melt method, 3) reaction
temperature for the bath method and 4) drying method. It was found that the synthesis
method, fatty acid composition and reaction temperature all affect the crystal form
yielded from synthesis, where high stearate content at 70 ° with the bath method is most

likely to produce the dihydrate form and 50:50 ratio of fatty acids at 90 °C with the melt
method is likely to produce the monohydrate form. Addition of 10 mL of water during
the melt reaction appeared to aid formation of the monohydrate form. In terms of drying,
the monohydrate sample was less affected by drying method than the dihydrate and
mixed form samples. The air-drying condition was found to affect the synthesized form
the least and the nitrogen drying tends to dehydrate the dihydrate form. Overall, synthesis
conditions likely to produce pure monohydrate and pure dihydrate were determined.

4.3   Introduction

The variability of MgSt can be a result of several key factors that influence the
physicochemical properties (fatty acid composition, crystal form/hydration state and
particle size) of the material, all of which are related to preparation and processing:
synthesis conditions, mixing, milling and form conversion and/or stability conditions. In
order to understand the variability of MgSt, it is important to understand the effect of
each of these factors. The synthesis is the first step in the material preparation process
and will be the primary focus in this chapter.
A wide range of chemical composition is allowed for magnesium stearate
samples. The USP monograph for MgSt allows for “variable proportions of magnesium
stearate and magnesium palmitate”(19). To meet USP standards, the MgSt sample must
be derived from at least 40% stearic acid and at least 90% of the sample must come from
a combination of stearic and palmitic acids. The remaining 10% of the sample may be
derived from other fatty acids, such as myristic, pentadecanoic, margaric, arachidic and
behenic acids. This leads to a Mg metal content between 4-5%, depending on the chain
lengths of the fatty acids and their ratios. The content of stearic and palmitic acids in a
MgSt sample can be determined using a boron trifluoride-methanol extraction method to
convert the stearate and palmitate to their methyl esters and separate and identify them
using GC-MS. (19-22) Although commercial MgSt samples have a range of chemical
compositions, and USP has set broad guidelines for chemical composition requirements,
several researchers have suggested that within these guidelines the fatty acid composition
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does not seem to affect lubrication. Interestingly, Rajala et al. found that two lots with
similar chemical composition behaved very differently, possibly due to their hydration
state differences.(23) The significance of fatty acid composition in relation to synthesis is
being investigated and reported here.
The synthesis preparation of MgSt has been described in the literature using two
basic reaction methods. Equation 1-1 is the most basic reaction for MgSt synthesis, and
was noted in Kahner’s 2017 review as one of two methods to make MgSt.(17) The
second reaction, shown in Equation 1-2, is a two-step reaction published by Miller and
York in 1985, Ertel et al. 1987 and Rajala et al. in 1995. (23-25)
2 H-St + Mg(OH)2 à Mg-St2 + 2 H2O

Equation 4-1

2 H-St + 2 NaOH à 2 Na-St + MgCl2 à Mg-St2 + 2 NaCl + H2O Equation 4-2
Aspects of the reaction shown in Equation 4-1 and Equation 4-2 have
subsequently been patented by Mallinckrodt for manufacturing use with high ratios of
stearate to prepare the dihydrate form of MgSt with a plate morphology. (26, 27) It is
noted that other alternative salts, such as NH4OH, may be substituted for NaOH in
Equation 4-2. Additionally, Mallinckrodt has also presented the same synthesis reaction
substituting MgSO4*7H2O for the MgCl2.(28) As Mallinckrodt recognized, the most
important effect of chemical composition appears to be its effect on the hydrate form
produced during synthesis.(29) Marwaha and Rubenstein suggested that the alignment of
fatty acid chains in a crystal is governed by the chain length in the crystal packing
structure, which would affect the shearing potential of MgSt.(98) This chapter addresses
some of the trends observed in MgSt synthesis, for both reaction methods, using varying
fatty acid ratios.
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4.4   Materials and Methods
4.4.1   Materials

Stearic and palmitic acids were purchased from TCI. Magnesium hydroxide,
ammonium hydroxide and magnesium chloride were purchased from Fluka (St. Louis,
MO) , JT Baker (Radnor, PA) and EMD (Darmstadt, Germany), respectively.
4.4.2   MgSt Synthesis Procedures

Two preparation methods can be used to make MgSt. In this chapter they are
referred to as the “melt method” and the “bath method”. The melt method is a straightforward, spontaneous reaction which entails melting the acids (stearic, palmitic, other)
together above 70 °C, then adding Mg(OH)2 and water to the melted acids. Solid
magnesium stearate (the magnesium salt of stearic acid) has a lower solubility than the
melted fatty acids and is formed from the reaction, according to Equation 4-1.
The bath method is a two-step reaction in which the acids are dissolved in a water
bath heated to 70-90 °C. The pH of the system is adjusted to ~ pH 9 using ammonium
hydroxide to create the ammonium soap of the fatty acids. Magnesium stearate is then
precipitated out in a replacement reaction with magnesium chloride, as outlined in
Equation 1-2. Alternative reactants may be substituted for the various salts, such as
replacing NH4OH to make the calcium soap using Ca2OH. Or, NH4OH versus NaOH to
adjust pH and make soap, or MgCl2 versus MgSO4 for the replacement step. The specific
reaction in this study utilizes NH4OH in place of NaOH:
Stearic acid + NH4OH à NH4-Stearate
2 NH4(Stearate) + MgCl2 à Mg(Stearate)2 + 2 NH4Cl
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Equation 4-3

Following synthesis, the solid MgSt particles were subjected to a washing
procedure involving a reflux with water and/or acetone, to remove any unreacted acids
and impurities, such as excess MgO or Mg(OH)2. The samples were then dried to remove
excess water. Drying procedure was either air drying at ambient conditions for a week or
vacuum dried at 25 °C for 24 hours.
4.4.3   SSNMR Method

13

C CP/MAS data were collected using a Tecmag Redstone NMR Spectrometer

(Houston, TX), Bruker 400 MHz magnet (Billerica, MA), and a rebuilt H-X Chemagnetics
(Ft. Collins, CO) NMR probe with 7.5 mm rotors spinning at 4000 Hz. A relaxation delay
of 10 - 30s seconds was used with 2K acquisition points and 512, 1024 or 2048 scans.
TNMR software (Houston, TX) was used to process the data. 3-methylglutamic acid was
used as a reference standard, with the methyl peak referenced to 18.84 ppm.
4.4.4   Thermogravimetric Analysis (TGA)

TGA weight loss was measured using TA Q50 (TA Instruments, Newcastle, DE)
with a 10 °C/min ramp from 25 °C to 250 °C.

4.4.5   Differential Scanning Calorimetry (DSC)

DSC thermal analysis was performed using Q2000 DSC (TA Instruments,
Newcastle, DE). The heating rate was 10 °C/min ramp from 25 °C to 250 °C.
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4.5   Results and Discussion
4.5.1   Effect of Chemical Composition on Crystal Form Produced from Synthesis

Several batches of MgSt were prepared with the melt method at various St:Pa
ratios, as shown in Figure 4-1. SSNMR of lab-synthesized MgSt prepared using the melt
method. It appears that there is a trend in preferred form that correlates with fatty acid
ratio. Specifically, 50:50 St:Pa ratio shows a clean monohydrate form, with dihydrate
character increasing with increasing stearate content. This was observed to be a general
trend for the melt method in our MgSt synthesis experiments.

Melt 50:50

Melt 66:34

Melt 80:20

Melt 90:10
190

180

170 ppm

Figure 4-1. SSNMR of lab-synthesized MgSt prepared using the melt method
Several batches of MgSt were prepared with the bath method at various St:Pa
ratios, as shown in Figure 4-2. For the bath method, it appears that there is a trend in
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preferred form that correlates with fatty acid ratio, which is different from that of the melt
method. For the bath method, the 50:50 St:Pa ratio shows mostly the trihydrate form,
with the dihydrate form dominating with increasing stearate content, with 90:10 showing
pure dihydrate form. Additionally, significant amounts of a new form of monohydrate is
observed in the 70:30 and 80:20 samples. These general trends for the bath method were
observed repeatedly in our MgSt synthesis experiments, particularly with higher stearate
ratios, such as the 90:10 ratio, yielding the dihydrate form from the bath method.

Bath 40:60

Bath 50:50

Bath 60:40

Bath 70:30

Bath 80:20

Bath 90:10
190

180

170 ppm

Figure 4-2. 13C SSNMR of Lab-synthesized MgSt prepared using the bath method
In order to investigate differences between the synthesis methods, pure
magnesium stearate and pure magnesium palmitate, as well as 50:50 stearate: palmitate
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mixtures were prepared using both the melt and the bath method. The SSNMR for these
samples are shown in Figure 4-3. Overall, it appears that the melt method easily yields
the monohydrate form for 50:50 mixture, while the bath method yields dihydrate for the
pure acids.

50:50 Bath

50:50 Melt

Pa only Bath

Pa only Melt

St only Bath

St only Melt

190

180

170 ppm

Figure 4-3. 13C SSNMR for MgSt batches showing the carbonyl region, 160-200 ppm
It is also noted that the “Pa only Bath” and “St only Melt” samples have a small
peak around 182 ppm. The trihydrate form of MgSt and the unreacted stearic and
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palmitic acids have chemical shifts in this region, so thermal data is necessary to identify
the small 182 ppm peak for these two samples. The DSC in Figure 4-4 shows the “Bath,
Pa only” sample has a small peak with a melting onset ~ 65 °C, consistent with unreacted
palmitic acid. Figure 4-5 also reveals a slight weight loss in the TGA for the “Bath, Pa
only” sample, consistent with a small amount of trihydrate. For the “Melt, St only”
sample, there is no visible melt in the DSC and no weight loss in the TGA. The melting
point of stearic acid is ~ 70 °C, and a trace amount may be hidden under the larger
dihydrate dehydration. The TGA is expected to show no weight loss for stearic acid, and
the small peak at 182 ppm in the “Melt, St only” sample is more likely to be stearic acid
than the trihydrate form.

4

Melt, St only

2

Heat,Flow,(W/g)

0

Melt, Pa only
!2

Bath, St only

!4

!6

Bath, Pa only
!8

!10
Exo,Up

25

75

125

Temperature,(°C)

175

225
Universal,V4.7A,TA,Instruments

Figure 4-4. DSC of lab-synthesized MgSt samples, prepared with pure stearate and pure
palmitate
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4.887%

Melt, St only

100
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Weight3(%)

95

Melt, Pa only
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90

Bath, St only
0.6992%

85
5.236%

Bath, Pa only
80

25
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125

Temperature3(°C)

175

225
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Figure 4-5. TGA of lab-synthesized MgSt samples, prepared with pure stearate and pure
palmitate

The melt method tends to generate more monohydrate form, especially at stearate:
palmitate ratios closer to 50:50, while the bath method generates more of the dihydrate
form, especially for samples with a higher stearate content. The melt method
crystallization is an immediate reaction of melted acids with magnesium hydroxide,
where the bath method is a slower reaction from ammonium fatty acid salts with
magnesium chloride. At first, the dihydrate appears to have delayed crystallization
kinetics, suggesting that the monohydrate form may be metastable compared to the
dihydrate form, but thermal data shows that monohydrate should be more stable at these
temperatures.
From Figure 4-3, it appears that pure acids prefer to crystallize as the dihydrate
form, whereas fatty acid mixtures are more likely to crystallize as the monohydrate form.
In other words, the monohydrate form was preferred when fatty acid mixtures were
present, and higher St:Pa ratios had a higher relative concentration of dihydrate. The
higher stearate ratio had more unmixed fatty acid content and more of the dihydrate form,
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whereas mixed composition samples had more of the monohydrate form. This basic
understanding enables synthesis of pure dihydrate with high stearate content and
synthesis of pure monohydrate with 50:50 mixtures of stearate: palmitate.
An important aspect of the synthesis method is to ensure that the crystal habit/
form of the acid starting material does not impact the form produced. The unit cell of
MgSt crystal forms are not yet known, due to the shearing tendency of MgSt and the
difficulty growing single crystals without twinning that are large enough to perform
single crystal analysis. If the acids are not completely dissolved or melted prior to making
the soap (or reacting with MgOH2 for the melt), the solid form of the acids could act as
seeds for the MgSt, impacting the crystal form of MgSt generated. However, this is not
likely to affect the observed trends in fatty acid composition. The thermodynamic driving
force for the reaction for stearic vs. palmitate is similar: 1) The pKas for stearic acid and
palmitic acid are both approximately 4.75. 2) The solubility of stearic acid is 0.6 µg/mL
and palmitic acid is 0.04 µg/mL, giving stearic acid a slightly higher driving force, but
both substances are virtually insoluble in water. Melting points are also similar, with 68.8
°C for stearic and 61.8 °C for palmitic acid, and both acids will be melted at the reaction
temperature range of 70 – 90 °C, for both synthesis methods.
From Figure 4-3, we may speculate that the kinetics of crystal formation for the
monohydrate and dihydrate are different, with the monohydrate crystals forming faster
and the dihydrate crystals forming preferentially with longer time. This scenario would
be reasonable if the dihydrate is the more stable form. However, thermal data is clear that
the monohydrate has a dehydration temperature of 90 - 105 °C while the dihydrate
dehydration temperature is lower, around 70 - 90 °C. Based on thermal stability, we
would expect the dihydrate to form first as a metastable form, followed by the more
stable monohydrate. It is possible that the molecules are oriented as pure strands (St-St)
or mixed (St-Pa) and may crystallize out in that formation. This scenario fits with the
observation that a higher stearate content yields a higher percentage of dihydrate form.
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4.5.2   Effect of Reaction Water on MgSt Form for Melt Method
For an investigation of the impact of water on the form produced from the melt
method, six samples were synthesized at 50:50 St:Pa ratio with the melt method.
Conditions were varied between 0 mL water, 10 mL water and 50 mL water and
compared at 70 °C and 90 °C reaction temperatures. The results are shows in Figure 4-6.
Monohydrate was produced at both 0 mL water conditions, with trace amounts of
dihydrate in both 10 mL samples, as well as the 50 mL 90 °C sample. The 50 mL – 70 °C
had significant dihydrate and this increase in dihydrate with additional water added is not
unexpected for the 70 °C, as the dihydrate form requires more water to be incorporated
into the crystal lattice. The 50 mL – 70 °C condition had significant dihydrate character,
50 mL - 90 °C condition had only a small amount of dihydrate. Here it is reasonable that
the 90 °C condition produces less dihydrate than the 70 °C condition because the
monohydrate form is more stable at 90 °C. This is discussed in more detail in Chapter 5
in relation to form conversions.

50 mL - 90 οC
10 mL - 90 οC
0 mL - 90 οC
50 mL - 70 οC
10 mL - 70 οC
0 mL - 70 οC
190

180

170 ppm

Figure 4-6. 13C SSNMR of MgSt samples synthesized at 70 °C and 90 °C, using various
amounts of water
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4.5.3   Effect of Synthesis Reaction Temperature on MgSt Form

To evaluate the effect of reaction temperature on form, a single lot of material
was synthesized to make MgSt at 90:10 ratio with the bath method. Half of the sample
was reacted at 70 °C and isolated as dihydrate after filtration. The remaining half of the
sample was boiled at 100 °C, then filtered and subsequently isolated as monohydrate, as
shown in Figure 4-7. The only difference between the two samples was the reaction
temperature.
The TGA clearly shows that the dihydrate form dehydrates around 70 °C and the
monohydrate dehydrates around 100 °C. Between 70 – 90 °C, the dihydrate is expected
to be the stable form based on its thermal properties. Above 100 °C, the monohydrate is
expected to be the stable form, which is what we observe for this sample, with the
preferential synthesized form of dihydrate between 70 – 90 °C and the monohydrate
above 100 °C. This phenomenon suggests that the reaction temperature for MgSt
synthesis is critical in controlling the physical form yielded from the synthesis.

70 οC Dihydrate

200 190 180 170 160 ppm

90 oC Monohydrate

200 190 180 170 160 ppm

Figure 4-7. SSNMR of a batch of 90:10 St:Pa prepared using the bath method. The batch
was split into two portions, the first portion with reaction temperature at 70 °C and the
second portion boiled at ~100 °C.

Four samples were synthesized at 66:34 St:Pa ratio, shown in Figure 4-8. The
reaction temperature was varied between 70 °C and 90 °C for melt and bath methods. At
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70 °C, the melt method produced monohydrate with trace dihydrate and the bath method
had a higher amount of dihydrate content. At 90 °C, the melt method produced
monohydrate with trace dihydrate and the bath method produced dihydrate. Overall, these
results are consistent with the previous trends where 1) mixtures of stearate and palmitate
tend to produce monohydrate, but 2) the bath method produces higher amounts of
dihydrate and 3) higher reaction temperature produces higher amounts of dihydrate.
These three variables in the synthesis process appear to be simultaneously impacting the
crystal form of MgSt produced.

Melt 70 οC
Bath 70 οC
Melt 90 οC
Bath 90 οC
190

180

170 ppm

Figure 4-8. 13C SSNMR of MgSt 66:34 St:Pa samples, synthesized with variations in
temperature and synthesis method

4.5.4   Effect of Drying Conditions on Crystal Form

The last step of the synthesis involves drying the samples. To evaluate the
conditions of the drying process, two samples were synthesized: 90:10 St:Pa using the
bath method and 50:50 St:Pa ratio using the melt method, shown in Figure 4-9 and Figure
4-10, respectively. Each sample was split into aliquots for drying at various conditions: 1)
air drying in a covered, open pan at ambient condition for 7 days, 2) vacuum drying in a
covered, open pan in a vacuum oven for 24 hours, 3) nitrogen drying in a vial with

67

flowing dry nitrogen gas for 7 days, 4) desiccated drying in a vial placed in a desiccator
for 7 days.

Air Dry
Vacuum Dry
Desiccator Dry
Nitrogen Dry
190

170 ppm

180

Figure 4-9. 13C SSNMR for MgSt samples from Bath method 90:10 after drying via
various methods
Figure 4-9 shows the drying for a 90:10 sample using the bath method. The airdry method is the least harsh and is the best representation of the material produced from
the synthesis. The vacuum drying condition appeared to show higher monohydrate
content and reduced dihydrate, suggesting possible rearrangement from dihydrate to
monohydrate. The desiccator condition showed some evidence of dehydration, with the
monohydrate peaks becoming less defined. Under nitrogen flow, the dihydrate appeared
to partially dehydrate into the disordered form, accompanied by rearrangement of the
monohydrate peaks. This behavior is consistent with other N2 drying data and this
phenomenon is discussed at length in Chapter 6, as nitrogen drying may inhibit the
normal lubricating effect of MgSt and result in fast dissolution and poor tablet lubrication
properties.
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Air Dry
Vacuum Dry
Desiccator Dry
Nitrogen Dry
190

180

170 ppm

Figure 4-10. 13C SSNMR for MgSt samples from Melt method 50:50 after drying via
various methods
For the 50:50 melt material, SSNMR showed a similar form for all four melt
method samples dried in different ways, which are all monohydrates. (Figure 4-10) The
drying method did not appear to significantly affect the crystal form for the monohydrate
samples. However, it appeared from the 90:10 bath sample that the dihydrate, and
mixtures containing the dihydrate form, were more sensitive to the drying method and
conditions that may promote dehydration of the MgSt physical forms.
4.5.5   Reproducibility of Lab-Synthesized MgSt Monohydrate and Dihydrate

The primary goal of the synthesis study was to create samples to be studied.
Therefore, it was important to evaluate reproducibility with regard to consistency of
crystal form produced from MgSt synthesis. Additional lab-synthesized samples were
prepared using the melt method at fixed fatty acid compositions of 55:45 and 90:10
stearate: palmitate. Figure 4-11 and Figure 4-12 show monohydrate produced from 55:45
melt condition and dihydrate produced from the 90:10 bath condition, with only very
minor differences between the samples.
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55:45 A
55:45 B
55:45 C
55:45 D
190

180

170 ppm

Figure 4-11. 13C SSNMR of monohydrate MgSt synthesized from melt method at 55:45
St:Pa

90:10 A

90:10 B

90:10 C

90:10 D
190

180

170 ppm

Figure 4-12. 13C SSNMR of dihydrate MgSt synthesized from bath method at 90:10 St:Pa
However, additional samples were prepared at 55:45, shown in Figure 4-13 with
some variations in crystal form produced. This illustrates the challenge of preparing
consistent materials. Conditions believed to influence the form and morphology of the
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material obtained from the synthesis process include reaction temperature, the amount of
water present during the synthesis and impurities in the synthesis reagents. Stirring rate is
also believed to impact the particle size of the MgSt formed. However, there was no clear
explanation for the observed variation from the synthesis conditions for the samples in
Figure 4-13. It was later discovered that some of the glassware contained residual solids
from previous experiments, which may have contributed to inadvertent seeding with the
dihydrate form.

55:45 E

55:45 F

55:45 G

55:45 H

55:45 I
190

180

170 ppm

Figure 4-13. 13C SSNMR of additional lab-synthesized prepared with the melt method at
55:45 St:Pa

4.6   Conclusions

There are several conclusions from this investigation of MgSt synthesis. First, the
chemical composition (stearate: palmitate ratio) and the reaction method both affect the
crystal form of magnesium stearate that is produced from synthesis reactions. Pure fatty
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acid compositions (i.e. stearate only or palmitate only) showed a preference to produce
the dihydrate form and fatty acid mixtures tended to yield more of the monohydrate form.
The melt method, a spontaneous reaction of fatty acids with magnesium hydroxide,
preferentially produced the monohydrate form, with increasing amounts of dihydrate
yielded from higher stearate content samples. The bath method, a two-step reaction
precipitating MgSt from soap and magnesium chloride, also yielded higher amounts of
dihydrate form at higher stearate content samples. Combining the observed trends with
fatty acid composition and method, it was found that the monohydrate form could be
most easily produced from the melt method with a 50:50 St:Pa composition and the
dihydrate form could most easily be produced from the bath method at 90:10 St:Pa
composition.
Second, addition of a small amount of water during the melt method reaction
appeared to aid formation of the monohydrate form. Additionally, the reaction
temperature in the bath method was found to affect the crystal form produced. For a
90:10 St:Pa composition, dihydrate was yielded at 70 °C, but monohydrate was yielded
when the temperature was increased to 100 °C.
Additionally, drying magnesium stearate may affect the physical form of the
material, with more significant effects seen for the dihydrate and form mixtures. On a
practical level, air drying for a few days was found to be the most gentle and effective
drying method for lab-scale synthesis of MgSt. The dihydrate appears to be more
sensitive to drying than the monohydrate form, but both forms can dehydrate in harsh
drying conditions such as nitrogen drying or desiccation. Further investigation of the
effect of drying on magnesium stearate are discussed in Chapter 6.
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CHAPTER 5.  
PREDICTING THE HYDRATE FORM CONVERSIONS
OF MGST IN BULK POWDER AND TABLET FORMULATIONS
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5.2   Abstract

Magnesium stearate (MgSt) is a popular pharmaceutical lubricant, but batch-tobatch variations in physical properties can cause variability in performance. It is proposed
that the variability in the dissolution and lubrication properties of MgSt can be related
back to its complicated structural properties, specifically the crystal hydrate forms of
MgSt. The crystal hydrate forms are believed to interconvert, which may affect
performance of MgSt in formulations. Thermal analysis was used to choose temperature
conditions to investigate the interconversions between the crystal forms. Dehydration
temperatures for the trihydrate ranges from 60 - 80 °C, from 80 – 100 °C for the
dihydrate and the monohydrate dehydrates around 105 °C. 13C SSNMR was used to
identify the crystal forms at different temperature and humidity conditions. The dihydrate
was found to dehydrate to the anhydrate form with a disordered intermediate form with
heating to 105 °C. The disordered form was rehydrated to the monohydrate form at 105
°C, 100 %RH and to the trihydrate form at 25 °C, 100 %RH. Direct conversions at 80 °C,
100 %RH reflected increasing thermal stability from trihydrate < dihydrate <
monohydrate. An updated schematic for MgSt form conversions was proposed,
encompassing form conversions from the intermediate disordered form as well as from
direct form conversions. Finally, tablet formulations stored at typical stability conditions

showed an increase in the dihydrate form at 40 °C/ 75% RH and dehydration of the
dihydrate to the disordered form at 40 °C/ 0% RH. Overall, it was shown that the crystal
form of MgSt can change under varying temperature and humidity conditions, both in
bulk and in tablet formulations.

5.3   Introduction

Magnesium stearate (MgSt) is the most commonly used excipient for
pharmaceutical tablet formulations, and is used in over half of the marketed
formulations.(1) MgSt is typically added to tablet formulations as a lubricant at a 0.25 5% level to prevent powder from sticking to the tablet die and manufacturing equipment
during the tableting process. Many formulation labs have experienced unexplained batchto-batch and lot-to-lot variation with MgSt, where the lubrication capability and/or the
dissolution rate varies unexpectedly.(16, 97) For example, one lot from a manufacturer
may show picking and sticking after several thousand tablets are made as powder builds
up on the equipment, but other lots do not show the same extent of picking and sticking.
In addition, tablets manufactured from different lots of MgSt may have different
dissolution properties. The reasons for the inconsistencies between lots and types of
MgSt are still poorly understood, (8, 149-151) but it is proposed that the variability in the
dissolution and lubrication properties of MgSt can be related back to its complicated
physicochemical properties.(98, 126)
One of the physicochemical properties of MgSt that have been proposed to have a
significant effect on its lubrication and dissolution is the crystalline hydrate form.(152)
Magnesium stearate is currently known to exist in multiple pseudo-polymorphic forms,
but it has taken a few decades to reach this understanding. In 1977, Mueller noticed that
the amount of water in a MgSt sample was related to its lubrication properties and that
thermal drying can change its polymorphic properties. They suggested that drying
changes the crystal structure from an orthorhombic or monoclinic crystal structure to
hexagonal structure.(31) A few years later, Miller and York began to investigate the
physical characterization of MgSt powders by preparing and characterizing pure
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magnesium stearate and magnesium palmitate samples. They identified that both pure
samples were associated with two molecules of water, and suggested that synthesis
conditions such as pH played a role in hydration state.(25) Ertel and Carstensen also
studied the physical properties of pure MgSt throughout the 1980s.(24, 32, 33) They
determined that preparation conditions affect the hydration state and modifying the
relative humidity (RH) and/or temperature can convert to a different hydration state. For
example, heating at 105 °C led to water loss as well as crystal lattice collapse. In
addition, they noted the importance of the long spacing of the crystal lattice structure,
which was dependent on the hydration state. Wada specifically looked at MgSt pseudopolymorphism and hydration using DSC,(34) but it was not until 1997 that Sharpe et al.
identified the pseudo-polymorphs as anhydrate, dihydrate and trihydrate (without
mention of a monohydrate form).(35) They proposed structures for the dihydrate and
trihydrate phases based on the long crystal spacing from XRPD and deduced that the
pseudo-polymorphism is a result of “changes in the angle of inclination of the
hydrocarbon chains relative to the plane of the Mg atom head groups, brought about by
the water content in the lattice.”(35) Bracconi et al. perform a thorough XRPD
investigation of two commercial lots without single crystals to fully elucidate the crystal
structure,(36) and two years later, their DSC evaluation of the same two lots did not
“fully clarify the relation between thermal and structural properties.”(37) In 2001,
Swaminathan and Kildsig published a schematic showing form conversions between the
different hydrate forms,(39) which was later expanded to include the monohydrate form
along with extensive evaluation of MgSt dihydrate properties from a commercial
manufacturer’s point of view.(28)
Although the single crystal structures of MgSt forms are still elusive, Delaney et
al. showed that SSNMR can uniquely and reliably identify the crystalline forms of MgSt.
Using SSNMR, five forms were identified as anhydrous, ordered monohydrate, dihydrate
and trihydrate forms and an additional disordered monohydrate.(38) The ability to
identify MgSt crystal forms using 13C SSNMR by Delaney et al. not only clarifies the
existing hydrate variability, but also provides a foundation for studying MgSt hydrate
form conversions.(38) This research provides a study of the MgSt form conversions
based on the dehydration and rehydration temperatures of the isolated MgSt hydrate
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forms. Using 13C SSNMR, we were able to easily identify form conversions in neat MgSt
samples. Additionally, we were able to study MgSt form conversions in tablet
formulations at low levels of MgSt, using 13C labeled stearic acid to synthesize MgSt. In
this chapter, we investigated in greater detail the form conversions of MgSt upon
exposure to different relative humidity conditions, temperature and processing
conditions.

5.4   Materials and Methods
5.4.1   Materials

Stearic acid and palmitic acid were purchased from TCI (Tokyo, Japan). Labeled
stearic and palmitic acids were purchased from Aldrich. Magnesium hydroxide was
purchased from Fluka (St. Louis, MO). Magnesium chloride hexahydrate was purchased
from EMD (Darmstadt, Germany). Tablet excipients Avicel (microcrystalline cellulose,
MCC) and alpha-Lactose monohydrate were obtained as a complimentary sample from
FMC Biopolymer (Philadelphia, MA) and purchased from Sigma (St. Louis, MO),
respectively. The commercial samples used in this study were obtained from Peter
Greven.
5.4.2   Thermogravimetric Analysis (TGA)

TGA weight loss was measured using TA Q50 (TA Instruments, Newcastle, DE)
with a 10 °C/minute ramp from 25 °C to 250 °C. TGA
5.4.3   Differential Scanning Calorimetry (DSC)
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DSC thermal analysis was performed using Q2000 DSC (TA Instruments,
Newcastle, DE). The heating rate was 10 °C/min ramp from 25 °C to 250 °C.
5.4.4   Solid-state NMR Spectroscopy (SSNMR)

13

C CP/MAS/TOSS SSNMR data were collected using a home built Tecmag

Redstone NMR Spectrometer (Houston, TX), Bruker 400 MHz magnet (Billerica, MA),
and Chemagnetics (Ft. Collins, CO) NMR probe with 7.5 mm rotors spinning at 4000 Hz.
A relaxation delay of 12 s was used with 2K acquisition points and 1024 scans. TNMR
software (Houston, TX) was used to process the data. 3-methylglutamic acid was used as
a reference standard, with the methyl peak referenced to 18.84 ppm.
5.4.5   Conditions for Form Conversions

Form conversions for MgSt samples were performed by placing ~ 500 mg powder
samples in an aluminum pan and heating in an oven at defined temperatures. Humidity
samples at 75 %RH condition were prepared using jars containing saturated salt solutions
of sodium chloride. Drying was performed by placing powder in a vial and holding under
nitrogen flow or in a desiccator.
5.4.6   MgSt Synthesis

Magnesium stearate lots were synthesized in various stearate: palmitate ratios of
50:50, 55:45, 66:34, 70:30, 80:20, 90:10 and 100:0. Two synthesis methods were used.
For the “melt” method, stearic and palmitic acids were melted at 70 °C, then reacted with
magnesium hydroxide and water. For the “bath” method, stearic and palmitic acids were
dissolved in a 90 °C water bath, ammonium hydroxide was added to adjust the pH above
pH 9, then magnesium chloride was added to precipitate magnesium stearate. The
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recovered solids from both methods were washed using a reflux bath of 1:1 acetone:
water for 24 hours to remove impurities and any unreacted starting materials. The MgSt
samples were air-dried and/or dried in a vacuum oven at 25 °C to remove surface water.
5.4.7   Mixing and Tableting

Indomethacin tablet formulations were prepared by adding MgSt to a “Premix”
mixture containing 16.7% indomethacin (Sigma, St. Louis, MO), 47.3% alpha-lactose
monohydrate (Sigma, St. Louis, MO), 34% Avicel (FMC Biopolymer, Philadelphia, PA)
in a ratio of 2:98 MgSt: Premix. The tablet powders were mixed as 1 g batches in 40 mL
glass vials for 60 minutes using a Turbula T-2C mixer (WAB, Basel, Switzerland) on the
highest setting. Six individual 150 mg tablets were made from each 1 g formulation batch
and pressed using a single tablet press (Globe Pharma, North Brunswick, NJ) at 50 bar
for 30 seconds. The tablet weights were recorded, and the dissolution results were
adjusted for tablet mass. Ball mixing was performed by adding 1g of MgSt to a 40 mL
glass vial with ten ¼-inch plastic balls and mixed for 60 minutes using the Turbula T-2C
mixer.

5.5   Results and Discussion
5.5.1   Thermal Analysis for MgSt Form Conversions
Magnesium stearate is known to be a physically stable powder at ambient
conditions. It was observed that each of the hydrate forms is stable for > 2 years at 25 °C
in closed vials. However, the hydrate forms have been reported to interconvert under
specific temperature and relative humidity conditions,(39) so investigation was
undertaken to confirm and define the conditions for interconversion of the MgSt crystal
forms. Thermogravimetric weight loss data for the five forms of MgSt is displayed in
Figure 5-1, showing the dehydration temperatures, which can be used to select
appropriate temperature conditions to promote interconversions between forms. The
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dehydration temperatures for the different hydrate forms are different, with trihydrate
dehydration between 60-80 °C, dihydrate between 80-100 °C and monohydrate
dehydration between 100-120 °C. The disordered form has a broad weight loss
temperature, ranging from 40-125 °C, indicating surface bound water or a possible
channel hydrate. It appears that all the hydrate forms can be completely dehydrated when
heated above 105 °C and can then be converted from the dehydrated state to the desired
hydrate form at selected temperature and humidity conditions.

Anhydrous
Disordered
Monohydrate
Dihydrate

Trihydrate

Figure 5-1. Thermal data showing the melting and dehydration temperature for different
MgSt forms. Used with permission from Delaney et al.

5.5.2   Form Conversions in MgSt with 100% Stearate Content
Figure 5-2 shows the SSNMR for the form conversions of a MgSt sample,
originally prepared as the dihydrate form, with 100% stearate content. When a portion of
this material was heated at 105 °C in an oven without humidity control, it visually
appeared melted. As this material was brought to room temperature, it solidified into an
anhydrous form with apparent crystalline order, as determined by 13C SSNMR. This
intermediate anhydrous melt was then rehydrated at 105 °C, 100%RH and recovered as
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the monohydrate form of MgSt. It was clear from this experiment that a single sample of
MgSt can undergo changes in hydrate form using the temperature and RH conditions.

Dihydrate

200

190

180

170 ppm

105 οC

200

Anhydrous

190

180

170 ppm

105 οC, 100 %RH

Monohydrate

200

190

180

170 ppm

Figure 5-2. Form conversions for MgSt prepared from 100% stearic acid

5.5.3   Form Conversions of MgSt due to Dehydration at 105 °C
The first step in understanding the form conversions observed in Figure 5-2 is an
examination of the dehydration process. Based on the thermogravimetric analysis in
Figure 5-1, the different forms of MgSt will dehydrate at different temperatures, and all
three hydrate forms will be dehydrated above 105 °C. Figure 5-3 shows a dihydrate
sample after heating at 105 °C. After 3h heating, the material was changed to the
disordered form. An additional 5h of heating, for a total of 8h, generated the anhydrous
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form. The disordered form appears to be an intermediate form, with the anhydrous form
as the stable form at 105 °C under dry conditions.

Dihydrate

Initial form

Disorder/Trihydrate

2h at 105 oC

Anhydrous

8h at 105 oC

190

180

170

160 ppm

Figure 5-3. 13C SSNMR of a MgSt dihydrate sample after drying at 105 °C

5.5.4   Form Conversions of MgSt due to Rehydration at 100% RH
Having established that dehydration by heating can generate the disordered form,
the rehydration process was investigated. Rehydration temperature conditions were
chosen with the aim of converting to specific forms of MgSt. Specifically, 105 °C, 100
%RH was chosen as a rehydration condition which was expected to convert to the
monohydrate form, since it is close to the dehydration temperature of monohydrate.
Similarly, 25 °C, 100 %RH was chosen as a rehydration condition expected to convert to
the trihydrate form, being below the dehydration temperature of the trihydrate form.
Figure 5-4 shows the dehydration and rehydration conversions at 105 °C, 100%
RH for several MgSt hydrate mixtures with a range of fatty acid ratios. These samples
were dried at 105 °C to promote dehydration, followed by rehydration at 105 °C, 100%
RH. As predicted from the thermal data, the monohydrate form was yielded at the 105
°C, 100% RH condition. Furthermore, it appeared that the starting form was irrelevant
when converting to the monohydrate form via the dehydration-rehydration process. This
made sense, since the trihydrate and dihydrate were expected to dehydrate into the

81

disordered form at 105 °C. The disordered material rehydrated into the form dictated by
the rehydration temperature, which in this case was the monohydrate form.

Fatty Acid

Form after 105 οC melt and
rehydration at 105 οC/ 100 %RH

Starting Form

50:50

60:40
105 οC,
100 %RH

105 οC
70:30

80:20

90:10
190

180

190

170
ppm

180

170
ppm

Figure 5-4. 13C SSNMR of MgSt form conversions to monohydrate after heating at 105
°C and subsequent rehydration at 105 °C/100% RH

Figure 5-5 shows the dehydration and rehydration MgSt form conversions at the
25 °C, 100 %RH condition. The starting materials contained mixtures of dihydrate and
monohydrate and were dehydrated to the disordered form at 105 °C prior to the
rehydration step at 25 °C, 100 %RH. The starting materials all had a 66:34 fatty acid
composition and were labeled with about 30% palmitic acid 13C label on the C1 carbon. It
was expected that the trihydrate would predominantly form from the disordered form at
these conditions, since the temperature was below the dehydration temperature for the
dihydrate and monohydrate. The results showed mixtures of the trihydrate form
(indicated by the single sharp peak around 183 ppm) and/or the disordered form
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(indicated by the broad peak). There appeared to be more of the disordered form when
the starting material was predominantly monohydrate, and more of the trihydrate form
with traces of the high melting anhydrate form when the starting material contained large
amounts of dihydrate. This may be due to partial conversion to the anhydrate
intermediate form during the drying step at 105 °C, if it was held at 105 °C for an
extended period of time. The implication of this set of experiments is that the disordered
form can be converted to the trihydrate form at moderate conditions of 25 °C/ 100 %RH,
conditions which may be relevant to storage conditions for the bulk raw materials.
Starting Form

Form after 105 οC melt and
rehydration at 25 οC/100 %RH

25 οC,
100 %RH

105 οC

190

180

170
ppm

190

180

170
ppm

Figure 5-5. MgSt conversions to trihydrate and/or disordered form by melting at 105 °C,
then rehydrating at 25 °C/100% RH

5.5.5   Direct Form Conversions at 80 °C/100%RH
Thus far we have seen that MgSt form conversions readily occur from the
dehydration of the hydrate forms to the disordered form, followed by rehydration of the
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disordered form at temperatures corresponding to the hydrate forms. This section
addresses the “direct” form conversions, without an intermediate disordered step.
Dihydrate interconversions are expected to occur at conditions around 80 °C/ 100
%RH. This condition represents the dehydration temperature of the dihydrate form and is
intermediate between the monohydrate and trihydrate hydration temperatures, which are
105 °C and 25-40 °C, respectively. Several MgSt mixtures of dihydrate-trihydrate were
placed at 80 °C/ 100 %RH for one week (without the melt intermediate prior to
rehydration). Figure 5-6 shows an increase in dihydrate content for these samples after
storage at 80 °C/ 100 %RH, but complete conversion is not attained in these experiments
after a week of storage. In addition to the increase in dihydrate, the trihydrate content
appears to partially convert into monohydrate under these conditions. These results
support the expected MgSt form conversions at this temperature and humidity. It is
challenging to convert completely to the dihydrate form, with the hydration temperature
transition existing between monohydrate and trihydrate hydration temperatures.

Fatty Acid

Starting Form

Form after storage at
80 οC, 100 %RH

40:60

50:50

60:40

80:20
190

180

170
ppm

190

180

170
ppm

Figure 5-6. MgSt form conversions to dihydrate after storage at 80 °C/100% RH
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5.5.6   Form Interconversion Schematic
As mentioned earlier, MgSt hydrate conversion schematics have been put forth by
previous researchers.(39) Our study revealed a form conversions which can be organized
into the schematic illustrated in Figure 5-7. The outer ring shows the conditions for direct
conversions between hydrate forms, while the inner ring shows conditions for form
conversions through the disordered or anhydrous intermediate step. This schematic shows
the conversions in a systematic manner and is more elegant than previous MgSt form
conversion schematics.
The intermediate form is a melt which forms upon dehydration at 105 °C and
solidifies when removed from the oven and can be recovered as either the disordered
form or the anhydrous form. The disordered form is generated with heating for ~ 2 hours.
If the material is heated for longer periods of time, the equilibrium shifts further and the
more crystalline anhydrate is formed. In the presence of water, both the disordered and
anhydrous forms readily sorb water to form the trihydrate at 25 °C, the dihydrate around
80 °C or the monohydrate at 105 °C.
The dehydration temperatures of MgSt hydrates are unusual in that the higher
order hydrates dehydrate at lower temperatures. In the presence of water, the trihydrate
converts to dihydrate and/or trihydrate above the trihydrate dehydration temperature, and
the dihydrate form converts to the monohydrate above the dihydrate dehydration
temperature. Removing the water dehydrates all of the forms, and both the disordered
form and the anhydrate will sorb water and form the hydrate that is most stable at the
given temperature condition. Temperature is the primary driver for determining the
crystal form, but the presence of water is required to form the hydrates. In the presence of
water, the monohydrate is the most stable hydrate form of MgSt, with dehydration around
105 °C, followed by the dihydrate at 70 – 90 °C and trihydrate below 50 °C. These
conditions are relevant for formulation development processes such as wet granulation
and the impact of MgSt form conversions should be considered when using processing
techniques which introduce water into the system at elevated temperatures.
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Monohydrate

100% RH
105 °C
100% RH
80 °C

Dihydrate

105 °C
100% RH
105 °C
Disordered
or
Anhydrous
Dry at 105 °C

100% RH
105 °C
100% RH
25 °C

Trihydrate

100% RH
80 °C

Figure 5-7. Proposed Schematic of MgSt Form Interconversions

5.5.7   Form Conversions at 75 %RH
The MgSt potential for form conversions in dry conditions and in 100 %RH
conditions has been discussed in the previous sections. The interconversion of MgSt
crystal forms may be a potential formulation stability concern. Therefore, storage
conditions are also an important consideration in formulation development situations.
Conditions such as 25 °C, 75 %RH, 40 °C, 75 %RH and 60 °C, 75 %RH may be
evaluated for storage and stability. This section briefly addresses the 75 %RH condition
at various temperatures, including some conditions commonly used in pharmaceutical
stability studies.
Figure 5-8 shows the conversion to monohydrate at 60 °C, 75 %RH, as well as a
partial conversion at 40 °C, 75 %RH. Under high humidity conditions, the disordered
form of MgSt was observed to convert to the monohydrate form. It was slightly curious
that the dihydrate was not formed at 60 °C, instead of the monohydrate. This data
suggests that the monohydrate is the more stable form at these temperatures, even though
the dihydrate was expected at intermediate temperatures around 60 °C. It is speculated
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that 75 %RH is not a high enough relative humidity to preferentially form the dihydrate
crystal form at 60 °C.

60 οC, 75 %RH

Monohydrate

40 οC, 75 %RH

Disordered/monohydrate

25 οC, 75 %RH

Disordered

190

180

170
ppm

Figure 5-8. MgSt form conversions from disordered starting material under various
temperature conditions at 75% RH

5.5.8   Form Conversions in Tablets after Storage at Stability Conditions
In addition to determining the form conversions in bulk MgSt, the possibility of
form conversions of MgSt in tablets was investigated. Due to the low level of MgSt in
most tablet formulations, it is often difficult to detect the MgSt in formulations. For this
reason, several lots of MgSt were synthesized in the lab using labeled stearic acid. The
stearic acid was 13C labeled at the C1 carbon of the carbonyl. This allows for enhanced
sensitivity of MgSt in the carbonyl region and MgSt form differences can be detected in
formulations prepared using labeled MgSt. For this study, the tablets were made on a
hydraulic, single tablet press using 200 bar compaction pressure. The starting form of
neat MgSt was compared with the form of MgSt in tablets.
Figure 5-9 shows tablets containing 2% MgSt after storage at various temperature
and humidity conditions. The starting form was a mixture of monohydrate, dihydrate and
trihydrate. Form conversions were observed, corresponding with the forms expected at
the temperature and humidity of each storage condition. The 25 °C, 75 %RH condition
showed a slight change in the form of MgSt, with the trihydrate peak decreasing relative
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to the dihydrate peaks, but this is can be attributed to an increase in resolution due to the
effects of tablet compression. At 40 °C/ 75% RH, there is significant increase in the
dihydrate peak relative to the monohydrate and trihydrate peaks. The dihydrate increase
at 40 °C/ 75% RH is nominally consistent with the dihydrate dehydration conditions,
suggesting the dihydrate is expected to exist at 40 °C/ 75% RH, which is in between the
conditions to form the monohydrate and trihydrate. At 40 °C/ 0% RH, the dihydrate peak
shrinks and almost disappears, accompanied by a small growth of disorder in the
baseline, indicating dehydration. Additionally, a decrease in the trihydrate peak and
shifting of the monohydrate peaks is observed, indicating a new form of MgSt. The
effects of dehydration on the monohydrate form will be discussed further in Chapter 6.
This dehydration and loss of crystallinity is particularly relevant for formulation
development, as solid oral dosage forms are often packaged in 0% RH conditions.

40 οC/ 0% RH

40 οC/ 75% RH

25 οC/ ambient

Starting form
200

190

180

170

160
ppm

Figure 5-9. SSNMR of MgSt in tablet formulations after storage at various stability
conditions
Stability conditions can clearly impact the form of MgSt in tablet formulations,
even at low levels of MgSt. Dehydration in particular is an important issue to be aware of
for tablet formulations, as storage at 40 °C/ 0% RH for just 7 days can impact the forms
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of MgSt. Dehydrating the sample pulls the water out of the crystal lattice, which may
collapse the crystal structure and disrupt the lubrication ability. This is bad for lubrication
efficiency, so the storage conditions prior to tableting should be chosen with this in mind.
However, the dehydration of MgSt after tableting may be beneficial in decreasing the
effect of MgSt on dissolution. After the tablets are made, this structure change may still
affect the particle-particle interactions inside the tablets, with implications for dissolution
and absorption, with the MgSt potentially affecting the ability of the drug to be released
into the body. The MgSt coverage of particles in the formulation will be less effective
after dehydration, increasing particle-particle adhesion and allowing for easier release
and faster dissolution. All of these things should be considered in developing the best
tablet formulations incorporating MgSt, with particular attention to the potential for form
conversion at elevated temperature and relative humidity conditions.

5.6   Conclusions
This chapter provides an increased understanding of the form conversions of
MgSt, both in bulk and in tablet formulations. Thermal data can be used as a guide to
choose likely conversion conditions based on the dehydration temperatures of the MgSt
hydrate forms. In dry conditions at 105 °C, the hydrates can be dehydrated into the
disordered form. The disordered form may then be rehydrated at 100 %RH at
temperatures corresponding to the various hydrate forms. It was shown that at 80 °C, 100
%RH, the trihydrate converts into the dihydrate and/or monohydrate form, showing that
in the presence of excess water, the crystal form depends on temperature. A form
conversion schematic for MgSt is presented, proposing conditions for direct conversions
between MgSt crystal hydrate forms, as well as form conversions through an intermediate
disordered or anhydrous form. Stability conditions for bulk MgSt samples were briefly
investigated and showed the monohydrate form was formed over the dihydrate form at 40
°C/ 75%RH and 60 °C/ 75 %RH. Tablet formulations also showed MgSt form
conversions at 40 °C/ 75%RH, with an increase in dihydrate form, and at 40 °C/ 0%RH
with dihydrate being dehydrated. Overall, it is shown that the crystal form of MgSt can
change under varying temperature and humidity conditions, both in bulk and in tablet
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formulations. Understanding the form conversions of MgSt in bulk and in tablets is
potentially relevant to formulation stability and storage conditions.
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CHAPTER 6.  
THE IMPACT OF DRYING ON MGST SURFACE AREA
AND HYDRATE FORM
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6.2   Abstract

Purpose: Magnesium stearate (MgSt) is a widely used pharmaceutical lubricant in
tablet manufacturing. However, batch-to-batch variability of MgSt can lead to
inconsistency in performance. Surface area is known to impact tablet performance. The
crystal form of MgSt has also been shown to affect lubrication performance. In this work,
we investigate how drying impacts the surface area results and may also induce a change
in crystal form.
Methods: Surface area analysis was conducted using a Micromeritics ASAP 2460
with Smart Vac Prep attachment to vary drying time and temperature. Specific surface
area was calculated using the BET method. Solid-state NMR was used to identify the
crystal form of MgSt samples. 13C spectra were acquired on a 9.4T spectrometer using a
home-built 7.5mm MAS probe at 4 KHz at room temperature and processed using
Tecmag software.
Results: The extent of drying MgSt prior to surface area analysis impacts the
surface area results, as well as the fit of the BET equation. Surface area after drying for
2h at 40 °C (USP conditions) showed a notable decrease in surface area for some
commercial samples, which also correlated with a physical form change in the MgSt
sample. Specifically, the dihydrate form of MgSt appeared to disappear and the
disordered form appeared with an increase in drying time. A similar form change for
MgSt was observed in tablets after storage in desiccated conditions for 7 days.
Conclusions: Drying is shown to affect the crystal form of MgSt, both in bulk and
in tablets. This has implications for appropriate storage conditions and the physical
stability of MgSt used in pharmaceutical formulations.

6.3   Introduction
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Magnesium stearate (MgSt) is the most common pharmaceutical excipient and is
used as a lubricant in approximately half of the tablet formulations on the market. (1) In
spite of its popularity as an effective lubricant, it has been repeatedly recognized that
there is significant variability between MgSt samples which can cause inconsistent
lubrication between lots and batches of MgSt. In addition to chemical composition
variability and pseudopolymorphism variability, the particle size and surface area of
MgSt have been investigated for their impact on performance variability. In 1984, Frattini
and Simioni reported a correlation between MgSt surface area and tablet ejection force.
(40) Phadke et al. suggested that particle size analysis would be a potential way to
evaluate batch-to-batch variation in MgSt, and studied the degassing effects associated
with BET surface area analysis, hypothesizing that lower surface area after degassing
could be due to hydrate form conversion.(40-42) Andres et al. recognized the need for an
improved understanding of MgSt degassing effects in 2001,(43) followed by Koivisto et
al. who noted that although all hydrate forms converted to anhydrous at 105 °C, the
hydrate surface area isotherms did not always fit properly with BET theory.(44)
Extensive investigation of the degassing of MgSt was undertaken by Lapham and
Lapham, revealing dehydration and unreliable BET results with degassing as low as 40
°C. In their 2019 study, the surface area and isotherms of four commercial samples were
analyzed before and after degassing at temperatures ranging from 30 – 110 °C. The
hydration state of the starting materials was determined from TGA weight loss and
vacuum drying, with assumptions of anhydrous and hydrated forms based on weight loss
temperatures. Looking closely at isotherms and low pressure hysteresis, the differences in
adsorption/desorption isotherms for the samples were found to be related to the hydrated
water in the starting form for each batch and a swelling effect causing adsorbate to be
entrapped in the sample during the adsorption process.(45-47) Expanding on the current
understanding of the degassing process from the Lapham work, we aim to relate the
dehydration to changes in MgSt crystal form. Our previous paper by Delaney at al.
presents a variety of characterization techniques for several MgSt commercial samples,
including SSNMR. The carbonyl region of the SSNMR spectrum clearly distinguishes
between crystalline hydrate forms, as well as the anhydrate and disordered forms of
MgSt.(48)
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In this present chapter, we characterize the surface area of selected commercial
and lab-synthesized MgSt samples, using various drying and degassing conditions prior
to surface area analysis. The samples are characterized by SSNMR before and after
drying, to evaluate the impact of drying conditions on neat MgSt. Drying/degassing leads
to dehydration, and a form change for MgSt hydrates, with this form change being easily
identified using SSNMR. It is also shown that the extent of drying time at 40 °C is
critical to not only the observed surface area but also the physical form of MgSt. Finally,
dissolution of tablet formulations before and after drying shows an effect of dehydration
on the functional properties of MgSt.

6.4   Materials and Methods
6.4.1   Materials

Magnesium hydroxide was purchased from Fluka (St. Louis, MO). Stearic acid
and palmitic acid were purchased from TCI (Tokyo, Japan). Magnesium chloride
hexahydrate was purchased from EMD (Darmstadt, Germany). Phosphate buffer was
prepared from sodium phosphate monobasic and sodium hydroxide, purchased from
purchased from BDH Analytical (Radnor, PA). Tablet excipients Avicel
(microcrystalline cellulose, MCC) and alpha-Lactose monohydrate were obtained as a
complimentary sample from FMC Biopolymer (Philadelphia, MA) and purchased from
Sigma (St. Louis, MO), respectively. The commercial MgSt samples were ordered
through VWR from Beantown (dihydrate) and Alfa Aesar (disordered), and the Peter
Greven (monohydrate) sample was purchased in bulk by Genentech.
6.4.2   MgSt Synthesis Methods

Magnesium stearate lots were synthesized in ratios using 90:10 and 55:45 stearic:
palmitic acids. To synthesize the 55:45 disordered sample, a “melt method” combined
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magnesium hydroxide and water with melted stearic and palmitic acids at 70-90 °C. To
synthesize the 90:10 samples, a “bath” method was used, where the stearic and palmitic
acids were dissolved in water and ammonium hydroxide at pH 9 to generate the sodium
soap, followed by addition of magnesium chloride to precipitate out the magnesium
stearate. The monohydrate 90:10 sample was subsequently heated above 100 °C before
the reflux step. In each case, the recovered solids were washed using a reflux bath of 1:1
acetone: water for 24 hours to remove impurities and unreacted starting materials. The
MgSt samples were dried in a vacuum oven at 25 °C overnight to remove surface water.
6.4.3   Mixing, Tableting and Sieving

MgSt tablets for dissolution were prepared by adding MgSt sample to a “Premix”
mixture containing 16.7% indomethacin (Sigma, St. Louis, MO), 50% alpha-lactose
monohydrate (Sigma, St. Louis, MO), 33.3% Avicel (FMC Biopolymer, Philadelphia,
PA) in a ratio of 2:98 MgSt: Premix. The tablet powders were mixed as 1 g batches in 40
mL glass vials for 60 minutes using a Turbula mixer (WAB, Basel, Switzerland) on the
highest setting. Individual 150 mg tablets were made from each 1 g formulation batch
and pressed using a single tablet press (Globe Pharma, North Brunswick, NJ) at 50 bar
for 30 seconds. The tablet weights were recorded and the dissolution results were
adjusted for tablet mass. When needed, MgSt samples were sieved using ASTM sieves
that range between 75 µm and 125 µm sieve sizes.
6.4.4   Dissolution

Dissolution was performed by dissolving each tablet in 900 mL of pH 7.2
phosphate buffer at 37 °C using a VanKel V7000 USP method 2 dissolution apparatus
(Varian, Cary, NC). The paddles were stirred at 100 rpm. µDISS fiber optic UV probes
(pION, Billerica, MA) were used to collect data at various time points from 0 - 120
minutes and processed using UV absorbance at 320 nm. The µDISS probes were
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calibrated using indomethacin in phosphate buffer. The dissolution data was processed
using the second derivative function to eliminate the effects of particles on the UV
absorbance reading.
6.4.5   Solid-state NMR Spectroscopy (SSNMR)

13

C CP/MAS and 1H T1 relaxation data were collected using a home built Tecmag

Redstone NMR Spectrometer (Houston, TX), Bruker 400 MHz magnet (Billerica, MA),
and Chemagnetics (Ft. Collins, CO) NMR probe with 7.5 mm rotors spinning at 4000 Hz.
A relaxation delay of 12 seconds was used with 2K acquisition points and 1024 scans.
TNMR software (Houston, TX) was used to process the data. 3-methylglutamic acid was
used as a reference standard, with the methyl peak referenced to 18.84 ppm.
6.4.6   Thermogravimetric Analysis (TGA)

TGA weight loss was measured using TA Q50 (TA Instruments, Newcastle, DE)
with a 10 °C/min ramp from 25 °C to 250 °C.
6.4.7   Surface Area Analysis

Surface area analysis was conducted using a Micromeritics ASAP 2460 with
a Micromeritics Smart Vac Prep attachment (Micromeritics Instrumentation Corporation,
Norcross, GA, USA). A sample of about 1000 mg was dried at 40 °C and outgassed
under nitrogen flow conditions. Krypton adsorption-desorption isotherms were recorded
at liquid nitrogen temperatures (77K) and specific surface area was calculated by the
Brunauer-Emmett-Teller (BET) method. Data was analyzed using Micromeritics
MicroActive version 5.0 software.

96

6.5   Results
6.5.1   Surface Area Analysis for Commercial MgSt Samples

To investigate the relationship of MgSt crystalline form with surface area, several
commercial MgSt samples were compared, shown in Table 6-1. Samples were analyzed
for BET surface area after degassing at 2h 40 °C and 48h 40 °C. This was done to
compare the USP method for MgSt with a condition where the samples were completely
dry. The surface area data reported in Table 6-1 includes the BET C constant values and
the correlation coefficients for the curves. In BET theory, the C value is an indicator of
the interaction of the sample with the adsorbate gas. A C value of 10 is considered a
minimum for a sample that behaves according to BET adsorption theory.(47) Table 6-1
shows that some of the MgSt samples have low C values (below 10) for the 2h drying
condition. A second indication of suspect surface area data is the correlation coefficient.
The correlation coefficients The BET curves were evaluated using 3 points in the range
0.05 - 0.30 p/p0. The USP chapter for surface area analysis for MgSt specifies a
minimum of 3 points.(19) Some of these samples had a poor correlation coefficient with
more than 3 points, indicating a poor BET fit, and can be an indication of incomplete
drying of the samples. A degassing step is generally required to be performed prior to the
gas adsorption step, to remove surface bound water and surface impurities from the
samples. Table 6-1 shows the C values for 48h drying are all > 10, indicating more
complete drying at 48 hours compared with 2 hours. Additionally, the % difference in
surface area before and after drying ranges from 5 – 21%, suggesting there may be a
reason for the surface area change. The surface area results for MgSt samples are
sensitive to drying conditions, as indicated by the noted differences between the samples
that were outgassed at 40 °C for 2 hours and 48 hours.
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Table 6-1. Surface area data for commercial samples dried at 2h 40 °C and 48h 40 °C
Sample

Crystal form

Alfa Aesar
Lot C01Y019
Alfa Aesar
Lot H03W054
MP Biomedical
Lot 75281
Chem-Impex
Lot 6301123019902
Acros
Lot A0288107
Sigma-Aldrich
Lot STBB0861V
Acros
Lot A0235781

Disordered
Disordered
Monodihydrate
Monodihydrate
Monodihydrate
Monodihydrate
Monohydrate

BET
(m2/g)

Drying: 2h 40 ℃
C value

Correlation BET
coefficient (m2/g)

Drying: 48h 40 ℃
C value

%
Correlation
Diff
coefficient

0.69

12.58

0.9986

0.77

14.22

0.9990

10.4

0.79

8.54

0.9995

0.89

13.98

0.9992

11.2

3.62

5.21

0.9985

3.83

15.47

0.9989

5.5

4.02

10.71

0.9995

3.78

14.74

0.9988

6.0

4.83

9.42

0.9991

3.92

12.85

0.9987

18.8

5.28

9.56

0.9993

4.17

13.66

0.9989

21.0

6.62

12.86

0.9993

6.02

10.72

0.9996

9.1

6.5.2   Effect of Drying on MgSt Crystal Form

To investigate the cause of these differences, the 2 hour drying samples and
selected 48 hour drying samples were characterized by 13C SSNMR after the surface area
analysis, to determine whether there was a form change during the surface area analysis.
The 13C SSNMR of these samples before and after drying for surface area analysis is
shown in Figure 6-1. The samples that were outgassed at 40 °C for 2 hours did not show
observable changes in the 13C SSNMR spectra. Before drying, two of the commercial
MgSt samples had a disordered form, four samples had a mixture of monohydratedihydrate and one sample was a pure monohydrate form. There appears to be a
relationship between the crystal form and the surface area recorded in Table 6-1. The
BET surface area results listed showed that the disordered samples had the lowest surface
area, while the monohydrate-dihydrate mixtures had intermediate surface area and the
pure monohydrate samples had the highest surface area. However, after 48h drying, clear
differences in the forms were observed, with a decrease in the dihydrate form,
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accompanied by the appearance of the disordered form. The monohydrate peaks also
appear to shift with excess drying, indicating a form change for the monohydrate.

No drying
Alfa Aesar Lot 019
Alfa Aesar Lot 054
48h 40 ºC
Peter Greven
MP Biomedicals

Chem Impex

Acros Lot 107

Sigma-Aldrich

Acros Lot 781
190

180

ppm

190

180

ppm

Figure 6-1. 13C SSNMR for several commercial MgSt samples, before and after drying at
40 °C for 48 hours. Only the carbonyl region of the spectrum (170 - 200 ppm) is shown,
to identify the crystal form of the samples. The box around 185-187 ppm indicates the
dihydrate peaks, and the box around 178-185 ppm indicates the monohydrate peaks.

The ChemImpex sample in Figure 6-2 illustrates these changes well, showing a
clear form change for the ChemImpex material after being outgassed at 40 °C for 48
99

hours. The dihydrate disappears and a broad, disordered peak appears in the spectrum.
Additionally, the monohydrate peaks are clearly shifted, indicating a form change as a
result of drying.

Monohydrate
Disorder

ChemImpex - 48h 40 oC

Dihydrate

ChemImpex - Before drying

200

190

180

170

160 ppm

Figure 6-2. 13C SSNMR of the ChemImpex MgSt lot before drying (bottom) and after
drying (top) for 48h at 40 °C. After drying, the dihydrate peaks in the SSNMR spectrum
disappear and a broad disordered peak appears in the spectrum.

Having observed an initial effect of drying to impact the crystal form of MgSt
during surface area analysis, more intensive work was performed for a single Peter
Greven commercial lot (PG). Various drying conditions were compared for the PG lot.
As shown in Figure 6-3, BET surface area analysis was performed on the same lot with
various outgassing conditions: no drying, 2h at 40 °C, 12h 40 °C, 24h 40 °C and 48h at
40 °C. It is clear from Figure 6-3 that the crystal form is changing with drying. The N2
and Kr adsorption BET surface area results are shown in Table 6-2, including the
correlation coefficients and C values. The surface area result decreased with additional
drying, corresponding with form changes in the SSNMR spectra. The dihydrate peaks
decreased and completely disappeared after 48h drying, accompanied by appearance of
traces of the disordered form. There is also a change in the SSNMR spectra of the
monohydrate peaks. The small peak on the left side of the monohydrate disappears at 12h
and a new peak appears between the next two peaks. The space between the last two
monohydrate peaks also increases slightly, as the peak on the right becomes sharper with
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an increase in resolution. This shifting of the peaks of the monohydrate indicates a new
crystal form, which appears in the 12h, 24h and 48h dried samples.

Dihydrate Monohydrate
No drying
2h 40 ºC
6h 40 ºC
12h 40 ºC
24h 40 ºC
48h 40 ºC
200

190

180

170 ppm

Figure 6-3. SSNMR for MgSt “PG” lot, showing the effect of the surface area drying
method on MgSt hydrate forms.
Table 6-2. Surface area data for MgSt PG lot under different drying conditions
N2 gas adsorption
Drying
conditions
No drying

BET (m2/g) C value

Krypton gas adsorption

TGA

Correlation
Correlation
BET (m2/g) C value
% loss
coefficient
coefficient
0.9972
5.54 + 0.21
9.24
0.9991
3.3

9.47 + 0.66

13.87

2h, 40 ºC

7.95 + 0.54

15.02

0.9974

5.35 + 0.18

10.45

0.9993

3.2

6h, 40 ºC

6.74 + 0.11

22.48

0.9999

4.89 + 0.15

10.42

0.9994

3.3

12h, 40 ºC

6.42 + 0.09

23.00

0.9999

5.11 + 0.17

8.24

0.9993

3.2

24h, 40 ºC

6.37 + 0.09

22.00

0.9999

4.99 + 0.08

8.45

0.9998

2.8

48h, 40 ºC

6.08 + 0.11

20.86

0.9998

4.81 + 0.07

6.21

0.9998

2.8
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Comparing the N2 with Kr surface area analysis in Table 6-2, it is noted that the C
values are slightly lower for Kr adsorption, but the correlation coefficients are higher for
Kr. It is interesting that the absolute values for BET surface area are smaller when using
Kr as the adsorbate, due to the adsorbate size. That is, the Kr cross sectional area is less
than N2 cross sectional area, so the calculations of surface monolayer coverage give
slightly different results. Kr also shows less variation in surface area, dropping 0.67 m2/g
(from 5.54 m2/g to 4.81 m2/g) after 48h, unlike N2 which shows a significant drop in
surface area from 9.47 m2/g to 7.95 m2/g after only 2h drying and 6.08 m2/g after 48h
drying. From the SSNMR in Figure 6-3, we see that 2h drying does not appear to change
the crystal form significantly, where drying for 12 - 48h appears to significantly change
the crystal form. In this case, the Kr adsorption surface area results appear to track better
with the crystal form change.

6.5.3   Effect of Drying on Tablet Dissolution

To evaluate the impact of the drying (dehydration) on functional property,
dissolution was performed for tablet formulations prepared using MgSt from the before
and after samples. Figure 6-4 shows the dissolution results indicate faster dissolution for
the dried samples, with up to 20% difference at 5 minutes and 5-10% difference at 15
minutes using this method. For clarity, 30 minutes dissolution is shown, but 95-100%
dissolution is achieved for all samples before 2 hours. From previous work, it is known
that the disordered form of MgSt leads to faster tablet dissolution, likely due to less
effective lubrication of the formulation particles.
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Figure 6-4. Tablet dissolution comparing formulations prepared with MgSt before drying
(closed circles) and after drying (open circles). Drying appears to cause ~10% faster
dissolution rate and may lead to less effective lubrication by MgSt.

6.6   Discussion
6.6.1   Correlation of MgSt Crystal Form with Surface Area

The surface area for several commercial MgSt samples appears to trend with the
crystal form of the material. The disordered samples have the lowest surface area, which
is consistent with poor lubrication ability. Monohydrate MgSt has higher surface area
above 5 m2/g, suggesting that this material may have the most effective lubricating ability
compared to the other samples in this data set. The monohydrate-dihydrate mixtures of
MgSt show an intermediate surface area in the range 3 - 5 m2/g. Looking closely at the
height of the peaks corresponding to the MgSt forms in the SSNMR spectra for the
monohydrate-dihydrate mixtures, it appears that the amount of dihydrate character in the
mixtures may affect the surface area as well.
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The surface area analysis for MgSt, as shown in Table 6-1, was challenging with
respect to obtaining consistent and reliable data for the “as is” commercial samples. Even
though the C values and correlation coefficients were met using 3 points, they were on
the borderline of acceptability for meeting the USP criteria for reporting surface area. The
difficulty of determining surface area for MgSt is well-known to those in the field(45)
and it is believed that surface water can freeze during the analysis and cause an
artificially high and often variable result. Outside of additional drying, the typical way of
dealing with the analysis is to focus on the lower p/p0 region between 0.05 - 0.1 p/p0 and
to use fewer points for the BET analysis to get an acceptable fit. The lower p/p0 region is
more likely to be before a complete adsorbate monolayer coverage of the particles, and
hydrated MgSt often behaves erratically with additional adsorbate added. The reasons for
this are not well understood, but several possible explanations are discussed in Lapham
and it is beyond the scope of this paper to pursue further.(46)
6.6.2   Correlation of Crystal Form with Drying

The 13C SSNMR for MgSt PG commercial material clearly shows the effect of
drying MgSt on the crystal form. Specifically, the dihydrate character of the material is
dehydrated. SSNMR clearly shows the decrease and disappearance of the dihydrate, with
the appearance of disordered form conversion upon dehydration Figure 6-3. Additionally,
a new form was observed in the shifting of the monohydrate peaks with drying. The
significance of these changes is not only that the surface area changes, but that the
lubrication ability of the MgSt sample also is likely to change as a result of the crystal
form change. Other studies have shown that the presence of both the disordered form and
the new monohydrate form, decreases the effect of MgSt on dissolution, and by
extension, the lubrication ability of MgSt. It is possible that a batch of MgSt that is stored
at 40 °C condition for an extended period could undergo a change in form, which could
adversely affect its lubrication performance.
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6.6.3   Effect of Drying on Dissolution

The dissolution of tablet formulations using MgSt before and after drying shows a
clear effect of drying and dehydration on dissolution. The disordered form has faster
dissolution compared to the monohydrate and hydrate mixtures, possibly due to less
effective lubrication ability of the disordered form. It is suggested in the literature and we
hypothesize that the drying removes the bound water from the crystal structure, causing
dehydration and disrupting the crystal structure. The crystal structure can then collapse,
resulting in the disordered form. This is consistent with the observed decrease in surface
area with drying Table 6-2, which could be due to the removal of water, as well as the
change in crystal structure. Overall, the dissolution is consistent with the effects of drying
on MgSt, with increased dissolution rate for tablets using dried MgSt compared to nondried MgSt. The dissolution behavior supports the expectation that drying MgSt can
affect its performance.

6.7   Conclusions

Several conclusions can be drawn from this study. First, there appears to be a
significant correlation between MgSt crystal form and surface area. The disordered form
shows low surface area and the monohydrate form shows higher surface area. Second,
drying MgSt at 40 °C leads to dehydration of the material, with a decrease in surface area
being accompanied by an increase in the amount of disordered form in the sample. In
addition to the form change with drying, dissolution showed that drying MgSt can also
have an impact on tablet performance.
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7.2   Abstract

Magnesium stearate (MgSt) is the most common pharmaceutical excipient and is
used as a lubricant in approximately half of the tablet formulations on the market.(1) In
spite of its popularity as an effective lubricant, it has been repeatedly recognized that
there is significant variability between MgSt samples which can cause inconsistent
lubrication and/or dissolution between lots and batches of MgSt. Dissolution is an
important functional property for pharmaceutical formulations. Differences in dissolution
for different crystal forms of MgSt have been reported, but an exhaustive study of the
influence of MgSt hydrate form on dissolution has not yet been published. In this study, a
dissolution method is developed for an indomethacin direct compression tablet

formulation. The method development discussed here covers: 1) manual dissolution
sampling, 2) formulation mixing methods, 3) use of fiber optic UV probes, 4) calibration
curves comparing UV spectrometer analysis and fiber optic probes, 5) effect of MgSt
concentration on dissolution, 6) powder vs. tablet dissolution profiles, 7) effect of tablet
compaction pressure, 8) effect of vial type and turbula speed, 9) effect of formulation
mixing time on dissolution for monohydrate and dihydrate forms, 10) reproducibility and
differentiation of tablets using various commercial MgSt lots, 11) sample homogeneity,
12) effect of MgSt particle size sieve fractions on dissolution rates and 13) effects of
grinding, sieving and ball-mixing of MgSt on tablet dissolution. A dissolution method is
developed which can distinguish between MgSt samples with different physicochemical
properties.

7.3   Introduction

Magnesium stearate (MgSt) is the most common pharmaceutical excipient and is
used as a lubricant in approximately half of the tablet formulations on the market.(1) In
spite of its popularity as an effective lubricant, it has been repeatedly recognized that
there is significant variability between MgSt samples which can cause inconsistent
lubrication and/or dissolution between lots and batches of MgSt. Incomplete lubrication
can cause picking and sticking, so MgSt is typically added as a solid lubricant to tablet
formulations as a lubricant at a 0.25 - 5% level to prevent powder from sticking to the
tablet die and manufacturing equipment during the tableting process. Many formulation
labs have experiences with MgSt where the lubrication capability and/or the dissolution
rate varies unexpectedly, with unexplained batch-to-batch and lot-to-lot variation.(16, 97)
For example, one lot from a manufacturer may show picking and sticking after several
thousand tablets are made as powder builds up on the equipment, but other lots do not. In
addition, tablets manufactured from different lots of MgSt may have different dissolution
properties. The reasons for the inconsistencies between lots and types of MgSt are still
poorly understood, (149-151) but it is proposed that the variability in the dissolution and
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lubrication properties of MgSt can be related back to its complicated structural
properties.(98, 126)
Dissolution is an important functional property for pharmaceutical formulations.
It is known since 1963 that MgSt causes slowed dissolution of API formulations(89) and
that formulation mixing time and compression force affect the dissolution rate(90, 91) as
well as the amount of MgSt in the formulations. The mechanism was investigated and the
effect of MgSt on mixing time and compression force was attributed to lamination and
adhesion of MgSt to the other particles in the formulation, along with the flaking of MgSt
causing an increase in surface area.(90, 92) Hussain et al. suggested that the extent of
surface coverage of the hydrophobic film on the particles is the most important factor in
affecting dissolution.(83) Patra et al. studied the effect of MgSt concentration and granule
size on the dissolution rate of ciprofloxacin HCl and found that a hydrophobic lubricant
like MgSt decreases the drug-solvent interface, causing slower dissolution due to
decreased wettability and increased dissolution rate with smaller granules.(93) Possible
interactions with MgSt have been explored for their effects on dissolution, including the
addition of colloidal silica by Johansson et al.,(94) the interactions of surfactants with
MgSt during mixing,(50) and the interaction of MgSt with HPMC-AS in ASDs and
hydrogen bonding with itraconazole ASDs.(95, 96) The effects of acidic media was also
investigated by Ariyasu et al. and indicates conversion of MgSt to stearic acid during
dissolution.(97, 98) Additionally, other lubricants were explored as alternatives to MgSt,
including calcium stearate,(98) glycerin fatty acid esters,(99, 100) Stear-o-Wet,(101)
talc.(102) Hussain, York and Timmins compared the dissolution of paracetamol tablets
with different grades of MgSt. No relationship between physical properties such as
surface area and dissolution was found. (83) In 2013, Okoye et al. observed differences in
dissolution between naproxen and acetaminophen comparing MgSt dihydrate,
monohydrate and anhydrate.(87) However, an exhaustive study of the influence on MgSt
hydrate form on dissolution has not yet been published.
In this study, a dissolution method is developed for an indomethacin direct
compression tablet formulation. An appropriate dissolution method is needed to show
distinguish between different MgSt samples, to enable a comprehensive investigation of
the properties of various MgSt samples. This method is specifically designed to be an
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over-lubricated situation, to differentiate between varying types of MgSt in the tablet
formulations. The method development discussed here covers: 1) manual dissolution
sampling, 2) formulation mixing methods, 3) use of fiber optic UV probes, 4) calibration
curves comparing UV spectrometer analysis and fiber optic probes, 5) effect of MgSt
concentration on dissolution, 6) powder vs. tablet dissolution profiles, 7) effect of tablet
compaction pressure, 8) effect of vial type and turbula speed, 9) effect of formulation
mixing time on dissolution for monohydrate and dihydrate forms, 10) reproducibility and
differentiation of tablets using various commercial MgSt lots, 11) sample homogeneity,
12) effect of MgSt particle size sieve fractions on dissolution rates and 13) effects of
grinding, sieving and ball-mixing of MgSt on tablet dissolution.

7.4   Materials and Methods
7.4.1   Materials

Magnesium hydroxide was purchased from Fluka (St. Louis, MO). Stearic acid
and palmitic acid were purchased from TCI (Tokyo, Japan). Indomethacin was purchased
from Sigma (St. Louis, MO). Magnesium chloride hexahydrate was purchased from
EMD (Darmstadt, Germany). Phosphate buffer was prepared from sodium phosphate
monobasic and sodium hydroxide, purchased from purchased from BDH Analytical
(Radnor, PA). Tablet excipients Avicel (microcrystalline cellulose, MCC) and alphaLactose monohydrate were obtained as complimentary samples from FMC Biopolymer
(Philadelphia, MA) and purchased from Sigma (St. Louis, MO), respectively. The
sources of the commercial samples were reported previously.(48)
7.4.2   Tablet Composition

The tablet formulation composition is 16.7% indomethacin, 50% alpha-lactose
monohydrate, 33.3% microcrystalline cellulose (Avicel PH 102) and 2% magnesium
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stearate (MgSt). Lactose is a commonly used filler/diluent known to have good
compressibility. Avicel PH 102 is a binder often used in direct compression in tablet
formulations. A “premix” containing all the formulation ingredients except MgSt was
prepared first, to minimize the formulation variation in each tablet due to the other
ingredients. The type of magnesium stearate was intentionally varied from batch to batch,
to study the impact of MgSt properties on the functional properties of the tablets.
Formulations of 1g size were prepared. The 1g size allows for six 150 mg tablets to be
prepared from each formulation batch.
7.4.3   Mixing and Tableting

Indomethacin tablet formulations were prepared by adding MgSt to a “Premix”
mixture containing 16.7% indomethacin (Sigma, St. Louis, MO), 47.3% alpha-lactose
monohydrate (Sigma, St. Louis, MO), 34% Avicel (FMC Biopolymer, Philadelphia, PA)
in a ratio of 2:98 MgSt: Premix. The tablet powders were mixed as 1 g batches in 40 mL
glass vials for 60 minutes using a Turbula T-2C mixer (WAB, Basel, Switzerland) on the
highest setting. Six individual 150 mg tablets were made from each 1 g formulation batch
and pressed using a single tablet press (Globe Pharma, North Brunswick, NJ) at 50 bar
for 30 seconds. The tablet weights were recorded and the dissolution results were
adjusted for tablet mass. Ball mixing was performed by adding 1g of MgSt to a 40 mL
glass vial with ten ¼-inch plastic balls and mixed for 60 minutes using the Turbula T-2C
mixer.
7.4.4   Drug Properties and Buffer Selection

Indomethacin is a popular model NSAID drug, with low aqueous solubility of 0.9
mg/L(153) and pKa of 4.5. The buffer for this project was potassium phosphate, pH 7.2.
This is a simple and commonly used buffer for pharmaceutical drug development studies.
This pH is more than 2 pH units above the pKa of indomethacin, to maximize the
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solubility of the drug in the buffer. The solubility of indomethacin in the buffer at this pH
is > 30 µg/mL. Each 150 mg tablet contains 25 mg of indomethacin (16.7% drug load). If
the entire 25 mg of drug is completely dissolved in 900 mL of buffer, the concentration
of indomethacin in the buffer is 27.8 µg/mL. This is below the solubility of the drug in
the buffer, allowing for complete dissolution. Potassium phosphate buffer was prepared
in 9 L batches by adding 2.0 L of 0.2M potassium phosphate solution, 1.4 L of 0.2M
sodium hydroxide solution and 5.4 L of deionized water. The pH was confirmed to be 7.2
+/- 0.2 with a pH meter.
7.4.5   Dissolution

Dissolution was performed by placing each tablet in 900 mL of pH 7.2 phosphate
buffer at 37 °C using a VanKel V7000 USP method 2 dissolution apparatus (Varian,
Cary, NC). The paddles were stirred at 100 rpm. µDISS fiber optic UV probes (pION,
Billerica, MA) were used to collect data at various time points from 0 - 120 minutes, and
processed using UV absorbance at 320 nm. The µDISS probes were calibrated using
indomethacin in potassium phosphate buffer. The dissolution data was processed using
the second derivative function to eliminate the effects of particles on the UV absorbance
reading.
7.4.6   Grinding, sieving and ball mixing

Grinding was performed using a mortar and pestle. Ball mixing was performed by
adding 1g of MgSt to a 40 mL glass vial with ten ¼-inch plastic balls and mixed for 60
minutes using the Turbula T-2C mixer. MgSt samples were sieved on a Gilson Performer
Model SS-3 sieve shaker for approximately 60 minutes, using ASTM sieves that range
between 20 micron and 250 micron sieve sizes.
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7.5   Results and Discussion
7.5.1   Effect of Manual Sampling and Hand-mixing

Method development was initiated with a simple experimental design. Tablets
were prepared using four different commercial lots of MgSt and mixed by hand for two
minutes. Dissolution samples were pulled at various time points and the drug
concentration was analyzed by UV-vis. Figure 7-1 shows similar dissolution for the four
formulations, after 2 minutes of mixing by hand.

Figure 7-1. Indomethacin dissolution of tablet formulations comparing four commercial
samples of MgSt. The formulations were hand-mixed for 2 minutes.

A short mixing time is normal for formulation development, but it does not
address the fundamental reason that MgSt variability sometimes causes dissolution
failure. Over-lubrication is the underlying issue for MgSt dissolution failure, so to
investigate MgSt with dissolution, we need to be looking at an over-lubricated state. The
easiest ways to create an over-lubricated state is to increase the formulation mixing time
or the % MgSt in the formulation. If some types of MgSt are more susceptible to over-
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lubrication than other types of MgSt, those differences will be observed by increasing the
mixing time and the % MgSt in the formulation.
Extending the formulation mixing time to 30 minutes of hand-mixing resulted in
the dissolution shown in Figure 7-2. Five batches of tablets containing ChemImpex brand
of MgSt performed similarly, with ~ 80% dissolution at 15 minutes. However, there was
more variation between the five batches of tablets containing Fisher brand MgSt.
Additionally, it is unclear whether 100% dissolution is reached for all of these curves,

% Indoethacin Dissolution

even after 60 minutes.

ChemImpex

100
80
60

Batch 1
Batch 2

40

Batch 3
Batch 4
Batch 5

20
0

0

7

21

28

Fisher

100

% Indomethacin Dissolution

14
Time (min)

80
60

Batch 1
Batch 2
Batch 3
Batch 4
Batch 5

40
20
0

0

7

14
Time (min)

21

28

Figure 7-2. Comparison of indomethacin dissolution for tablet formulations using
ChemImpex (top) and Fisher (bottom) brands of MgSt. The formulations were handmixed for 30 minutes.
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Investigating the method details revealed several potential sources of error and/or
variability in the method. First, hand-mixing could introduce inconsistency in mixing,
depending on the angle of shaking and how rigorously the shaking was performed. This
would be expected to vary between batches and analysts. A standardized mixing method
is preferred. To address this, a Turbula mixer was obtained and used for subsequent
studies. Second, the tablet weights were not tracked for these early studies, leaving room
for significant error in calculating % dissolution. A large tablet weight variation could
also affect the tablet hardness and disintegration of the tablets. Clearly, it would be
preferred to compare tablets of a similar weight. Going forward, the tablet weights were
recorded and % dissolution was adjusted accordingly for each individual tablet.

7.5.2   Advantages of uDISS Fiber Optic UV Probes for Direct Sampling

Manual sampling for dissolution studies can have several drawbacks. First,
removing aliquots for sampling at various time points affects the total volume of the
dissolution bath. If the volume is replaced after sampling, then the concentration in the
bath is changed. Second, manual sampling is time consuming and labor-intensive,
limiting the time points that can be collected in the early section of the curve. Third,
transferring the aliquots of sample to another apparatus for concentration analysis can
introduce error. In particular, for samples that need to be filtered to remove particle prior
to HPLC analysis, the filtering process may affect the concentration of the aliquot,
skewing the results of the experiment. For all these reasons, an in situ method is
preferred. For this project, fiber optic UV probes were available to use with the
dissolution bath, by placing the probes in the vessels at an appropriate height for
sampling. The accompanying software was programmed to take many more points in
every section of the curve, allowing for a more complete dissolution curve with minimal
labor. A second-derivative function is built into the software to address concerns with undissolved particles in the solution. Table 7-1 shows aspects of the traditional dissolution
method compared with the new dissolution method being developed.
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Table 7-1. Components of Traditional dissolution method vs. New dissolution method
Traditional method
New method
Hand-mixing

Turbula mixing

Tablet weights uncontrolled

Adjust for tablet weight

Labor-intensive

Automated

Manual sampling

Direct sampling

Sample each time point

Multiple probes, more replicates

Volume corrections

In situ sampling

UV-vis spectrometer

Fiber optic probes

Need to filter samples

2nd derivative option

7.5.3   Calibration Curves Comparing UV-vis Spectrometer with UV Fiber Optic Probes

To confirm the reliability of the fiber optic probes, indomethacin calibration curves for
the manual sampling method using UV-vis analysis were compared with calibration
curves for the fiber optic UV probes. The absorbance of indomethacin was measured at
320 nm wavelength. As shown in Figure 7-3 both curves are linear through 30 µg/mL,
with acceptable correlation coefficients for both curves. Additionally, the y-intercepts are
close to zero for both curves. This data allows us to be confident in the ability of the fiber
optic probes to provide acceptable quantitative analysis for our indomethacin tablets
using the dissolution method.
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UV-vis Spectrometer
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0.4
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R² = 0.9993

0.2
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0.8
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y = 0.0197x + 0.0027
R² = 0.9999
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0.0

0

10
20
30
40
Concentration (µg/mL)

Figure 7-3. Indomethacin curves comparing data from UV-vis spectrometer and fiber
optic UV probes.

7.5.4   Effect of MgSt Concentration in Indomethacin Tablet Formulations

The concentration of MgSt in the formulation is known to affect the performance of
tablets, so this % of MgSt used in the formulation was varied to determine the effect in
our dissolution method. Figure 7-4 compares tablet formulations containing 0.5%, 1%,
2% and 7% MgSt, using a commercial monohydrate MgSt designated “PG 193”.
Decreased dissolution was observed for increasing amounts of MgSt in the formulations,
with 7% MgSt having less than 30% dissolution at 15 minutes. Clearly, the amount of
MgSt in the formulation has an effect on dissolution. In order to promote overlubrication in this study, a 2% level of MgSt was chosen for the formulation.
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Figure 7-4. Effect of amount of MgSt on indomethacin tablet dissolution

7.5.5   Powder vs. Tablet Dissolution Profiles

As a control, dissolution was performed for samples containing no MgSt. Two different
batches of premix powder and tablets were analyzed in triplicate, shown in Figure 7-5.
The powder was observed to float on top of the buffer solution and dissolved slowly, due
to poor wetting properties of the formulation components. The tablets sank to the bottom
of the vessel and were observed to dissolve quickly. In order to investigate dissolution,
rather than wetting, it was decided to focus on tablet dissolution rather than powder
dissolution. The control with no MgSt shows the expected dissolution when MgSt is
having no effect on tablet dissolution.
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Powder
% Indomethacin Dissolution

100
80
60
Lot
Lot
Lot
Lot
Lot
Lot

40
20
0
0:00

0:07

0:14
Time (h:min)

0:21

1 Powder Ch1
1 Powder Ch2
1 Powder Ch3
2 Powder Ch1
2 Powder Ch2
2 Powder Ch3
0:28

Tablets
% Indomethacin Dissolution

100
80
60
Lot
Lot
Lot
Lot
Lot
Lot

40
20
0
0:00

0:07

0:14
Time (h:min)

0:21

1 Tablets Ch1
1 Tablets Ch2
1 Tablets Ch3
2 Tablets Ch1
2 Tablets Ch2
2 Tablets Ch3
0:28

Figure 7-5. Indomethacin dissolution of premix formulation containing no MgSt,
comparing powder (top) and tablets (bottom)

7.5.6   Effect of Tablet Compaction Pressure

Disintegration can also affect dissolution profiles for tablet formulations. In order
to minimize the impact of disintegration on dissolution for the method here. Figure 7-6
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shows the effect of compaction pressure on indomethacin tablet dissolution for Premix
and tablets containing 2% MgSt from Acros. The effect of compaction pressure to delay
disintegration and dissolution is seen in the first few minutes. Clearly, the Acros MgSt is
causing a delay in both disintegration and dissolution, whereas the Premix only shows an
effect on disintegration. The delay in dissolution due to disintegration is the relevant issue
for method development. To minimize the effect of disintegration on dissolution, a low
compaction pressure of 50 psi was chosen for tableting.
The solid fraction (SF) numbers show that for the premix tablets, the solid
fraction is > 1. This indicates that, in the absence of MgSt, the lactose and/or Avicel is
being compressed beyond the original density. However, the high solid fraction (i.e. more
effective compression and likely greater hardness) does not prolong disintegration.
Rather, the presence of MgSt is resulting in softer tablets and slower dissolution. This is
due to the MgSt forming a hydrophobic film coating around the particles in the
formulation, which has a two-fold effect. First, it keeps the formulation particles from
interacting to compress like the non-lubricated particles would and second, it delays
dissolution by slowing drug release from coated particles.

Acros Monohydrate

40

20

0
0:00

50 bar n=3, SF 1.003
100 bar n=3, SF 1.086
150 bar n=3, SF 1.121
200 bar, SF 1.141

0:01
Time (h:min)

0:02

% Indomethacin Dissolution

% Indomethacin Dissolution

No MgSt
40

20

0
0:00

50 bar, SF 0.832
100 bar, SF 0.917
150 bar, SF 0.940
200 bar, SF 0.954

0:01
Time (h:min)

0:02

Figure 7-6. Dissolution of indomethacin tablets showing the effect of compaction
pressure on disintegration and dissolution
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7.5.7   Effect of Mixing Configuration and Turbula Speed

To test mixing configuration and Turbula mixing speed, three conditions were compared:
a “slow-tumbling” condition where “slow” indicates a ~ 50-75 rpm setting on the
Turbula, “fast” indicates ~ 100 rpm Turbula speed, and “tumbling” indicates a vial placed
inside a plastic bottle to allow extra tumbling during the mixing process.
Figure 7-7 compares these three mixing conditions for a 10 min mixing time and
40 mL vial. All conditions were similar for the dihydrate formulations. However, the
“fast-falling” condition was the most differentiating for the monohydrate. The “fastfalling” condition uses a 40 mL vial on the fast Turbula setting, and this is the condition
used for subsequent dissolution testing.

Dihydrate

100

80
60
40
20
0
0:00

Slow - Falling
Slow - Tumbling
Fast - Falling

0:07 0:14 0:21
Time (h:min)

% Indomethacin Dissolution

% Indomethacin Dissolution

100

Monohydrate

80
60
Slow - Falling

40

Slow - Tumbling
Fast - Falling

20

0:28

0
0:00

0:07
0:14
0:21
Time (h:min)

0:28

Figure 7-7. Dissolution of tablets containing lab-synthesized dihydrate and monohydrate
MgSt, after mixing the formulation in various ways

7.5.8   Effect of Formulation Mixing Time on Dissolution
Another important factor in over-lubrication with MgSt is mixing time. Longer mixing
times allows for a greater extent of surface coating of particles by MgSt, and this results
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in slower dissolution. This effect of MgSt mixing time is well-documented in the
literature.
Figure 7-8 shows the difference in dissolution as a function of mixing time.
Monohydrate MgSt was compared with dihydrate MgSt after sieving to < 45 µm. The
monohydrate MgSt shows greater sensitivity to over-lubrication compared to the
dihydrate form of MgSt. A 60 minute mixing time was chosen as a standard mixing time
for this method, to enable good discrimination between samples. This is significantly
longer than the normal mixing time for formulation development and represents an overlubricated state for many MgSt samples. As such, it enables our study to discriminate
between MgSt samples which are sensitive to over-lubrication and those MgSt samples
which are less sensitive to over-lubrication.

Dihydrate 50:50
<45µm

100

% Indomethacin Dissolution

% Indomethacin Dissolution

100
80
60

2 min
10 min
60 min

40
20
0
0:00

0:07
0:14
0:21
Time (h:min)

0:28

Monohydrate 50:50
<45µm

80
60
40
20
0
0:00

2 min
10 min
60 min

0:07 0:14 0:21
Time (h:min)

0:28

Figure 7-8. Effect of mixing time on MgSt dihydrate < 45 µm and MgSt monohydrate <
45 µm.

7.6   Conclusions

A discriminating dissolution method was developed to study the over-lubrication
of indomethacin tablets using various lots of MgSt. Several different factors were
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explored in the method development, including mixing method, sampling technique, the
effect of MgSt concentration, compaction pressure, formulation mixing speed,
formulation mixing time, reproducibility of the overall method and differentiation
between samples. Using this method, differences between variations in properties of
MgSt samples are addressed in Chapter 8.
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THE IMPACT OF MGST VARIABILITY ON
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FORM, PARTICLE SIZE AND SURFACE AREA

8.1   Author Information

Julie L. Calahan, University of Kentucky, Lexington, KY
Daniel DeNeve, Purdue University, West Lafayette, IN
Evelyn G. Yanez, Genentech, Inc., South San Francisco, CA
Evan T. Liechty, University of Colorado, CO
Job K. Limo, Berea College, Berea, KY
Christopher J. Mays, Ross University, Dominica
Benjamin J. Munson, Eastern Kentucky University, KY
Jonathan Gerzberg, University of Michigan, MI
Kanika Sarpal, Vertex, Boston, MA
Job Lubach, Genentech, Inc., CA
Sean P. Delaney, US Pharmacopeia, Rockville, MD
Eric J. Munson, Purdue University, IN

8.2   Abstract

Magnesium stearate (MgSt) is a pharmaceutical excipient that is used in
approximately half of all pharmaceutical tablet formulations. It is typically added as a
lubricant prior to tableting to ensure proper ejection of the tablet from the press. The
physicochemical properties of MgSt that have been proposed to impact lubrication and
dissolution include fatty acid composition, crystalline form, and particle size and surface
area. This study focuses on the dissolution properties of commercial and lab-synthesized
MgSt samples. No obvious correlation between fatty acid composition and dissolution

performance was observed between commercial or lab-synthesized MgSt samples.
However, higher surface area appeared to correlate with slower dissolution rate.
Additionally, lab-synthesized samples showed that smaller particle size fractions
correlated with slower dissolution compared to larger particle size fractions of the same
starting material. A further effect of ball mixing was observed to slow dissolution rate for
the disordered form, indicating the importance of processing effects by mixing and/or
shearing.

8.3   Introduction

Magnesium stearate (MgSt) is the most commonly used excipient for
pharmaceutical tablet formulations, with over half of the marketed formulations including
MgSt as one of the formulation excipients.(1) MgSt is typically added to tablet
formulations as a lubricant at a 0.25 - 5% level to prevent powder from sticking to the
tablet die and manufacturing equipment during the tableting process. Many formulation
labs have experiences with MgSt where the lubrication capability and/or the dissolution
rate varies unexpectedly, with unexplained batch-to-batch and lot-to-lot variation.(16, 97)
For example, one lot from a manufacturer may show picking and sticking after several
thousand tablets are made as powder builds up on the equipment, but other lots do not. In
addition, tablets manufactured from different lots of MgSt may have different dissolution
properties. The reasons for the inconsistencies between lots and types of MgSt are still
poorly understood, (149-151) but it is proposed that the variability in the dissolution and
lubrication properties of MgSt can be related back to its complicated structural properties.
(126, 154)
The physicochemical properties of MgSt that have been proposed to have the
greatest effect on the functional properties of MgSt include fatty acid composition,
crystalline form and particle size/surface area.(152) Magnesium stearate is historically
derived from vegetable and animal sources, and is usually composed of a mixture of
magnesium fatty acid salts, although in this paper the salts are also referred to as fatty
acids. The USP monograph for MgSt specifies that magnesium stearate must contain at
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least 40% stearate, with at least 90% being a combination of stearate and palmitate fatty
acid salts.(19) The remaining 10% may be magnesium salts derived from other fatty
acids, typically the C12-C22 straight-chain fatty acids.(19) A large variation in fatty acid
salts can exist between magnesium stearate lots and samples, which may or may not be
specified in the certificate of analysis from the manufacturer. Magnesium stearate also
exists in multiple hydrate forms as well as an anhydrate form.(35, 155) The monohydrate
and dihydrate forms have been reported and characterized by various techniques.(37, 39)
Delaney et al. showed that there are at least five forms of MgSt, where solid-state NMR
(SSNMR) spectroscopy was able to clearly distinguish between the five forms - an
anhydrous form, a disordered monohydrate form, an ordered monohydrate, a dihydrate
and a trihydrate.(48) Particle size and surface area have also been shown to impact
performance.(151, 152, 156) In addition, some of these properties, such as particle
size/surface area and crystalline form, may change upon blending time, tableting pressure
and particle size reduction method and other processing operations.
Chapter 3, adapted from Delaney et al., describes a comprehensive analytical
characterization of several commercial MgSt samples, where commercial refers to
samples either purchased or obtained from various sources, as opposed to lab-synthesized
samples. In that study, analytical techniques such as gas chromatography-mass
spectrometry (GC-MS), scanning electron microscopy (SEM), differential scanning
calorimetry (DSC), thermogravimetric analysis (TGA), powder X-ray diffraction
(PXRD), and SSNMR were used to investigate the properties of these samples. (48) It
was shown that SSNMR is very useful for identifying the crystalline form of the MgSt
samples, and GC-MS could be used to characterize the fatty acid composition. However,
the impact of these variables on the functional properties, specifically the lubrication and
dissolution properties, was not investigated.
Dissolution is an important functional property for pharmaceutical formulations.
It is known since 1963 that MgSt can cause slower dissolution of formulations(89) and
that formulation mixing time, compression force, and amount of MgSt in the
formulations can affect the dissolution rate(90, 91). The impact that MgSt has on
dissolution rate is due to differences in mixing time and compression force was attributed
to lamination and adhesion of MgSt to the other particles in the formulation, along with
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the flaking of MgSt causing an increase in surface area.(90, 92) Hussain et al. suggested
that the extent of surface coverage of the hydrophobic film on the particles is the most
important factor in affecting dissolution.(83) Patra et al. studied the effect of MgSt
concentration and granule size on the dissolution rate of ciprofloxacin HCl and found that
a hydrophobic lubricant like MgSt decreases the drug-solvent interface, causing slower
dissolution due to decreased wettability and increased dissolution rate with smaller
granules.(93) The interactions of other formulation ingredients with MgSt have been
explored for their effects on dissolution, including the addition of colloidal silica by
Johansson et al.,(94) the interactions of surfactants with MgSt during mixing,(50) the
interaction of MgSt with HPMC-AS in ASDs, and hydrogen bonding with itraconazole
ASDs.(95, 96) The effect of acidic media was also investigated by Ariyasu et al., and
their results indicated the conversion of MgSt to stearic acid during dissolution.(97, 98)
Additionally, dissolution has been used to explore alternative lubricants for MgSt,
including calcium stearate,(98) glycerin fatty acid esters,(99, 100) Stear-o-Wet,(101) and
talc.(102) Hussain, York and Timmins compared the dissolution of paracetamol tablets
with different grades of MgSt. Although marked differences between samples were
noted, no clear relationship between physical properties of MgSt such as surface area and
dissolution was defined. (83) In 2013, Okoye et al. observed differences in dissolution
between naproxen and acetaminophen formulations comparing MgSt dihydrate,
monohydrate and anhydrate. In their study, the monohydrate form slowed dissolution to a
greater extent than the dihydrate and anhydrate forms of MgSt .(87) We hope to further
this understanding of the effects of MgSt hydrate form on tablet dissolution with the aid
of SSNMR characterization data.
This chapter will focus on the dissolution properties of both commercial and labsynthesized MgSt samples. Dissolution was chosen as a discrimination method instead of
lubrication, since formulated samples could be prepared at relatively small scales, and
once the properties that impacted dissolution were identified, later studies could focus on
their lubrication properties. It is important to note that the dissolution method developed
for this study is only used to compare the performance of different MgSt samples. It was
not designed for use in release testing, nor for meeting USP or product specifications, nor
for correlations with bioavailability, but is specifically for discriminating between MgSt
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lots used in tablet formulations. For this study, a simple direct compression tablet
formulation comprised of 16.7% indomethacin, 35% microcrystalline cellulose, 47%
lactose, and 2% MgSt was prepared with different MgSt samples, and the processing
parameters (e.g. mixing time and compression forces) were optimized such that the
dissolution data showed differences between MgSt samples. Each of the MgSt
commercial samples characterized previously in the Delaney paper was analyzed here by
dissolution.(11, 48) The commercial samples showed that the disordered form of MgSt
leads to a faster dissolution rate than formulations prepared with the other MgSt hydrate
forms. No clear correlation with fatty acid composition was observed, but lower surface
area appeared to correlate with faster dissolution rate and higher surface with slower
dissolution rates. Additionally, lab-synthesized samples showed that smaller particle size
fractions correlated with slower dissolution compared to larger particle size fractions of
the same material. A further effect of ball mixing was observed to slow dissolution for
the disordered form.

8.4   Materials and Methods
8.4.1   Materials

Magnesium hydroxide was purchased from Fluka (St. Louis, MO). Stearic acid
and palmitic acid were purchased from TCI (Tokyo, Japan). Magnesium chloride
hexahydrate was purchased from EMD (Darmstadt, Germany). Phosphate buffer was
prepared from sodium phosphate monobasic and sodium hydroxide, purchased from
purchased from BDH Analytical (Radnor, PA). Tablet excipients Avicel
(microcrystalline cellulose, MCC) and alpha-Lactose monohydrate were obtained as a
complimentary sample from FMC Biopolymer (Philadelphia, MA) and purchased from
Sigma (St. Louis, MO), respectively. The sources of the commercial samples were
reported previously.(48)
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8.4.2   MgSt Synthesis

Magnesium stearate lots were synthesized in a range of fatty acid ratios, notated
using either “% stearate” or “St:Pa” to indicate the stearic acid: palmitic acid (St:Pa)
ratio. Two synthesis methods were used: 1) a “melt method” combined magnesium
hydroxide and water with melted stearic and palmitic acids at 70-90 °C, in a spontaneous
reaction producing magnesium stearate. 2) a “bath method” dissolved the fatty acids in a
heated water bath, to which ammonium hydroxide was added to create the ammonium
soap, followed by a titration with magnesium chloride to precipitate out the magnesium
stearate solid. These methods are described in greater detail in Chapter 4. In each case,
the recovered solids were washed using a reflux bath of 1:1 acetone: water for 24-48
hours to remove impurities and unreacted starting materials. The MgSt samples were airdried and/or dried in a vacuum oven at 25 °C to remove surface water. The disordered
form was prepared by heating a dihydrate or monohydrate-dihydrate mixture to 105 °C
for 48 hours. LS 1 “rehydrated” monohydrate was dehydrated and then the disordered
sample was rehydrated by heating to 105 °C for 1 hour, then placing the sample in a
humidity chamber at 105 °C for 24 hours. The dehydration/rehydration process produced
a mixture of monohydrate with disordered forms, which appears as mostly monohydrate
by SSNMR.
8.4.3   Mixing, Tableting and Sieving

MgSt tablets were prepared by adding MgSt sample to a “Premix” mixture
containing 16.7% indomethacin (Sigma, St. Louis, MO), 50% alpha-lactose monohydrate
(Sigma, St. Louis, MO), 33.3% Avicel (FMC Biopolymer, Philadelphia, PA) in a ratio of
2:98 MgSt: Premix. The tablet powders were mixed as 1 g batches in 40 mL glass vials
for 60 minutes using a Turbula T-2C mixer (WAB, Basel, Switzerland) on the highest
setting. Six individual 150 mg tablets were made from each 1 g formulation batch and
pressed using a single tablet press (Globe Pharma, North Brunswick, NJ) at 50 bar for 30
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seconds. The tablet weights were recorded and the dissolution results were adjusted for
tablet mass. Ball mixing was performed by adding 1g of MgSt to a 40 mL glass vial with
10 ¼ inch plastic balls and mixed for 60 minutes using the Turbula T-2C mixer. MgSt
samples were sieved on a Gilson Performer Model SS-3 sieve shaker for approximately
60 minutes, using ASTM sieves that range between 20 µm and 250 µm sieve sizes.
8.4.4   Dissolution

Dissolution was performed by placing each tablet in 900 mL of pH 7.2 phosphate
buffer at 37 °C using a VanKel V7000 USP method 2 dissolution apparatus (Varian,
Cary, NC). The paddles were stirred at 100 rpm. µDISS fiber optic UV probes (pION,
Billerica, MA) were used to collect data at various time points from 0 - 120 minutes and
processed using UV absorbance at 320 nm. The µDISS probes were calibrated using
indomethacin in potassium phosphate buffer. The dissolution data was processed using
the second derivative function to eliminate the effects of particles on the UV absorbance
reading.
8.4.5   Solid-state NMR Spectroscopy (SSNMR)

13

C CP/MAS and 1H T1 relaxation data were collected using a home built Tecmag

Redstone NMR Spectrometer (Houston, TX), Bruker 400 MHz magnet (Billerica, MA),
and Chemagnetics (Ft. Collins, CO) NMR probe with 7.5 mm rotors spinning at 4000 Hz.
A relaxation delay of 12 s was used with 2K acquisition points and 1024 scans. TNMR
software (Houston, TX) was used to process the data. 3-methylglutamic acid was used as
a reference standard, with the methyl peak referenced to 18.84 ppm.
8.4.6   Thermogravimetric Analysis (TGA)
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TGA weight loss was measured using TA Q50 (TA Instruments, Newcastle, DE)
with a 10 °C/minute ramp from 25 °C to 250 °C.
8.4.7   Gas Chromatography-Mass Spectroscopy (GC-MS)

MgSt samples were derivatized using a boron trifluoride-methanol procedure to
convert the acids to their methyl derivatives. An Agilent 7890A GC with 5975C Mass
Spec Component and 7693 autosampler was used with an HP-5 capillary column (30 m
0.320 mm bore 0.25 mm Film) and helium carrier gas at 0.9 mL/min flow rate. A 48-min
program was used, with an injection temperature of 270 °C. The oven temperature was
held at 70 °C for 2 min, then ramped up at 5 °C /min to 240 °C, held for 5 min, then
ramped at 10 °C /min to 260 °C and held for 5 min. Data were collected using the Agilent
ChemStation software, and was processed using OpenChrom software with the Agilent
plugin. The identity of fatty acid derivative peaks was confirmed based on MS spectra
using the NIST database.
8.4.8   Surface Area Analysis

Surface area analysis was conducted using a Micromeritics ASAP 2460 with
a Micromeritics Smart Vac Prep attachment (Micromeritics Instrumentation Corporation,
Norcross, GA, USA). A sample of about 1000 mg was dried at 40 °C and outgassed
under nitrogen flow conditions. Krypton adsorption-desorption isotherms were recorded
at liquid nitrogen temperatures (77K) and specific surface area was calculated by the
Brunauer-Emmett-Teller (BET) method. Data was analyzed using Micromeritics
MicroActive version 5.0 software.
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8.5   Results
8.5.1   Control and Reproducibility of the Dissolution Process

In order to ensure that the dissolution data could be used to discriminate between
samples, it was critical that the formulation, processing, and testing of the tablet
dissolution was both extremely reproducible and gave consistent results. We found that
the formulation mixing process and the dissolution measurement conditions were the
critical aspects of the testing process that impacted dissolution rate, as discussed in
Chapter 7. This method was used to investigate all the samples described here.
The mixing process was standardized by using an automated Turbula mixer.
Kushner and co-workers have published a comprehensive comparison of the properties of
a Turbula mixer and the formula necessary to translate results from a Turbula mixer to
larger scale mixing equipment. (54) As Kushner has noted, the Turbula mixer does not
represent the more common V-mixer blending used in many formulation labs, but it does
provide a consistent and reproducible blending process. Because the Turbula mixer is a
small-scale mixer, it likely does not produce the same shear forces as would be used on a
manufacturing scale. For this reason, a longer mixing time is required to achieve the same
shear effect with formulations containing MgSt. To accentuate differences between lots
and batches, a 60-minute mixing condition was chosen as the standard method for the
remaining dissolution studies. This is probably on the extreme edge of the Turbula
mixing reported in the Kushner paper, but was chosen to enhance differences in the
variability of the MgSt samples, and not necessarily to correlate with scale-up to larger
batches.
All of the conditions for the dissolution measurement were standardized and
found to be reproducible for replicate tablet formulations from the same lot when
processed in the same way. Figure 8-1 shows the reproducibility of dissolution data for
three commercial samples for multiple runs of the same sample. Six separate formulation
samples were prepared from each lot and 3 tablets were prepared from each formulation,
making a total of 18 tablets per lot. Our method shows RSD < 10% for replicate samples
in each lot, as indicated by the error bars. There is also significant differentiation between
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the three commercial lots presented in Figure 8-1. These three commercial samples have
differences in their physicochemical properties (hydrate form, fatty acid composition and

% Indomethacin Dissolved at 15 minutes

particle size) which may contribute to the observed differences in dissolution.(154, 157)

100
80
60

Mallinckrodt Type I (Mono, 55:45)

40

Mallinckrodt Type II (Mono, 90:10)

20

ChemImpex (Mono-Di mix,
55:35:10)

0
0:00

0:07

0:14
Time (Hour:min)

0:21

0:28

Figure 8-1. Dissolution of three commercial samples (n=18) shows reproducibility for
multiple runs of each sample. Commercial lots are from Mallinckrodt 1726, Mallinckrodt
5712 and Chem-Impex suppliers, listed from fastest to slowest dissolution.

8.5.2   Variation in Dissolution using Commercial Samples

Figure 8-2 shows the dissolution profiles for eight commercial samples, all of
which had been previously characterized in the literature, including determining the
crystalline form from the carbonyl peak in the 13C SSNMR spectrum.(48) For these
samples, our dissolution method shows a tight RSD <10% for triplicate samples, as
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indicated by the error bars in Figure 8-2. All the samples indicate > 95% dissolution in
less than 2 hours, with most of dissolution occurring within 30 minutes.

% Indomethacin Dissolved at 15 minutes

100
80
Alfa Aesar C01Y019
Alfa Aesar H03W054
Mallinckrodt 1726
Mallinckrodt 5712
Chem-Impex
Acros A0235781
MP Biomedicals
Aldrich STBC0861V
Acros A0288107

60
40
20
0
0:00

0:07

0:14
Time (Hours:mins)

0:21

0:28

Figure 8-2. Dissolution of indomethacin tablets containing MgSt from several different
commercial suppliers. Listed from fastest to slowest dissolution: Alfa Aesar Lot
C01Y019, Alfa Aesar Lot H03W054, Mallinckrodt 1726, Mallinckrodt 5712, ChemImpex, Acros Lot A0235781, MP Biomedicals, Aldrich Lot STBC0861V, Acros Lot
A0288107.

The commercial samples in Figure 8-2 were evaluated with respect to how their
physicochemical properties related to dissolution. Previous studies have suggested that
the dissolution performance may be related to different crystalline forms, chemical
composition and/or particle size. Accordingly, crystal form, fatty acid composition,
particle size, surface area and dissolution rate characterization data for these samples are
indicated in Table 8-1. For commercial MgSt samples, it can be particularly challenging
to define the properties of the sample, since the sample preparation and manufacturing
process of the samples is largely unknown, aside from what may be listed in a certificate
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of analysis from the manufacturer. In particular, the processing is unknown, including
how the materials were prepared and the extent to which the particles were milled. Both
of these types of processing can affect the dissolution.

Table 8-1. Physicochemical properties of MgSt commercial samples: Crystal form, fatty
acid composition, surface area and dissolution
Supplier  

Crystal Form  

Fatty Acid   
Surface Area
Composition   (m2/g)  

% Dissolution   
at 15 min  

Alfa Aesar   
Lot 019  

Disordered  

64:27:9  

0.77  

86.1  

Alfa Aesar   
Lot 054  

Disordered  

66:28:6  

0.89  

84.2  

Mallinckrodt    Monohydrate1726  
dihydrate  

90:10  

2.83  

78.6  

ChemImpex  

Monohydratedihydrate   

55:35:10  

3.78  

73.1  

MP
Biomedical  

Monohydratedihydrate  

58:36:6  

3.83  

72.0  

Acros   
Lot 107  

Monohydratedihydrate   

64:34:2  

3.92  

69.3  

SigmaAldrich  

Monohydratedihydrate   

63:34:3  

4.17  

71.6  

Mallinckrodt    Monohydrate  
5712  

55:45  

4.31  

75.3  

Acros   
Lot 781  

63:35:2  

6.02  

72.7  

Monohydrate  

A significant correlation between the disordered form and fast dissolution was
observed. The two lots with the fastest dissolution are from Alfa Aesar, with 84 - 86%
dissolution at 15 minutes. The Alfa Aesar lots shown in Figure 8-2 have a disordered
crystal form, and indomethacin tablets made with these MgSt samples had the fastest
dissolution. There is a large variability between the rest of the commercial samples, with
dissolution from 69 - 79% at 15 minutes. As indicated in Table 8-1, these samples are
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monohydrate and monohydrate-dihydrate mixtures by SSNMR. It is difficult to draw any
further conclusions about the relationship between MgSt crystal form and dissolution
with these commercial samples, largely because crystal form appears not to be the only
variable affecting dissolution. Fatty acid composition and surface area also need to be
investigated for correlation with dissolution rate.

8.5.3   Effect of Fatty Acid Composition on Indomethacin Tablet Dissolution
In addition to analyzing the commercial MgSt samples, and in order to better
elucidate the effects of fatty acid composition, crystalline form and particle size/surface
area on dissolution rate, additional MgSt samples were synthesized under controlled
conditions to enable better control and identification of each of these properties
individually. Table 8-2 lists these lab-synthesized samples and their properties.
Specifically, the fatty acid composition (stearate: palmitate ratio) was controlled by the
fatty acids used in synthesis and the crystal form was identified by 13C SSNMR. To
assess the influence of particle size within an individual sample, the sample was sieved
into different size sieve fractions prior to preparing the formulations. For comparison
between samples, the MgSt surface area was measured using BET adsorption analysis.
Figure 8-3 shows the % stearate for each commercial and lab-synthesized samples
plotted against % dissolution at 15 minutes. Since the USP monograph for magnesium
stearate specifies a range of acceptable fatty acid content for MgSt samples, chemical
composition was evaluated as a potential important variable affecting functional
properties such as dissolution. There does not appear to be an obvious correlation
between fatty acid composition and dissolution, especially for the samples with stearate
concentrations below 70%. In an attempt to control particle size, several lab-synthesized
samples were sieved to a 75 – 125 µm sieve fraction, shown in Figure 8-4 and listed in
Table 8-3. No correlation with fatty acid content was apparent for the commercial
samples and unprocessed lab-synthesized samples.
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The fatty acid content was measured for the commercial samples using GC-MS
analysis, and the fatty acid ratio used in synthesis was used for the lab-synthesized
samples. While fatty acid composition for the commercial samples was measured with a
GC-MS extraction method using boron trifluoride, the composition of the lab-synthesized
samples is defined from the acids used in synthesis, since the stearate and palmitate are
chemically independent molecules and do not interconvert. That is, after the synthesized
samples are prepared and dried, the fatty acid ratio is fixed for the samples. In a separate
study (data not shown), some of the lab-synthesized MgSt samples were analyzed by GCMS and found to have the same fatty acid ratio as used in preparation.

% Indomethacin Dissolved at 15 minutes

Synthesized

Commercial

100
90
80
70
60
50

40

50

60

70
% Stearate

80

90

100

Figure 8-3. Dissolution of tablet formulations as a function of chemical composition (%
stearate). Indomethacin tablet formulations were prepared containing different samples of
MgSt from either commercial or lab synthesized sources.
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Figure 8-4. Dissolution of tablet formulations containing different samples of MgSt with
75-125 µm sieve fraction, as a function of chemical composition (% stearate)

8.5.4   Effect of Crystal Form on Indomethacin Tablet Dissolution
Figure 8-5 shows the effect of crystal form on dissolution for a few dozen
commercial and lab-synthesized samples of MgSt, listed in Table 8-4. Monohydrate,
dihydrate, trihydrate and disordered forms are compared. The dissolution observed for
these lab-synthesized MgSt samples for each form is shown, ranging from 65 – 92% for
monohydrate, 73 – 90% for dihydrate, 71 – 92% for trihydrate and 75 – 89% for
disordered. Overall, it appears inconclusive that crystal form alone has a strong
correlation with dissolution.
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Figure 8-5. Comparison of tablet dissolution using different lab-synthesized crystal forms
of MgSt

8.5.5   Effect of Particle Size and Surface Area on Indomethacin Tablet Dissolution

To investigate the effect of particle size on dissolution rate, a single sample of
MgSt was sieved into different sieve fractions sizes and the dissolution rates were
measured for formulations prepared using each sieve fraction. A pure monohydrate
sample with 55:45 stearate: palmitate chemical composition, was used for this purpose.
Figure 8-6 shows the dissolution rate of indomethacin tablets prepared using various
sieve fractions. There is a clear effect of particle sieve size on dissolution rate when the
crystalline form and fatty acid composition are controlled. For example, the particle size
sieve fraction of 20-45 µm shows 67.8% dissolution at 15 minutes, where the 125-250
µm sieve fraction shows 86% dissolution at 15 minutes. As indicated by the error bars in
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Figure 8-6, there is good reproducibility in the dissolution rates between formulation

% Indomethacin Dissolved at 15 minutes

batches prepared from the same lot.

100
80
60

125-250µm
75-125µm

40

45-75µm
20-45µm

20
0
0:00

0:07

0:14

0:21

0:28

Time (Hours:Mins)
Figure 8-6. Effect of Particle Size for MgSt Monohydrate 55:45. Dissolution of
indomethacin tablet formulations using MgSt of various particle size sieve fractions.

Figure 8-6 addresses the size of MgSt particles within a sample, and surface area
was used to assess whether this trend holds between samples. Surface area was
determined to be the most relevant measure of particle size for the purposes of
dissolution, since it is the surface of the particles that is affected by the hydrophobic film
coating of MgSt around the particles. Additionally, surface area eliminates differences
based on agglomeration and particle morphology, which may differ significantly between
the monohydrate and dihydrate forms.
Figure 8-7 showed a clear relationship between tablet dissolution and MgSt
surface area for the commercial MgSt samples. A regression line drawn through the
dissolution-surface area points shows a r2 value of 0.74, as in Figure 8-8, indicating a
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possible relationship with other factors, such as crystal form. In order to discern whether
MgSt crystal form impacts dissolution rate, additional lines were drawn, separating the
points corresponding to the different crystal forms. Interestingly, the surface areadissolution relationship for the five monohydrate samples has a r2 = 0.97. To confirm the
relationships for all the forms, additional surface area-dissolution data for the different
MgSt crystal forms is needed. While surface area is clearly the primary impact on
dissolution between MgSt samples, additional studies separating out the effects of MgSt
crystal forms will confirm (or deny) the secondary impact of MgSt crystal form on
dissolution. Additional studies are needed to confirm the correlation of surface area and
dissolution with crystal form.

% Indomethacin Dissolved at 15
minutes

Disorder, commercial

Mono-Dihydrate, commercial

100
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Figure 8-7. Correlation of surface area with dissolution for formulations containing
commercial MgSt.
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Figure 8-8. Correlation of surface area with dissolution for tablet formulations containing
various samples of MgSt. Trend lines are added corresponding to the MgSt crystal forms
present in the samples.

In summary, no relationship between fatty acid composition and dissolution is
apparent. However, there does appear to be a correlation between surface area and
dissolution, with a possible secondary effect of crystal form on dissolution rates.
Additional studies are needed to confirm the correlation of surface area and dissolution
with crystal form.
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Table 8-2. List of lab-synthesized and commercial MgSt samples with physicochemical
properties, used for Dissolution – Fatty Acid graph in Figure 8.3
Form by
SSNMR
Source
NB#/Lot#
St Pa % Disso at 15min
Lab Synth
SD1-6
Trihydrate
40 60
70.9
Lab Synth
SD1-7
Di, tri
40 60
77.6
Lab Synth
CM1-71
Monohydrate
50 50
75.6
Lab Synth
BM1-20
Mono, di
55 45
83.1
Lab Synth
BM1-22
Mono, di
55 45
84.6
Lab Synth
JC3-52 melt
Mono, di
55 45
84.3
Lab Synth
JC3-58 bath
Di, tri
55 45
81.5
Lab Synth
CM1-14
Monohydrate
66 34
80.2
Lab Synth
CM1-95
Dihydrate
66 34
76.1
Lab Synth
MS1-07
Dihydrate
80 20
72.5
Lab Synth
JC3-51 melt
Di, tri
90 10
78.7
Lab Synth
JC3-56 melt
Mono, di
90 10
90.1
Lab Synth
JC4-49B
Monohydrate
90 10
64.6
Lab Synth
SD1-17
Dihydrate
90 10
87.8
Lab Synth
SD1-83 bath
Dihydrate
90 10
84.6
Commercial
Commercial
Commercial
Commercial
Commercial
Commercial
Commercial
Commercial
Commercial
Commercial

ChemImpex
Mallinckrodt 5712
MP Biomedicals
Sigma Lot
STBB0861V
Acros Lot 781
Acros Lot 107
Alfa Aesar 019
PG 315377
Alfa Aesar 054
Mallinckrodt 1726

Mono, di
Monohydrate
Di, mono

55 35
55 45
58 42

72.8
74.0
73.8

Mono, di
Monohydrate
Mono, di
Disorder
Mono, di
Disorder
Mono, di

63
63
64
64
66
66
90

70.5
71.8
69.0
86.6
62.0
85.2
78.4
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37
37
36
36
34
34
10

Table 8-3. List of lab-synthesized samples, sieved to 75 – 125 µm, with physicochemical
properties used for Figure 8.4
Form by
Source
NB#/Lot#
SSNMR
St
Pa Disso % at 15min
Commercial ChemImpex
Mono, di
55 35
72.8
Lab Synth
Monohydrate
50 50
81.3
JC3-76 75-125 µm
Lab Synth
Mono, di
50 50
77.2
JC4-45 75-125 µm
Lab Synth
JC4-47 75-125 µm
Mono, di, tri
50 50
77.2
Lab Synth
JC4-51 75-125 µm
Monohydrate
50 50
76.7
Lab Synth
JC4-53 75-125 µm
Monohydrate
50 50
77.5
Lab Synth
Monohydrate
50 50
71.3
JC4-55 75-125 µm
Lab Synth
SD1-9 75-125 µm
Trihydrate
50 50
76.6
Lab Synth
BM1-1 75-125 µm
Monohydrate
55 45
78.6
Lab Synth
BM1-10 75-125µm
Mono, di, tri
55 45
75.1
Lab Synth
BM1-19 75-125µm
Monohydrate
55 45
72.7
Lab Synth
55 45
72.0
BM1-21A 75-125µm Monohydrate
Lab Synth
BM1-21 75-125 µm
Trihydrate
55 45
83.8
Lab Synth
BM1-24 75-125µm
Mono, di
55 45
70.2
Lab Synth
BM1-25 75-125µm
Mono, tri
55 45
70.2
Lab Synth
BM1-4 75-125 µm
Monohydrate
55 45
81.1
Lab Synth
Monohydrate
55 45
91.4
BM1-6 75-125 µm
Lab Synth
JC4-37 75-125 µm
Mono, di
66 34
82.5
Lab Synth
JC4-39A 75-125 µm Dihydrate
66 34
78.7
Lab Synth
JC4-41 75-125 µm
Monohydrate
66 34
74.7
Lab Synth
JC4-43A 75-125 µm Mono, di
66 34
63.8
Lab Synth
Dihydrate
80 20
77.2
MS1-13 75-125µm
Lab Synth
SD1-23 75-125µm
Dihydrate
80 20
81.2
Lab Synth
BM1-12 75-125µm
Dihydrate
90 10
77.9
Lab Synth
BM1-15 75-125µm
Mono, di
90 10
77.0
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Table 8-4. List of Lab-synthesized MgSt samples with physicochemical properties, used
for Dissolution – Crystal Form graph
Source
NB#/Lot#
SSNMR Form
% Disso at 15min
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono
Lab synthesized mono

CM1-71
CM1-14
JC4-49B
JC3-76 75-125µm
JC4-53 75-125 µm
JC4-51 75-125 µm
JC4-55 75-125 µm
BM1-19 75-125µm
BM1-4 75-125 µm
BM1-6 75-125 µm
BM1-1 75-125 µm
JC4-41 75-125 µm
JC4-37 75-125 µm
CM1-16 < 45 µm

Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate
Monohydrate

75.6
80.2
64.6
81.3
77.5
76.7
71.3
72.7
81.1
91.4
78.6
74.7
82.5
84.0

Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate
Lab synth dihydrate

JC3-1A > 45 µm
JC3-59 bath
JC3-37A 75-125 µm
CM1-95
MS1-07
SD1-17
SD1-83 bath
NW1-33 75-125 µm
JC4-39A 75-125 µm
MS1-13 75-125 µm
SD1-23 75-125 µm
BM1-12 75-125µm
BM1-17 125-250 µm
JC4-49A1 125-250

Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate
Dihydrate

86.9
87.0
88.9
76.1
72.5
87.8
84.6
87.9
78.7
77.2
81.2
77.9
89.4
85.6

Lab synth trihydrate
Lab synth trihydrate
Lab synth trihydrate
Lab synth trihydrate
Lab synth trihydrate

JC3-6B
JC3-53AA 75-125µm
SD1-6
SD1-9 75-125 µm
BM1-21 75-125 µm

Trihydrate
Trihydrate
Trihydrate
Trihydrate
Trihydrate

92.4
75.0
70.9
76.6
83.8
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Table 8.4 continued
Lab synth Disordered
Lab synth Disordered
Lab synth Disordered
Lab synth Disordered

JC4-16A 75-125µm
JC4-14A
JC4-12A
JC4-16B 75-125µm

Disordered
Disordered
Disordered
Disordered

89.2
85.4
87.9
80.3

8.6   Discussion
8.6.1   Variability of Dissolution with Commercial MgSt Samples

The dissolution profiles of the commercial samples reported here vary from 69%
to 86% at 15 minutes. The dissolution profiles show a consistent logarithmic trend, as
opposed to a bi-exponential curve, suggesting that the samples are uniformly changed
during the preparation. Fatty acid composition did not seem to directly correlate to any
particular dissolution trend, for commercial or lab-synthesized samples. This exemplifies
one of the problems with MgSt variability, as one variable that was expected to exhibit an
influence showed no obvious trends with dissolution rate. However, MgSt particle size
and surface area did show correlations with dissolution rate. The fastest dissolving
commercial samples were the disordered samples, which have 84 - 86% dissolution at 15
minutes. The disordered samples also have a lower surface area, which is consistent with
the fast dissolution, potentially resulting from a lack of lubrication. The commercial
monohydrate lots have much slower dissolution and higher surface area. It is
hypothesized that the monohydrate form consists of MgSt agglomerates of small fines
and flakes surrounding the particles. These flakes and small fines are imagined to break
off from the larger particles to provide a hydrophobic coating to other drug and excipient
particles in the formulation and thereby slowing dissolution. The higher surface area of
the monohydrate and slower dissolution are consistent with more effective lubrication
coating of the other formulation particles by MgSt. Low surface area for the disordered
samples is consistent with fast dissolution for formulations containing MgSt which does
not coat the other formulation components as well. Similarly, the higher surface area
observed for mixtures and pure monohydrate samples is consistent with fines and flakes
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breaking off and coating the other formulation components. An implication of this is that
switching MgSt suppliers could have a very large impact on dissolution profiles,
especially if the existing supplier has MgSt that has properties that are closer to the fastdissolving profile and was switched to a supplier with MgSt properties closer to the slowdissolving profile.
The presence of significant dihydrate form in some of the commercial samples,
such as the Chem-Impex and MP Biomedicals lots, did not seem to correlate with
dissolution rates, as the MP Biomedicals sample had the greatest dihydrate concentration
but also one of the slowest dissolution profiles. However, surface area data suggests not
only a trend with dissolution, but also with hydrate form in general. It may be possible
that monohydrate-dihydrate mixtures exhibit slightly slower dissolution due to crystal
form inhomogeneity/defects which allow the particles to break apart easier, thus
providing the lubricating coating characteristic of magnesium stearate.

8.6.2   Significant Variables Impacting MgSt Performance

Clearly one of the challenges that exists with MgSt is the fact that there are
multiple variables that could impact dissolution rate, including the fatty acid composition,
crystalline form, surface area, particle size, morphology and processing. Of these
variables, surface area was clearly observed to trend with dissolution, with low surface
area samples showing fast dissolution rate. Fatty acid composition showed no clear trend
with the dissolution data for commercial or lab-synthesized samples.
In these studies, sieving was used to control particle size by selecting particle size
fractions. The process of sieving can potentially cause changes in the structure of MgSt
by reducing agglomerate size of the MgSt original particles. MgSt particles are often
agglomerates of smaller particles with an “intrinsic” particle size of < 10 µm. Sieving
may allow some of the more loosely bound particles on the surfaces of the agglomerates
to come apart from the large agglomerates. These smaller particles may be described as
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fines with < 1-2 µm size. It is believed that such small particles will more readily
participate in lubrication by coating the other particles in the formulation.
Most of our data shows a clear correlation between surface area and dissolution,
where samples prepared using smaller particle size sieved fractions of MgSt have a
slower dissolution rate. One interpretation that can be drawn is that for samples sensitive
to processing, such as the monohydrate form, smaller particles lead to slower dissolution.
Surface area results for the samples discussed here indicate a correlation between surface
area and hydrate form, as indicated in Figure 8-8. Surface area appears to be the primary
factor in determining the impact of MgSt on dissolution rate. However, the surface areadissolution curve is not perfectly linear, suggesting crystal form as a secondary variable
impacting dissolution. The surface area-dissolution curves for the different crystal forms
appear to differ and may account for the deviations from linearity in the surface areadissolution curve.

8.7   Conclusions

Several conclusions could be made about the impact of MgSt variability on
dissolution rate. First, no clear correlation could be made for the commercial samples or
lab-synthesized samples based on fatty acid composition. Second, there is a clear impact
of particle size on dissolution. Sieve fraction was used to show the particle size effect
within a sample and surface area was used to assess the effect of size differences between
samples on dissolution. Third, dissolution rate was found to trend with surface area for
both commercial and lab-synthesized MgSt samples. Finally, the surface area-dissolution
relationship may be impacted by crystal form as a secondary factor, where variation is
observed in the slopes of the surface area-dissolution lines corresponding to different
crystal forms.
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CHAPTER 9.  
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9.2   Abstract

Magnesium stearate (MgSt) is a widely used pharmaceutical lubricant in tablet
manufacturing. However, batch-to-batch variability in hydrate form and surface area can
lead to inconsistency in tablet performance. In this work, the role of solid-state form and
particle properties on lubrication efficiency, tabletability, and dissolution are studied
using a model direct compression (DC) tablet formulation. It was found that the
monohydrate and dihydrate forms had good lubrication efficiency compared to the
disordered form, but also had poorer tabletability. The dissolution rate correlated with
surface area, where monohydrate samples had high surface area and slower dissolution,
and disordered samples had low surface area and faster dissolution. Of the dihydrate
samples, a higher surface area sample had a slower dissolution rate, and a lower surface
area sample had a faster dissolution rate. The choice of the best MgSt grade depends on
the comprehensive evaluation of not only lubrication efficiency but also tabletability and
dissolution. Overall, the lower surface area dihydrate MgSt had the best performance for
this DC formulation.

9.3   Introduction

Magnesium stearate (MgSt) is the most commonly used excipient in solid oral
dosage forms, with over half of the tablet formulations on the market using it as a
lubricant. (1) The main function of MgSt is to reduce friction during the tableting process
by forming a film between the tablet and the die wall,(2) reducing the tendency of a the
active pharmaceutical ingredient (API) to stick to the tablet punch or die. However,
because of its hydrophobicity, MgSt can also significantly impact the dissolution rate of
API from tablets, especially if the amount of MgSt added is too high or the blending time
is too long. Additionally, the weak bonding strength of MgSt can reduce tablet
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mechanical strength, resulting in poor tabletability (tensile strength as a function of
compaction pressure). Hence, the use of excessive MgSt may cause unacceptably slow
API dissolution rate or poor tabletability.(16)
The popularity of MgSt as a lubricant in tablet formulation is linked to several
distinct aspects of its lubricating mechanism: a) It is characterized as a “low shear
strength laminar solid” that adheres to the lubricated surface with the polar head, with the
long hydrophobic fatty acid chains pointing outward. (49) b) It can form a lubricant film
one to two molecules thick. (2) c) It has a high melting point and is able to reduce static
charges in the formulation powder. (49, 75) d) It can fill the particle cavities and spaces
between the lubricated surfaces.(78)
The lubrication efficiency (ejection force as a function of compaction pressure)
has been shown to be affected by several factors related to MgSt: a) amount in the
formulation, (86) b) fatty acid composition, (30) c) particle size and surface area, (8, 85)
d) mixing process, (80-82, 158) e) tableting speed, and f) crystal form. (85) It is generally
accepted that higher surface area and/or smaller particle size corresponds to better
lubrication. It has also been suggested that the hydration state likely affects lubrication
properties,(84) with some sources suggesting the dihydrate form of MgSt was a better
lubricant than other forms,(9, 28, 33, 87) but more work is needed to clarify the trends for
the different crystal forms.
Because multiple factors can simultaneously affect lubrication efficiency of MgSt,
it is hard to identify a single factor that accounts for different performance among
commercial MgSt samples, (84) especially because there has been a general lack of form
control when studying lubrication efficiency. A thorough investigation of lubrication
efficiency of MgSt requires a technique capable of reliably identifying its crystal forms.
(8, 39, 43, 84, 159)
Identifying the crystal form of MgSt is challenging with traditional analytical
techniques. Thermal analyses are non-specific, which leaves room for error in assigning
crystal hydration state, particularly for a mixture of forms. When XRPD is used to
identify the crystal forms, the diffraction patterns can be hard to interpret due to the
mixtures of fatty acid salts, as well as mixtures of hydrate forms in the sample.(30)

152

We have recently shown that SSNMR can reliably characterize MgSt crystal
forms, regardless of particle size and fatty acid content.(38) SSNMR is particularly
powerful for analyzing mixtures of crystal forms of MgSt, especially because it can be
used to analyze the state of MgSt in a formulation.
In this paper, six samples of MgSt, two monohydrates, two dihydrates and two
disordered samples of MgSt were studied with respect to lubrication efficiency,
dissolution, and tabletability. In addition to crystal form, the samples also varied with
respect to surface area, fatty acid content and water content. (160) It was found that the
monohydrate and dihydrate samples had the best lubrication efficiency, but the
disordered form had the best tabletability. The dissolution rate was fastest for the low
surface area materials. The best performing MgSt sample was the dihydrate with low
surface area.

9.4   Materials and Methods
9.4.1   Materials

Magnesium hydroxide was purchased from Fluka (St. Louis, MO). Stearic acid
and palmitic acid were purchased from TCI (Tokyo, Japan). Magnesium chloride
hexahydrate was purchased from EMD (Darmstadt, Germany). Phosphate buffer was
prepared from sodium phosphate monobasic and sodium hydroxide, purchased from
BDH Analytical (Radnor, PA). Tablet excipients Avicel PH102 (microcrystalline
cellulose, MCC) and alpha-Lactose monohydrate were obtained as a complimentary
sample from FMC Biopolymer (Philadelphia, MA) and Sigma Aldrich (St. Louis, MO),
respectively. The commercial MgSt samples were ordered through VWR from Beantown
(dihydrate) and Alfa Aesar (disordered), and the Peter Greven (monohydrate) sample was
purchased in bulk by Genentech (South San Francisco, CA). The commercial and labsynthesized MgSt samples are denoted “C” and “LS”, respectively, throughout the
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manuscript. Indomethacin (Sigma Aldrich, St. Louis, MO) was used as model drug for
direct compression formulation.
9.4.2   MgSt Synthesis

Magnesium stearate lab-synthesized lots were prepared using stearate: palmitate
ratios of 55:45 for the lab-synthesized disordered sample (LS-Disordered) and 90:10 for
LS-Dihydrate and LS-Monohydrate.(38) The synthesis “melt” method for the LSDisordered material combined magnesium hydroxide and water with melted stearic and
palmitic acids at 70 - 90 °C, followed by heating/dehydrating the solid MgSt sample at
105 °C. To synthesize the 90:10 samples, a “bath method” was used, where the stearic
and palmitic acids were dissolved in water, followed by addition of ammonium
hydroxide at pH 9 to generate the ammonium soap. MgSt was then precipitated with the
slow addition of MgCl2 at 70 - 75 °C. Half of the reacted MgSt slurry was transferred to a
filter before a reflux step to remove impurities and this material was recovered as the
dihydrate form. The second half of the slurry was further heated up to 105 °C, then
filtered and refluxed, producing the monohydrate form of MgSt. The only difference
between LS-Monohydrate and LS-Dihydrate was the reaction temperature. The reflux
step for all three LS samples involved washing the recovered solids using a reflux bath of
1:1 acetone: water for 24 hours to remove impurities and unreacted starting materials.
The MgSt samples were dried in a vacuum oven at 25 °C overnight to remove surface
water.

9.4.3   Mixing and Tableting

MgSt tablet formulations were prepared by adding the MgSt sample to a “Premix”
containing 16.7% indomethacin, 50% alpha-lactose monohydrate and 33.3% Avicel
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PH102. The lab-synthesized MgSt samples were sieved to 75–125 µm sieve fraction prior
to mixing. Tablets for lubrication studies were prepared using 1% MgSt in the premix
and blended for 15 minutes, then 300 mg tablets were compacted on Presster (Presster,
Metropolitan Computing Corp., NJ) simulating Korsch XL100 press (10 stations) at a
dwell time of 50 ms using 10 mm round flat-faced tooling. Necessary parameters such as
in-die thickness, ejection force and take-off force were recorded as a function of pressure.
For dissolution studies, the powders were prepared using 2% MgSt in the premix,
then mixed as 1 g batches in 40 mL glass vials for 60 minutes using a Turbula mixer
(WAB, Basel, Switzerland) at ~ 100 rpm. Individual 150 mg tablets were made from
each 1 g formulation batch and pressed using a single tablet press (Globe Pharma, North
Brunswick, NJ) at 50 bar for 30 seconds. The tablet weights were recorded and the
dissolution results were adjusted for tablet mass. A 2% level of MgSt was used for the
dissolution studies to enhance the dissolution rate differences between samples.
9.4.4   Determination of Particle Density

The particle or true density (ρt) of formulated blends with different forms of MgSt
was determined by helium pycnometry (Quantachrome Instruments, Ultrapycnometer
1000e, Byonton Beach, Florida). 1-2 g of powder was accurately weighed and placed into
the sample cell. The measurement was allowed to repeat for a maximum of 100
iterations. The experiment was terminated when the coefficient of variation of five
consecutive measurements was below 0.005%. The mean of the last five measurements
was reported as the absolute density of the sample. The tablet porosity was obtained from
Equation 9-1 where ρ is the tablet density:
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34

155

9.4.5   Compressibility Analysis

The powder deformability of different formulations under compressive stress was
assessed by nonlinear fitting of the pressure (P) – porosity (ε) data using Kuentz –
Leuenberger equation as follows:(161)
6
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7

=>

The parameter 1/C is related to yield stress of the material where a higher 1/C value
corresponds to lower plasticity. εc denotes the porosity at which a powder bed just starts
to approach a state with mechanical rigidity.(162)

9.4.6   Diametric Tablet Strength

Tablets were broken on a texture analyzer (Texture Technologies Corp., Surrey,
UK) at 0.01 mm/s. Tablet tensile strength, σ, was calculated using Equation (3),
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  Equation 9-3

where F, D, and h are the breaking force, tablet diameter, and thickness,
respectively(163).
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9.4.7   Compactibility Analysis

Compactibility profile (σ vs. ε) of each formulation was analyzed by non-linear
regression of data using Equation (4) (84, 164).
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  Equation 9-4

where σ0 is the tensile strength of the tablet at zero porosity and b is an empirical constant
that quantifies sensitivity of σ to changes in ε.

9.4.8   In Vitro Dissolution

Dissolution was performed by suspending each tablet in 900 mL of pH 7.2
phosphate buffer on a VanKel V7000 USP method 2 (paddle type) dissolution apparatus
(Varian, Cary, NC) which was thermo-regulated at 37°C and equipped with 100 rpm
stirring speed. The µDISS fiber optic UV probes (pION, Billerica, MA) were used to
collect UV absorbance data at 320 nm over a 120-min period and the concentration of
drug in solution was calculated based on an indomethacin standard curve. The µDISS
probes were calibrated using indomethacin in phosphate buffer. The dissolution data was
processed using the second derivative function to eliminate the effects of particles on the
UV absorbance reading.
9.4.9   Solid-state NMR Spectroscopy (SSNMR)
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13

C CP/MAS and 1H T1 relaxation data were collected using a home-built

SSNMR system consisting of a Tecmag Redstone NMR Spectrometer (Houston, TX),
Bruker 400 MHz magnet (Billerica, MA), and rebuilt Chemagnetics (Ft. Collins, CO)
NMR probe with 7.5 mm rotors spinning at 4000 Hz. A relaxation delay of 12 seconds
was used with 2K acquisition points and 1024 scans. TNMR software (Houston, TX) was
used to process the data. 3-methylglutamic acid was used as a reference standard, with
the methyl peak referenced to 18.84 ppm.
9.4.10   Thermogravimetric Analysis (TGA)

TGA percent weight loss was measured using TA Q50 (TA Instruments,
Newcastle, DE) with a 10 °C/min ramp from 25 °C to 250 °C.

9.5   Results and Discussion
9.5.1   Characterization of MgSt Samples

Six MgSt samples, having a variety of physicochemical properties, were used to
study lubrication and tableting properties, as listed in Table 9-1. To evaluate the impact
of MgSt crystal form, samples of three forms (monohydrate, dihydrate and disordered)
are compared from both commercial and lab-synthesized sources. The crystal form of
MgSt is differentiated based on crystal packing differences in the carbonyl end of the
molecules, observed in the 160 - 200 ppm region of the 13C SSNMR spectrum (Figure
9-1). The monohydrate form has six signature peaks in the 177 - 183 ppm range, while
the dihydrate has two peaks between 183 - 187 ppm and the disordered form is
differentiated by a single broad peak centered around 182 ppm. Multiple peaks indicate
different possible orientations of the carbon atoms in the crystal structure, arising from
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the atoms being in different molecular environments. This is often an indication of having
more than one molecule in the crystal unit cell.(165)

LS-Disordered
C-Disordered
LS-Dihydrate
C-Dihydrate
LS-Monohydrate
C-Monohydrate

200

190

180

170

160 ppm

Figure 9-1. 13C SSNMR spectra of the three lab-synthesized (LS) and three commercial
(C) MgSt samples. Crystal form can be differentiated by the distinct peaks for
monohydrate (177-183 ppm), dihydrate (183-187 ppm) and a single broad peak for
disordered (around 182 ppm). SSNMR peaks indicate orientations of the carbon atoms in
the crystal structure.
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Table 9-1. Physicochemical characterization of lab-synthesized and commercial
monohydrate, dihydrate and disordered forms of MgSt
Source
Crystal Form
Surface area
TGA
2
m /g
% weight loss
Lab-synthesized
Monohydrate
5.6
3.1
Commercial

Monohydrate

5.8

3.0

Lab-synthesized

Dihydrate

1.2

5.5

Commercial

Dihydrate

5.5

5.4

Lab-synthesized

Disordered

0.7

0.4

Commercial

Disordered

0.8

3.3

The two monohydrate samples had 3.1 or 3.0% weight loss when heated on TGA
(Figure 9-2), consistent with the theoretical 3.0% water in the monohydrate. The 5.5 and
5.4% weight losses of the two dihydrate samples also reasonably agreed with the
theoretical 5.7% of water for MgSt dihydrate. The disordered samples, on the other hand,
showed broad weight loss from 25 - 100 °C, where the LS-Disordered and the CDisordered materials showed 0.4% and ~3.3% weight loss, respectively.

160

105

LS#Disordered+MgSt

0.3758%

3.308%

100

C#Disordered+MgSt

5.489%

Weight3(%)

95

LS#Dihydrate MgSt

5.357%

90

C#Dihydrate MgSt

3.074%

LS#Monohydrate+MgSt

2.968%

C#Monohydrate+MgSt

85

80

25

75

125

Temperature3(°C)

175

225
Universal3V4.7A3TA3

Figure 9-2. Thermogravimetric Analysis (TGA) for the three lab-synthesized (LS) and
three commercial (C) MgSt samples. The monohydrate and dihydrate weight loss agreed
with the theoretical water content.

9.5.2   Lubrication Properties

Lubrication efficiency of formulations containing various lots of MgSt in a
lactose-MCC-indomethacin mixture was assessed in terms of the ejection force (EF)
profile, i.e., EF vs. compaction pressure. EF is strongly associated with residual die-wall
pressure.(158, 162, 166) Materials with greater rigidity tend to shrink less in the radial
direction during decompression, resulting in greater residual die-wall pressure and higher
EF than elastic or plastic materials. These forces could also be influenced by particle size
and surface roughness, where EF could be higher as a result of greater friction caused by
irregular small particles sliding against the die-wall. When the contact area between
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tablet and die wall is controlled, EF is indicative of die-wall friction. In this study, EF
increased with compaction pressure (Figure 9-3). The overall lubrication efficiency
follows the order of Disordered > Monohydrate ≥ Dihydrate MgSt (Figure 9-3). The
monohydrate and dihydrate forms, irrespective of their source, showed comparable EF
profiles, hence, similar lubrication efficiency. The higher lubrication efficiency of the
monohydrate and dihydrate is consistent with their particle structures that favor easy
flaking off during mixing. Both disordered forms had higher EF, corresponding to poorer
lubrication efficiency. The much lower lubrication efficiency of the LS-Disordered
sample, indicated by the highest EF profile, corresponds to its much lower water content
(0.4 %) compared to the C-Disordered form (3.3 %). Thus, water content in disordered
MgSt may be critical for the lubrication efficiency of MgSt. The poor lubrication of the
LS-Disordered sample (0.4 %) suggests that surface bound water (as opposed to hydrate
water incorporated into the crystal lattice) could be an important factor in providing
lubrication efficiency for the disordered samples.
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Figure 9-3. Lubrication efficiency (ejection force as a function of compaction pressure)
of formulations containing different MgSt samples.

9.5.3   Effects on Tablet Compression Properties
At 1% MgSt level, the different solid-state forms of MgSt had a significant effect
on the tabletability profiles. The tablet tensile strength (σ) increased with compaction
pressure for all formulations. However, tabletability diverged with increasing pressure,
leading to large variations in σ (4 - 6 MPa) at 330 MPa (Figure 9-4). The tabletability
followed the order of LS-Disordered > C-Disordered > C-Dihydrate =LS-Dihydrate >
LS-Monohydrate > C-Monohydrate (Figure 9-4). The reduced tabletability by MgSt was
attributed to the coating of particles by the MgSt film, which leads to reduced interparticulate bonding due to the low bonding strength of MgSt. Thus, a better lubrication
efficiency is expected to be accompanied by greater reduction in tabletability for
materials that do not undergo extensive brittle fragmentation during compaction. This
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view is supported by the observation in this work, where bonding strength, σ0, which
indicates the inter-particulate bonding strength in a pore-free tablet, followed
approximately the same order as that of tabletability (Table 9-2 and Figure 9-4). The
tabletability of all the formulations was adequate despite the deteriorating effect by MgSt,
since all the formulations could form tablets with tensile strength higher than the
minimum proposed values of 2.0 MPa, and 1.7 MPa.(167-169)

Figure 9-4. Tabletability (tensile strength as a function of compaction pressure) profiles
of formulations containing different MgSt samples.
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Table 9-2. Tensile strength at zero porosity (σ0) and plasticity parameter (1/C) of tablet
formulations containing different MgSt samples. Standard errors of fitting are shown in
parenthesis.
MgSt source and form
σ0 (MPa)1
1/C (MPa)2
LS-Disordered

12.4 (0.5)

635 (107)

C-Disordered

11.8 (0.7)

661 (102)

LS-Dihydrate

8.9 (0.8)

444 (56)

C-Dihydrate

11.4 (0.7)

672 (104)

LS-Monohydrate

9.5 (0.2)

624 (105)

C-Monohydrate

8.9 (0.3)

744 (106)

According to the bonding area - bonding strength (BABS) theory, (170, 171)
another factor that controls tablet tensile strength is bonding area, which is assessed by
compressibility (porosity as a function of compaction pressure). The compressibility plots
did not visually differ among the different MgSt containing formulations (Figure 9-5),
indicating that bonding area differences did not significantly contribute to the differences
in tabletability among the formulations. The plasticity parameter, 1/C, obtained from
quantitative analysis of compressibility data using the Kuentz –Leuenberger (K-L)
method, shows the plasticity of the formulation containing LS-Dihydrate was
significantly higher (p < 0.05) than all other five formulations (Table 9-2). The 1/C
values of these five formulations were not significantly different. The K-L analysis was
shown to be superior to the commonly used Heckel analysis in assessing deformability of
diverse materials.(161) The significantly higher plasticity of the formulation containing
LS-Dihydrate suggests the LS-Dihydrate had much higher plasticity than the other
samples of MgSt.
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Figure 9-5. Compressibility profiles (porosity as a function of compaction pressure) of
formulations containing each of the six different samples of MgSt.

9.5.4   In Vitro Dissolution

The tablet dissolution of the two monohydrate MgSt formulations was slowest,
whereas dissolution from tablets using the two disordered MgSt formulations was fastest
(Figure 9-6). To accentuate the differences in dissolution between the MgSt samples, the
formulation mixtures were over-lubricated by using a 2% MgSt level and mixing the
formulations for 60 minutes with a Turbula mixer. Minimal difference was observed
between the lab-synthesized and commercial monohydrate samples, or between the labsynthesized and commercial disordered MgSt samples. However, the lab-synthesized
MgSt dihydrate had faster dissolution and the C-Dihydrate had slower dissolution (Figure
9-6). This may be attributed to the difference in their particle surface areas (Table 9-1),
where the C-Dihydrate had surface area of 5.5 m2/g, similar to surface area for the
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monohydrate samples, and the LS-Dihydrate had surface area of 1.2 m2/g, slightly higher
than surface area for the disordered samples. Dissolution showed a trend with surface
area, where monohydrate samples with high surface area had slower dissolution and
disordered samples with low surface area had faster dissolution. In terms of dissolution,
the primary factor differentiating between MgSt samples appears to be surface area. The
difference observed between the dissolution of tablets made from the two dihydrate
samples is also likely due to MgSt surface area variability, which affected the extent of
MgSt covering particle surfaces during the mixing process. MgSt with a much larger
surface area can more efficiently coat drug particles, which slows down dissolution due
to the hydrophobicity of MgSt.

Figure 9-6. Dissolution of tablets containing different lots of MgSt

The comparable lubrication properties of the two sources of monohydrate and
dihydrate MgSt (Figure 9-3), despite the very different specific surface area (Table 9-1),
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suggests that the crystalline nature of MgSt is a more important variable in determining
the lubrication efficiency than particle properties. Tabletability also suggests that the
crystal form of MgSt impacts hardness more than specific surface area or water content
(Figure 9-4). This may be explained from the mechanism of lubrication by MgSt, which
is the shearing of lamellar layers of MgSt crystals during mixing to provide a
hydrophobic coating of MgSt around the other particles in the formulation.
The formulation containing MgSt LS-Monohydrate had a lower EF profile than
the formulation containing C-Disordered MgSt, despite similar water content. Here we
note that the monohydrate has hydrated water incorporated into the crystal lattice, where
the disordered water is not bound into the crystal. Thus, the lattice water in crystalline
MgSt, rather than total water content, appears critical for good lubrication efficiency of
MgSt. However, between the two disordered samples, the one with more water
corresponded to much lower EF. This indicates the amount of non-lattice water also plays
an important role in lubrication efficiency of disordered MgSt. Therefore, the role of
water content on the lubrication efficiency of MgSt depends on the type of water in the
sample. Total water content between disordered MgSt samples is critical, but the
presence of hydrated water (i.e. crystalline MgSt hydrates) is even more important for
lubrication efficiency.
While the main functionality of MgSt is to reduce EF to facilitate tablet
manufacturing, the same mechanism of lubrication (i.e., covering of particle surfaces by
MgSt) also tends to reduce tablet tensile strength and slow dissolution. Overall, the
monohydrate form appears to be most effective in all these aspects of lubrication.
However, low tensile strength and slow dissolution are not ideal for many formulations.
The direct compression formulations in this work contained an appropriate proportion of
plastic MCC and brittle lactose to attain a balanced mechanical property. This was to
avoid the expected high sensitivity of tabletability to MgSt by a predominantly plastic
powder, and insensitivity to MgSt by a brittle powder.(163, 172). Among the six MgSt
samples evaluated in this study, LS-Dihydrate exhibited low EF, acceptable tabletability,
and fast dissolution. Thus, the LS-Dihydrate MgSt is the best lubricant for this
formulation. Although previous studies have suggested that the dihydrate performs better
than the monohydrate, the choice of optimum MgSt depends on the nature of the
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formulation that needs to be lubricated. For a formulation requiring stronger tablets and
less effect on dissolution, the disordered form of MgSt may be a better choice. Instead of
categorically claiming superiority for one type of MgSt, a comprehensive evaluation of
lubrication efficiency, tabletability, and dissolution should be performed for the
formulation, if possible.

9.6   Conclusions

Monohydrate and dihydrate forms of MgSt exhibited similar lubrication
efficiency, while disordered MgSt was less effective, presumably due to differences in
the extent of MgSt coating particle surfaces in the formulation. However, more efficient
MgSt coating also tends to decrease the tabletability of the formulation. For tabletability,
the lab-synthesized and commercial samples performed similarly for each form, with
monohydrate MgSt leading to softer tablets (lower tensile strength), followed by the
dihydrate and disordered forms. Disordered MgSt was least efficient in terms of
lubrication efficiency, but also exhibited the least effect on dissolution, consistent with a
low surface area and less effective particle coating by MgSt. These clear differences
between monohydrate, dihydrate and disordered forms suggest that the crystal form of
MgSt is an important variable in determining the lubrication properties, along with
particle size which appears to be the primary factor affecting dissolution.
Given the different performance among these MgSt solid forms, the best choice of
MgSt properties in a formulation depends on the desired formulation properties. To
obtain lower ejection force, the monohydrate or dihydrate form is preferred. However, if
the dissolution slowdown must be avoided, disordered MgSt with low surface area is
preferred. For the six samples of MgSt evaluated in this work (monohydrate, dihydrate
and disordered samples from lab-synthesized and commercial sources) with the model
direct compression formulation, the lab-synthesized dihydrate MgSt was the best
lubricant, with good lubrication efficiency and acceptable dissolution.
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CHAPTER 10.  

CONCLUSIONS

10.1   Physicochemical Properties of MgSt and their Relationships
10.1.1   Characterization of Magnesium Stearate Solid-state Properties

The solid-state characterization for eight commercial MgSt samples and five labsynthesized samples identified five different pure forms of MgSt and that 13C SSNMR
was the best technique to distinguish between the forms, particularly for mixtures of
forms. The TGA water loss dehydration peaks were used to assign the proposed
hydration states for monohydrate, dihydrate and trihydrate samples. DSC and XRPD data
were consistent with SSNMR form trends and it was possible to identify the forms for the
pure form samples. However, it is much more challenging to distinguish and/or quantify
for mixtures of MgSt forms with traditional techniques, compared with 13C SSNMR. The
additional correlation of 1H T1 relaxation values with TGA weight loss, and potentially
fatty acid composition, may provide insight into structural aspects of the various forms.
10.1.2   Fatty Acid Composition – Synthesis and Fatty Acid Effects on Crystal Form

The investigation of magnesium stearate synthesis revealed an important role of
fatty acid composition for MgSt, particularly in the relationship between fatty acid
composition and crystal form. First, the chemical composition (stearate: palmitate ratio)
and the synthesis reaction method both affect the crystal form of magnesium stearate that
is produced from synthesis reactions. Pure fatty acid compositions (i.e. stearate only or
palmitate only) showed a preference to produce the dihydrate form and mixtures of fatty
acids tended to yield more of the monohydrate form. The melt method, a spontaneous
reaction of fatty acids with magnesium hydroxide, preferentially produced the
monohydrate form, with increasing amounts of dihydrate yielded from higher stearate
content samples. The bath method, a two-step reaction precipitating MgSt from soap and

magnesium chloride, also yielded higher amounts of dihydrate form at higher stearate
content samples. Combining the observed trends with fatty acid composition and
synthesis method, it was concluded that the monohydrate form could be most easily
produced from the melt method with a 50:50 St:Pa composition and the dihydrate form
could most easily be produced from the bath method at 90:10 St:Pa composition.
Second, synthesis reaction conditions, such as reaction water and reaction
temperature, affect the form of MgSt produced. Addition of a small amount of excess
water during the melt method reaction appeared to aid formation of the monohydrate
form. The reaction temperature in the bath method was also found to affect the crystal
form produced. For a 90:10 St:Pa composition, dihydrate was yielded at 70 °C, but
monohydrate was yielded when the temperature was increased to 100 °C.
Additionally, drying magnesium stearate was found to affect the physical form of
the material, with more significant effects seen for the dihydrate and form mixtures. On a
practical level, air drying for a few days was found to be the most gentle and effective
drying method for lab-scale synthesis of MgSt. The dihydrate appears to be more
sensitive to drying than the monohydrate form, but both forms can dehydrate in harsh
drying conditions such as nitrogen drying or desiccation.
10.1.3   Crystal Form – Conditions for Form Conversions

An increased understanding of the form conversions of MgSt, both in bulk and in
tablet formulations was gained by investigating the crystal form at various storage
conditions. Thermal data was used as a guide to choose likely conversion conditions
based on the dehydration temperatures of the MgSt hydrate forms. It was shown that at
80 °C, 100 %RH, the trihydrate converts into the dihydrate and/or monohydrate form,
indicating that in the presence of excess water, the crystal form depends on temperature.
A form conversion schematic for MgSt is presented, proposing conditions for direct
conversions between MgSt crystal hydrate forms, as well as form conversions through an
intermediate disordered or anhydrous form. Tablet formulations also showed MgSt form
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conversions at 40 °C/ 75%RH, with an increase in dihydrate form, and a loss of dihydrate
form at 40 °C/ 0%RH due to likely dehydration. Overall, it is shown that the crystal form
of MgSt can change under varying temperature and humidity conditions, both in bulk and
in tablet formulations.
10.1.4   Surface Area – Effect of Drying on Crystal Form

Several conclusions can be drawn from the study of surface area and the effects of
drying on MgSt samples. First, there appeared to be a correlation between MgSt crystal
form and surface area, where the disordered form showed low surface area and the
monohydrate form showed higher surface area. Second, drying MgSt at 40 °C led to
dehydration of the material, with a decrease in surface area being accompanied by an
increase in the amount of disordered form in the sample. In dry conditions, the dihydrate
appeared to dehydrate into the disordered form and the monohydrate also changed form.
In addition to the form change with drying, dissolution showed that drying MgSt can also
have an impact on tablet performance.

10.2   Effects on Functional Properties
10.2.1   Dissolution

A discriminating dissolution method was developed to study the over-lubrication
of indomethacin tablets using various samples of MgSt. Several different factors were
explored in the method development, including mixing method, sampling technique, the
effect of MgSt concentration, compaction pressure, formulation mixing speed,
formulation mixing time, reproducibility of the overall method and differentiation
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between samples. Using this method, differences between variations in properties of
MgSt samples were addressed in Chapter 8.
Several conclusions could be made about the impact of MgSt variability on
dissolution rate. First, no clear correlation could be made for the commercial samples or
lab-synthesized samples based on fatty acid composition. Second, there is a clear impact
of particle size on dissolution, in terms of sieve fraction within a sample and surface area
between samples. Sieve fraction was used to show a clear effect particle size on
dissolution rate within a sample and surface area was used to assess the effect of size
differences between samples on dissolution. Third, a correlation between surface area and
dissolution rate was found for both commercial and lab-synthesized MgSt samples.
Additionally, the surface area-dissolution relationship may also be impacted by crystal
form as a secondary factor, where variation was observed in the slopes of the surface
area-dissolution lines corresponding to different crystal forms.
10.2.2   Lubrication

In terms of lubrication, several conclusions were made. Monohydrate and
dihydrate forms of MgSt exhibited similar lubrication efficiency, while disordered MgSt
was less effective, presumably due to differences in the extent of MgSt coating particle
surfaces in the formulation. However, more efficient MgSt coating also tended to
decrease the tabletability of the formulation. For tabletability, the lab-synthesized and
commercial samples performed similarly for each form, with monohydrate MgSt leading
to softer tablets (lower tensile strength), followed by the dihydrate and disordered forms.
Disordered MgSt was least efficient in terms of lubrication efficiency, but also exhibited
the least effect on dissolution, consistent with a low surface area and less effective
particle coating by MgSt. These clear differences between monohydrate, dihydrate and
disordered forms suggest that the crystal form of MgSt is an important variable in
determining the lubrication properties, along with particle size which appears to be the
primary factor affecting dissolution.
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Given the different performance among these MgSt solid forms, the best choice of
MgSt properties in a formulation depends on the desired formulation properties. To
obtain lower ejection force, the monohydrate or dihydrate form is preferred. However, if
the dissolution slowdown must be avoided, disordered MgSt with low surface area is
preferred. For the six samples of MgSt evaluated in this work (monohydrate, dihydrate
and disordered samples from lab-synthesized and commercial sources) with the model
direct compression formulation, the lab-synthesized dihydrate MgSt was the best
lubricant, with good lubrication efficiency and acceptable dissolution.

10.3   Overall Conclusions

Overall, this work showed that the variability in the physicochemical properties of
magnesium stearate samples can affect the dissolution and lubrication performance of
tablet formulations. A major factor in understanding this variability is the ability to
identify and track the crystal forms of MgSt. This is most easily done using 13C SSNMR,
an important analytical technique used throughout the project. The synthesis process
showed the effect of fatty acid composition and other reaction conditions on crystal form.
It was then shown that the crystal forms can interconvert based on temperature and
humidity conditions, both in bulk and in tablet formulations. A dissolution method was
developed to distinguish between MgSt samples and this method showed that the primary
property of MgSt affecting dissolution was particle size and surface area, with a possible
secondary effect of crystal form. Specifically, lower surface area correlated with faster
dissolution rates, while higher surface area correlated with slower dissolution rates. In
terms of lubrication, MgSt crystal form was found to impact lubrication efficiency and
tabletability. An overall trend with crystal form was observed, with disordered <
dihydrate ~ monohydrate in terms of lubrication efficiency but monohydrate < dihydrate
< disordered for tabletability. It has been shown that the physicochemical properties of
MgSt, particularly crystal form and surface area, show trends with functional properties
of MgSt dissolution and lubrication. This highlights the importance of choosing a MgSt
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material with the desired form and surface area properties to match the lubrication and
dissolution requirements for the formulation.
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